{
    "pages" :
    [
        {
        "key" : "adult_intubation_checklist",
        "title" : "Controlled Intubation Checklist",
        "type" : "document",
        "content" :
        [
                [
                    ["<section><left><b>Resuscitation</b>", "<width=25>"],
                    ["Hemodynamics Optimized - Hypotension + Metabolic Acidosis Addressed", "<checkbox>"]
                ],
                [
                    ["<section><left><b>Preparation</b>", "<width=25>"],
                    ["Patient Positioned - Ear to Sternal Notch, Head Up, Occiput Elevated", "<checkbox>"],
                    ["Cardiac Monitor - NIBP (q 2 minutes), SpO2, EtCO2", "<checkbox>"],
                    ["O2 Supply Sufficient", "<checkbox>"],
                    ["Preoxygenation - Mask O2 > 15 LPM + Nasal O2 15 LPM/NPPV/BVM + PEEP", "<checkbox>"],
                    ["Ducanto Suction Prepared and Tested", "<checkbox>"],
                    ["360 Degree Access if Possible", "<checkbox>"]
                ],
                [
                    ["<section><left><b>IV/IO Medications</b>", "<width=25>"],
                    ["2 IV/IOs Running Well", "<checkbox>"],
                    ["BP Cuff on Opposite Arm", "<checkbox>"],
                    ["Drug/Doses - Inducation, Paralysis, Post ETI Analgosedation", "<checkbox>"]
                ],
                [
                    ["<section><left><b>Team Brief</b>", "<width=25>"],
                    ["Airway Plan Briefed", "<checkbox>"],
                    ["MILS Assistant Briefed - Neck Stabilized, Collar Open", "<checkbox>"],
                    ["Airway Assistant Briefed - ELM/Bougie", "<checkbox>"],
                    ["Brief 30 Second Drills - Additional ELM / Extra Head Lift / Operator Position / Blade Change / Blade Deep", "<checkbox>"]
                ],
                [
                    ["<section><left><b>Equipment</b>", "<width=25>"],
                    ["Assembled BVM Kit, (ETCO2, PEEP, Manometer)", "<checkbox>"],
                    ["Standardized Airway Bag Open and Reviewed", "<checkbox>"],
                    ["PPE including mask/face sheild", "<checkbox>"],
                    ["CMAC On + Working", "<checkbox>"],
                    ["ETT", "<checkbox>"],
                    ["Syringe + Cuff Tested", "<checkbox>"],
                    ["Alternate ETT", "<checkbox>"],
                    ["Bougie", "<checkbox>"],
                    ["Hyperangulated CMAC + Stylet", "<checkbox>"],
                    ["ETT/SGA Securing Method", "<checkbox>"],
                    ["SGA", "<checkbox>"],
                    ["Cricothyrotomy Set", "<checkbox>"],
                    ["Cricothyrotomy Assessment Completed", "<checkbox>"]
                ],
                [
                    ["<left>Check complete - Anaesthetizing at ___________"],
                    ["<left><red>Press CMAC Record Button</red>"]
                ],
                [
                    ["<section><left><b>Post Intubation Checklist</b>", "<width=25>"],
                    ["ETT/SGA Placement Confirmed with ETCO2", "<checkbox>"],
                    ["ETT/SGA Secured, Depth Confirmed, Cuff Pressure 20-30 cmH20", "<checkbox>"],
                    ["Re-assess ABCs", "<checkbox>"],
                    ["CMAC Record Button Off if Not Already Done", "<checkbox>"],
                    ["Ventilator - Settings, Circuit, In-Line Suction, Filter, ETCO2", "<checkbox>"],
                    ["Analgesia + Sedation", "<checkbox>"],
                    ["HOB Raised to 30 degrees", "<checkbox>"],
                    ["NG + Foley PRN", "<checkbox>"],
                    ["Secure all Lines and Tubes", "<checkbox>"],
                    ["Rescue Airway Equipment within Reach", "<checkbox>"],
                    ["Supplies - Oxygen, Drugs, Power, Airway Bag Packed Up", "<checkbox>"]
                    
                ]
            ]
        },
        {
            "key" : "adult_sga",
            "title" :"Adult - Supraglottic Airway",
            "type" : "medical_directive",
            "indications" : "• Weight > 2 kg\n• Need for ventilatory assistance OR airway control AND\n• Other airway management is inadequate OR ineffective OR unsuccessful",
            "contraindications" : "• Intact gag reflex\n• Caustic ingestion\n• Active vomiting",
            "clinical" : "• Supraglottic airway should be the initial airway strategy in out of hospital cardiac arrest unless endotracheal intubation is deemed more appropriate by the paramedic\n• Endotracheal intubation is usually preferred for secure airway management in the non cardiac arrest patient. In this setting, SGA is considered a rescue device if BLS airway/ventilation and other advanced airway maneuvers have been unsuccessful\n• Confirm placement (EtCO2 waveform + chest rise)",
            "drug_cards" : [
            	{
                "loc" : [["pcp", "after"]],
                "title" : "<b>Supraglottic Airway</b>",
                "dose_route" : [["<center>Insert Airway\nMAX 2 attempts\n\nIf two (2) attempts at supraglottic airway have failed, then revert to BVM and oral / nasal pharyngeal airway management</center>"]]
            	}
            ]
        },
        {
            "key" : "adult_rsi",
            "title" : "Adult - Pre-Intubation and Intubation Medications",
            "type" : "medical_directive",
            "indications" : "• Intubation attempts",
            "contraindications" : "• Allergy or sensitivity to the medication\n• See specific contraindications for medications below",
            "treatment" : "It is expected that in virtually ALL circumstances the Paramedic will patch to the TMP prior to performing a Rapid Sequence Intubation or Sedation Facilitated Intubation (SFI) (see mandatory patch points below) but it is recognized that there may be rare circumstances in which a patient requires immediate intubation with sedation/dissociation and a timely patch cannot be completed. In this circumstance utilize the medication guidelines below to perform the intubation and patch as soon as possible.",
            "flowchartkeys" : [["Universal Airway Algorithm", "adult_airway_universal_algorithm" ], ["Universal Airway Continued", "adult_airway_flowchart"]],
            "clinical" : "<tab1>• RSI intubation falls under the CCP and PCCP/PCCN scope\n• If patient requires recurrent doses of phenylephrine to maintain adequate MAP consult the TMP</tab1>",
            "drug_cards" : [
                {
                    "loc" : [["acp", "after"]],
                    "section" : "Topicalize the airway",
                    "title" : "<b>Lidocaine (Xylocaine) Spray</b>",
                    "drugKey" : "lidocaine",
                    "dose_route" : [
                        ["<center>10 mg/spray onto the pharynx, hypopharynx\nMAX cumulative dose of 5 mg/kg or 400 mg</center>"]
                    ],
                    "notes" : "*Consider Lidocaine for oro-tracheal facilitated and awake intubations"
                },
                {
                    "section" : "<b>For Sedation</b>\nChoose only one sedative agent +/- analgesic\nKETAMINE IS THE PREFERRED AGENT IN THE MAJORITY OF PATIENTS",
                    "drugKey" : "ketamine",
                    "treatmentKey" : "ketamine_adult_induction",
                    "title" : "<b>Ketamine</b>"
                },
                {
                    "title" : "<b>Midazolam</b>",
                    "loc" : [["acp", "first"]],
                    "drugKey" : "midazolam",
                    "dose_route" : [
                        ["<center>0.1 mg/kg IV (to a MAX of 8 mg\ncontraindicated if MAP < 80\n<b>Titrating doses (up to the above doses) in potentially difficult airway for awake intubation (1-2 mg every 3-5 minutes)</center>"]
                    ]
                },
                {
                    "section" : "OR",
                    "title" : "<b>Etomidate</b>",
                    "drugKey" : "etomidate",
                    "loc" : [["ccp", "first"]],
                    "dose_route" : [["<center>0.2-0.3 mg/kg IV/IO</center>"]]
                },
                {
                    "section" : "OR",
                    "title" : "<b>Propofol</b>",
                    "drugKey" : "propofol",
                    "loc" : [["ccp", "first"]],
                    "dose_route" : [["<center>MAP > 100\n1.0-1.5 mg/kg IV/IO</center>"]],
                    "notes" : "CAUTION:\n• Respiratory apnea and hypotension may occur with rapid induction \n• Avoid in elderly or hypovolemia or poor cardiovascular reserve\n• Phenylephrine should be used to support BP if hypotension occurs\n• Should be avoided in hypotension with head injury"
                },
                {
                    "section" : "<b>For Analgesia</b>",
                    "title" : "<b>Fentanyl (Sublimaze)</b>",
                    "drugKey" : "fentanyl",
                    "loc" : [["acp", "first"]],
                    "dose_route" : [["<center>MAP > 80\n1-2 microgram/kg IV/IO</center>"]],
                    "notes" : "Avoid or reduced titrated dosage (25-50 microgram IV every 3-5 minutes) if elderly, decreased level of consciousness, or maximally sympathetically stimulated and poor cardiovascular reserve"
                },
                {
                    "section" : "<b>For Paralysis\nROCURONIUM IS THE PREFERRED PARALYTIC IN THE MAJORITY OF PATIENTS</b>",
                    "title" : "<b>Rocuronium (Zemuron)</b>",
                    "drugKey" : "rocuronium",
                    "loc" : [["ccp", "first"]],
                    "dose_route" : [["<center>1.2 mg/kg IV/IO</center>"]]
                },
                {
                    "title" : "<b>Succinylcholine (Anectine)</b>",
                    "drugKey" : "succinylcholine",
                    "loc" : [["ccp", "first"]],
                    "dose_route" : [["<center>1.5 mg/kg IV/IO</center>"]],
                    "notes" : "Contraindicated With:\n<tab1>• Malignant hyperthermia\n• Hyperkalemia (known or concern)\n• Myopathies/Muscular dystrophies\n• Amyotrophic Lateral Sclerosis, Multiple Sclerosis\n• Guillain-Barre Syndrome, botulism\n• Burns ≥ 2nd degree over 10% BSA > 24 hours until healed\n• Stroke with hemiparesis, spinal cord injury > 72 hours until 6 months post injury\n• Severe intra-abdominal sepsis > 72 hours until resolution</tab1>"
                },
                {
                    "section" : "Treatment of Hypotension associated with Sedation",
                    "title" : "<b>Phenylephrine (Neosynephrine)</b>",
                    "drugKey" : "phenylephrine",
                    "loc" : [["ccp", "none"]],
                    "dose_route" : [
                        ["<center><b>MAP < 65</b>\nMAP < 80 (high ICP, ischemic stroke or spinal cord injury)\n100 micrograms IV/IO q 3 minutes prn\nMAX 3 doses (300 micrograms)</center>"]
                    ]
                }
            ]
        },
        {
            "key" : "adult_tracheostomy",
            "title" : "Adult - Emergency Tracheostomy Tube Reinsertion",
            "type" : "medical_directive",
            "indications" : "<tab1>• Patient with existing tracheostomy where the inner and/or outer cannula(s) have been removed from the airway;\nAND\n• Respiratory distress\nAND\n• Inability to adequately ventilate</tab1>",
            "contraindications" : "<tab1>• Inability to landmark or visualize</tab1>",
            "flowchartkeys" : [["Tracheostomy Risk Matrix", "adult_trach_flowchart" ]],
            "clinical" : "<tab1>• Risk is much higher on reinsertion of tube into tracheostomy, cricothyrotomy, or laryngectomy site when less than 7 days since creation. Reinsertion may create a false passage with subcutaneous emphysema and fatal hypoxia due to inability to secure the airway\n• Risk is higher if tube placed for airway obstruction, difficult airway, or laryngectomy (due to inability to manage airway from above)\n• At minimum always bring a spare inner cannula which is size and type (disposable or reusable) specific for patient’s tracheostomy tube\n• At minimum, a complete spare tracheostomy tube one size smaller should be available during transport\n• Ensure tracheostomy ties are snug (i.e. can only fit two fingers between the tie and the patient’s neck) prior to transport\n• A reinsertion attempt is defined as the insertion of the cannula into the tracheostomy replacing the inner and/or outer cannula with a new one is preferred over cleaning and reusing an existing one\nNOTE: Please refer to the matrix below on the next page.</tab1>",
            "drug_cards" : [
                {
                    "title" : "<b>Consider Emergency Tracheostomy Tube Reinsertion</b>",
                    "loc" : [["pcp", "after"]],
                    "dose_route" : [
                        ["<center>The Maximum number of attempts is 2\n\nIf unable to replace, initiate BVM from above\nRequires occlusion of the stoma with palm of hand, tegaderm or occlusive dressing</center>"]
                    ]
                },
                {
                    "title" : "",
                    "loc" : [["acp", "after"]],
                    "dose_route" : [["<center>If cannot re-insert existing tracheostomy tube or re-insert an alternate tracheostomy tube\nPlace cuffed ETT 6.0 or smaller over bougie through patient stoma site\nConfirm with ETC02 and clinical indicators</center>"]]
                }
            ]
        },
        {
            "key" : "adult_bronchoconstriction",
            "title" : "Adult - Bronchoconstriction",
            "type" : "medical_directive",
            "indications" : "<tab1>• Respiratory distress AND\n• Suspected bronchoconstriction</tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication\n• Allergy to peanuts (i.e. Ipratropium Bromide (Atrovent))</tab1>",
            "flowchartkeys" : [["Bronchoconstriction Flowchart", "adult_bronchoconstriction_flowchart" ]],
            "clinical" : "<tab1>• MDI delivery systems require 45 seconds to “re-charge” between doses. Not waiting the recommended length of time between doses will result in significantly decreased amounts of medication being delivered/activation\n• In the event of a respiratory outbreak as identified by originating facility / Ornge, the MDI must be used instead of nebulization\n• Side effects of Magnesium Sulfate include hypotension; monitor BP closely</tab1>",
            "drug_cards" : [
                {
                    "section" : "<b>Bronchoconstriction - All patients</b>",
                    "drugKey" : "salbutamol",
                    "title" : "<b>Salbutamol (Ventolin) MDI (100 microgram/puff)</b>",
                    "loc" : [["pcp", "none"]],
                    "dose_route" : [
                        ["<center>8 puffs\n(45 seconds between each administration)\nmay repeat x 3 q 5-15 minutes prn</center>"]
                    ]
                },
                {
                    "title" : "<b>Salbutamol (Ventolin) Solution Via Nebulized Aerosol (2.5 mg/2.5 mL)</b>",
                    "drugKey" : "salbutamol",
                    "loc" : [["pcp", "none"]],
                    "dose_route" : [
                        ["<center>5 mg q 5-15 minutes x 3 prn</center>"]
                    ],
                    "notes" : "*Total volume of Salbutamol and Normal Saline should be 3 mL"
                },
                {
                    "title" : "<b>Ipratropium Bromide (Atrovent) MDI (20 microgram/puff)</b>",
                    "drugKey" : "ipratropium",
                    "loc" : [["acp", "none"]],
                    "dose_route" : [
                        ["<center>5 puffs\n(45 seconds between each administration)\nmay repeat x 3 every 15 minutes prn\nMAX 3 doses</center>"]
                    ]
                },
                {
                    "title" : "<b>Ipratropium Bromide (Atrovent) Solution< Via Nebulized Aerosol (250 mg/mL)</b>",
                    "drugKey" : "ipratropium",
                    "loc" : [["acp", "none"]],
                    "dose_route" : [
                        ["<center>500 micrograms q 15 minutes x 3 prn\nMAX 3 doses</center>"]
                    ],
                    "notes" : "*Total volume of Ipratropium Bromide (Atrovent) and Normal Saline should be 3 mL"
                },
                {
                    "section" : "<b>Severe Bronchoconstriction/Asthma Exacerbation</b>",
                    "title" : "<b>EPINEPHrine (Adrenalin)</b>",
                    "drugKey" : "epinephrine",
                    "loc" : [["pcp", "after"]],
                    "dose_route" : [
                        ["<center>0.01 mg/kg IM (1:1000)\nMAX 0.5 mg IM</center>"]
                    ],
                    "notes" : "Use with caution when history of coronary artery disease or stroke"
                },
                {
                    "title" : "<b>Steroids</b>",
                    "loc" : [["acp", "first"]],
                    "dose_route" : [
                        ["<center><a href=\"drugKey=methylprednisolone\">methylPREDNISolone</a> 125 mg IV/IO\nOR\n<a href=\"drugKey=dexamethasone\">Dexamethasone</a> 8 mg IM/IV/IO</center>"]
                    ]
                },
                {
                    "title" : "<b>Magnesium Sulfate</b>",
                    "drugKey" : "magnesium",
                    "loc" : [["acp", "first"]],
                    "dose_route" : [
                        ["<center>2 g (4 mL)/100 mL\nAdminister over 15 minutes</center>"]
                    ]
                },
                {
                    "title" : "<b>EPINEPHrine (Adrenalin</b>",
                    "drugKey" : "epinephrine",
                    "loc" : [["ccp", "first"]],
                    "dose_route" : [
                        ["<center>0-0.5 microgram/kg/min IV/IO</center>"]
                    ]
                }
            ]
        },
        {
            "key" : "adult_pneumothorax",
            "title" : "Adult - Tension Pneumothorax",
            "type" : "medical_directive",
            "indications" : "<tab1>• Severe respiratory distress in the setting of chest trauma with hemodynamic compromise\nAND/OR\n• Traumatic VSAs\nAND/OR\n• Severe hemodynamic compromise during positive pressure ventilation particularly in trauma or asthma or COPD patients\nAND/OR\n• Chest trauma, Severe Asthma or COPD, hemodynamic compromise <b>and</b> one or more of the following:\n</tab1><tab2>◦ Decreased/absent breath sounds on affected side\n◦ Cyanosis\n◦ JVD\n◦ Hyper resonance on affected side\n◦ Tracheal shift (late sign)</tab2>",
            "contraindications" : "• Not applicable",
            "clinical" : "<tab1>• The patient must be seen as soon as possible at an appropriate facility for the insertion of chest tube(s)\n• Consider differential diagnosis:\n</tab1><tab2>◦ Main stem intubation\n◦ Pleural effusion\n◦ Hemothorax\n◦ Consolidated pneumonia\n◦ Auto PEEP\n◦ Dynamic hyperinflation</tab2>",
            "drug_cards" : [
            {
                "title" : "",
                "loc" : [["acp", "after"]],
                "dose_route" : [
                    ["<center><b>Consider differential diagnosis and decompress if high probability of tension pneumothorax</b></center>"]
                ]
            }
          ]
        },
        {
            "key" : "adult_chest_tube",
            "title" : "Adult - Maintenance of Chest Tubes",
            "type" : "medical_directive",
            "indications" : "• Initiated by sending facility",
            "contraindications" : "• Not applicable",
            "clinical" : "<tab1>• A Heimlich flutter valve may be adequate if no drainage system has been implemented\n• Suction beyond -20 cm H2O requires patch authorization prior to transport</tab1>",
            "drug_cards" : [
            {
                "title" : "<b>Maintain chest drainage systems during call to keep the drainage system clear</b>",
                "loc" : [["acp", "none"]],
                "dose_route" : [
                    ["If the patient’s chest tube was maintained by suction at the sending facility, the Paramedic may maintain suction to no greater than -20 cm H2O", "If the patient’s chest tube was maintained by gravity drainage, the Paramedic may maintain by gravity drainage to underwater seal or to suction as per patient presentation"]
                ]
            }
           ]
        },
        {
            "key" : "adult_ventilation",
            "title" : "Adult - Initiating or Maintaining Mechanical Ventilation",
            "type" : "medical_directive",
            "indications" : "<tab1>• Need for mechanical ventilation\n• Hypoxemic respiratory failure\n• Hypercapnic respiratory failure\n• Mixed hypoxemic hypercapnic respiratory failure\n• ETI airway management for transport</tab1>",
            "contraindications" : "<tab1>• Not applicable</tab1>",
            "treatment" : "<left>All mechanically ventilated patients should be managed using standard settings with 'goal-directed ventilation orders'\n<tab1>• CCPs may initiate and maintain mechanical ventilation without patching for patients who are intubated/ventilated for airway protection/patency; or patients with mild-to-moderate respiratory failure that do not require high levels of mechanical ventilation support\n• CCPs are not required to patch if they can achieve the following:</tab1>\n<tab2>o Ventilation goals:</tab2>\n<tab3>• SpO2 94-98% (88-92% if known CO2 retainer and this is target SpO2 at sending facility)\n• ETCO2 35-45 (or 33-38 if increased ICP)</tab3>\n<tab2>o Using mechanical ventilation settings within the following safety parameters:</tab2>\n<tab3>• Vt 6-8 ml/kg IBW (target Vt must be calculated and documented in ePCR)\n• Frequency of 10-20 breaths per minute\n• FiO2 0.6 or less\n• PEEP range 5-10\n• Peak and plateau pressure less than or equal to 30 cm H20\n• I:E ratio range 1:1.5-3.0</tab3>\n<tab1>• Contraindications to CCP initiation and maintenance of mechanical ventilation without patch include:</tab1>\n<tab2>o Sending facility ventilation settings outside of safety parameters above</tab2>\n<tab3>• Exception: If FiO2 at sending facility higher than 0.6, CCP medics may attempt brief weaning trial prior to departing sending facility and if able to wean to 0.6 and achieve oxygen saturation 94-98% patch not required</tab3>\n<tab2>o Inability to maintain mechanical ventilation goals without exceeding safety parameters above\no Use of oxygenation adjuncts at sending facility such as inhaled heliox, nitric oxide, inhaled Flolan or prone positioning\no Serum bicarbonate (from ABG/VBG/electrolytes) < 15 or > 35 (need to clarify pH/ETCO2 target with TMP)</tab2>\n<tab1>• CCPs may use AC Pressure Control ventilation or Volume Control ventilation to achieve mechanical ventilation goals for patients requiring controlled ventilation with guaranteed rate/minute ventilation; for patients spontaneously breathing consider Pressure Support ventilation* (potential benefit of decreased need for sedation)\n• ACP(f)s MUST patch prior to initiating or maintaining ventilation in ALL patients.\n• All paramedics should plan to ventilate patients utilizing the treatment guidelines below.\n• When mechanical ventilation is initiated, all settings and patient’s response to treatment must be documented on the Call Report. The patient’s end tidal CO2, O2 saturation levels, RRtotal, Vt, FiO2, PEEP and PIPs must be continuously monitored and recorded</tab1>\n*<i>Pressure Support Ventilation (PSV) on the LTV 1200 is achieved by setting the ventilator to Pressure + SIMV/CPAP + Breath Rate to zero (--).</i>",
            "clinical" : "<tab1>• Not applicable</tab1>",
            "drug_cards" : [
            {
                "section" : "<b>Assessment and Preparation of the Ventilated Patient</b>",
                "title" : "",
                "loc" : [["acp", "none"]],
                "dose_route" : [
                    ["Confirm ETT placement (ETCO2 & Auscultation) and ETT depth at least 21 cm at the lips in females and 23 cm at the lips in males.\nCheck ETT cuff pressure 20-30 cm H2O.\nObtain baseline vital signs.\nChoose mode of ventilation for patient:\n<tab1>• PSV if awake & spontaneously breathing;\n• AC with either PCV or VC if inadequate respirations, heavily sedated or high ventilator settings required.</tab1>\nPerform leak test on ventilator circuit.\nCalculate and document on the call report the ideal body weight based on measured height/gender table*\n<tab1>• IBW in kg for females = 45.5 + 2.3 x [height in inches-60]\n• IBW in kg for males = 50 + 2.3 x [height in inches-60]</tab1>\nMay use measured height from sending facility to calculate if available.\nReview most recent chest film and arterial blood gas if available, and confirm ETT in good position as per sending facility CXR or sending MD or radiology report; document confirmation:\n<tab1>• If unable to confirm ETT position with CXR as above consider delay time to obtain CXR versus clinical impact to patient in delayed transport</tab1>\rDocument ETT size and depth at the lips.\rConfirm serum bicarbonate level from electrolytes, ABG or VBG (require ETCO2 target adjustment if HCO3 < 15 or > 35).\rDetermine if patient has the following:\n<tab1>• Normal lung physiology\n• COPD/Asthma\n• Lung Injury/ARDS\n• Severe Metabolic Acidosis</tab1></left>"]
                ]
            },
            {
                "section" : "<b>Initiaition/Maintenance of Ventilation-Normal Lungs</b>",
                "title" : "",
                "loc" : [["acp", "first"], ["ccp", "none"]],
                "dose_route" : [
                    ["<left>Start Assist Control\nAdjust pressure control or set volume to achieve Vt 6-8 ml/kg.\nFrequency 10-20/min to achieve ETCO2 of 35-45 mm Hg unless increased ICP= ETC02 33-38.\nInitiate FiO2 at 1.0 or match FiO2 from sending facility if available, wean FiO2 to keep SpO2 94-98%.\nMinimum PEEP of 5 for all patients, may increase up to 10 if required to match sending facility ventilator setting or to achieve O2 saturation target.\nTitrate FiO2 and PEEP to achieve O2 sat 94-98% target (88-92% if known CO2 retainer and matches target at sending facility).\nAdjust inspiratory time to achieve I:E ratio between 1:1.5 and 1:3.0 (may use longer I time to improve mean airway pressure and subsequently oxygenation, shorter I time if obstructive airway disease).\nAdjust sensitivity to trigger with respiratory effort (default is 3 lpm).\nPIP < 30 cm H20.\nPlateau < 30 cm H20.\nDeltaP (PPlat - PEEP) < 15 cm H2O\nIf already well ventilated, consider maintaining current setting.\nEnsure BVM with external PEEP valve and manometer available for duration of transport.\nTarget ETCO2 35-45 unless increased ICP + ETCO2 33-38\nTarget Vt to 6-8 mL/kg IBW.\nAdjust PSV/PCV (or set Vt in VC) to obtain Vt target. Adjust RR 10-20 to achieve target ETCO2 once target Vt obtained. NOTE: minimum PSV 8 cm H2O. Chronically ventilated patients may have PSV as low as 5/5 provided tidal volume according to IBW is maintained.\nMust maintain plateau/peak airway pressure < 30 cm H20 with adjustments.\n<left><center><b>Alarm Guidelines</b></center>\n<left>Set High pressure 5-10 cm H20 above the PIP.\nSet Low pressure alarm 5-10 cm H20 below PIP.\nSet minute ventilation alarm at 75% of actual VE."]
                ]
            },
            {
                "section" : "<b>Monitoring</b>",
                "title" : "",
                "loc" : [["acp", "blank"]],
                "dose_route" : [
                    ["<left>Record and monitor the following ventilator parameters:\n<tab1>• Target Vt/IBW\n• Pressure or Volume control\n• AC/SIMV/PSV\n• Sensitivity\n• Frequency\n• Tidal volume\n• Minute ventilation\n• PEEP\n• Pressure support\n• Inspiratory time\n• I:E ratio\n• ETCO2\n• FiO2\n• Peak Inspiratory Pressure\n• Mean Airway Pressure</tab1></left>", "<left>Monitor ETCO2 and capnographic waveforms throughout transport.\nMonitor mean arterial pressure changes related to potential ventilator changes during transport.\nConsider checking plateau pressure and/or auto PEEP if concerned about lung compliance or air trapping. NOTE: to perform either maneuver requires an apneic patient"]
                ]
            },
            {
                "section" : "<b>Cuff Pressures</b>",
                "title" : "",
                "loc" : [["acp", "none"]],
                "dose_route" : [
                    ["Maximum cuff pressure = 20-30 cm H2O\n<b>OR</b>\nMinimum Occluding Volume (MOV) - inflate until you hear no leak at PIP\nTracheal perfusion pressure =\n30mmHg (arterial) / 18mmHg (venous)\nRecommended cuff pressure is just enough to seal the trachea at PIP/MOV.\nCheck cuff pressure using a manometer. Palpating the pilot balloon is not an acceptable determination of cuff pressure."]
                ]
            },
            {
                "section" : "<b>COPD/Asthma Ventilation Strategies</b>",
                "title" : "",
                "dose_route" : [
                    ["<b>To prevent or treat autoPEEP</b>\nUse low to normal frequency (8-12 breaths/min). Titrate frequency to maximize I:E ratio > 1:4 – 1:5 allowing for long expiratory time.\nUse low tidal volume 4-6 mL/kg of ideal body weight.\nPEEP 5 cm H2O \nAdjust inspiratory time < 1.0 second (0.7-1.0).\nKeep Plateau Pressure < 30 cm H20.\nTitrate parameters to achieve Sp02 91%-94% or in keeping with patient’s baseline status.", "Severe airway obstruction may not allow complete expiration prior to the next delivered breath. Severe airway obstruction may result in PIPs > 30 cm H2O to achieve target Vt 4-6 ml/kg IBW\nIntrinsic or autoPEEP develops, leading to worsening hypoxia, hypercapnea and hypotension.\nMonitor capnographic waveform for sloped expiratory rise indicating airflow obstruction.\nConsider Salbutamol & Ipratropium Bromide via MDI."]
                ]
            },
            {
                "section" : "",
                "title" : "",
                "dose_route" : [
                    ["<b>If Difficult to ventilate or oxygenate consider:</b>\nPermissive hypercapnia\nConsider matching auto-PEEP; i.e. set PEEP to 2-3 cm H2O < then measured autoPEEP</left>", "<tab1>• Consider use of Magnesium Sulfate IV infusion\n• Consider Ketamine IV infusion\n• Consider paralysis\n• Optimize analgosedation and paralysis in combination with above therapies</tab1>"]
                ]
            },
            {
                "section" : "<b>Acute Lung Injury/ARDS Ventilation Strategies</b>",
                "title" : "",
                "dose_route" : [
                    ["Initial frequency 20-26/min. Adjust to maintain target ETCO2.\nInitial Vt 6 mL/kg. Adjust Vt based on plateau pressures:\n<tab1>• If plateau > 30 cmH20 then decrease Vt to 4-5 ml/kg\n• If plateau < 30 cmH20 then Vt may be increased to maximum 8 ml/kg</tab1>\nStart with FIO2 of 1.0 and PEEP of 5-8 cm H20<tab1>• If SpO2 >98% then decrease FIO2;\n• If SpO2 < 90% then increase PEEP to 10 and then incrementally by 2 cm H20 to maximum of 20.Refer to the ARDSnet PEEP/FiO2 table</tab1>\nCheck tidal volume with every adjustmentmadeto pressure control and PEEPsettings. Watch for drop in Vt indicating potential excessive PEEP).\nVC: Check peak/ plateau pressure with every change in PEEP and tidal volume.\nKeep plateau pressure < 30 cm H20.\nKeep Driving Pressure (DeltaP, Plat-PEEP) < 15 cm H2O\nMinimize FIO2 ideally < 0.60.\nAdjust PEEP ideally above lower inflection point and/or to achieve SpO2 > 92%.\nAllow for permissive hypercapnia.\nETCO2 45-80 mm Hg (based on ABG target pH 7.20-7.25).</left>", "<left>Inflamed lungs with decreased compliance and increased dead space are prone to atelectasis, barotrauma and volutrauma.\n<b>Do not decrease tidal volumes below 4 mL/kg</b>\nIncreased I:E ratio can improve oxygenation by increasing mean airway pressure and helping to maintain PEEP.\nI:E ratio’s < 1:2 should be considered. For example:<tab1>\n• 1:1.8\n• 1:1.6\n• 1:1.4\n• 1:1.2\n• 1:1.0</tab1></left>"]
                ]
            },
            {
                "section" : "<b>PEEP/FIO2 Table for patients with ARDS</b>",
                "title" : "<b>Simplified table (minimum target PEEP for increased FiO2)</b>",
                "dose_route" : [
                    ["FiO2", "0.3", "0.4", "0.5", "0.6", "0.7", "0.8", "0.9", "1.0"],
                    ["PEEP", "5", "5", "6", "8", "10", "12", "14", "16"]
                ],
                "notes" : "Use this table for guidance when addressing ongoing hypoxia and increasing oxygenation support, <b>do not use</b> for initial ventilator settings"
            }
           ]
        },
        {
            "key" : "adult_lvr",
            "title" : "Adult - Lung Volume Recruitment (LVR)",
            "type" : "medical_directive",
            "flowchartkeys" : [["Lung Volume Recruitment Flowchart", "adult_lvr_flowchart"]],
            "drug_cards" : [
                {
                    "title" : "",
                    "loc" : [["ccp", "first"]],
                    "dose_route" : [
                        ["<center><b>Lung Volume Recruitment (LVR)</b></center>"]
                    ]
                }
            ]
        },
        {
            "key" : "adult_nippv",
            "title" : "Adult - Non-Invasive Positive Pressure Ventilation (NPPV)",
            "type" : "medical_directive",
            "indications" : "<tab1>• Conscious patient able to protect airway in respiratory distress</tab1>",
            "contraindications" : "<tab1>• NPPV is contraindicated in patients with active vomiting and in those that are unable to manage airway secretions\n• Decreased level of consciousness/severe agitation\n• Inability to protect airway\n• Repeated hemoptysis\n• Cardiac arrest or respiratory arrest\n• Immediate need for endotracheal intubation\n• Upper airway obstruction\n• Facial trauma\n• Recent esophagostomy</tab1>\n<title>Relative Contraindications</title>\n<tab1>• Hemodynamic instability</tab1>",
            "clinical" : "<tab1>• <b>Patch first if</b> the patient has altered mentation or is lethargic\n• NIPPV may be of benefit in hypercarbia from ventilatory failure even with altered mental status\n• For agitated patients consider TMP discussion for sedation</tab1>\n<title>Understanding the numbers</title>\n<tab1>• <b>iPAP</b> = Inspiratory Positive Airway Pressure (Peak inspiratory pressure - PIP). iPAP is the sum of PEEP and PS; e.g. if the PEEP = 5 and you set a PS of 10, the resultant iPAP = 15\n• <b>ePAP</b> = Expiratory Positive Airway Pressure (PEEP)\n• <b>Pressure Support</b> = the difference between iPAP & ePAP\n• <b>CPAP</b> = when iPAP equals ePAP (example: CPAP 5=PS 0/PEEP 5)</tab1>",
            "drug_cards" : [
                {
                    "title" : "<b>Initiation of CPAP/NPPV</b>",
                    "loc" : [["acp", "after"]],
                    "dose_route" : [
                        ["<center><b>Initial Settings</b> \n iPAP 10 cmH2O/ePAP 5 cm H2O\nMAX iPAP 20 cmH2O/ePAP 10 cmH2O</center>"]
                    ]
                },
                {
                    "title" : "<b>Maintenance of NIPPV Initiated By Sending Facility</b>",
                    "loc" : [["acp", "after"], ["ccp", "none"]],
                    "dose_route" : [
                        ["<center>Patient's hemodynamics and ventilation status stable on current settings</center>"]
                    ]
                }
            ]
        },
        {
            "key" : "adult_hfnc",
            "title" : "Adult - High Flow Nasal Cannula Therapy (HFNC)",
            "type" : "medical_directive",
            "indications" : "<tab1>• Refractory hypoxemia despite optimized conventional nasal cannula and/or non-rebreather mask O2 therapy in individuals with an intact, acceptable respiratory drive\n</tab1><tab2>o Adults: SpO2 <90%</tab2><tab1>\n• COPD/CHF exacerbation requiring a minimal amount of PEEP\n• Palliative respiratory support with no endotracheal intubation or non-invasive ventilation (NIV) support in the care plan</tab1>",
            "contraindications" : "<tab1>• A definitive airway is required for airway protection and/or respiratory support characterized by acute respiratory acidosis\n• Complete nasal airway obstruction\n• Use with caution if there is a history of facial trauma, acute sinusitis or otitis\n</tab1><title>Complications</title><tab1>\n• Unmeasured PEEP may result in pneumothorax or lung hyperinflation</tab1>",
            "clinical" : "Prior to transport perform a 10 minute trial period off HFNC, using a NRB + conventional NC to determine patient tolerance when AC power is not available for HFNC; e.g. transfer between ambulance and hospital. A successful trial is confirmed by patient SpO2 > 88%. If battery power is not a concern, there is no requirement to conduct this trial.",
            "drug_cards" : [
                {
                    "title" : "",
                    "loc" : [["acp", "after"]],
                    "dose_route" : [
                        ["<center>Initiate treatment at 30 lpm and titrate flow and FiO2 to achieve SpO2 > 94%</center>"]
                    ]
                }
            ]
        },
        {
            "key" : "adult_flolan",
            "title" : "Adult - Inhaled Epoprostenol (Flolan®)",
            "type" : "medical_directive",
            "indications" : "<tab1>• Severe ARDS with refractory hypoxemia\n• Pulmonary hypertension\n• Right heart failure</tab1>",
            "contraindications" : "<tab1>• Severe left ventricular systolic dysfunction\n• Pulmonary hemorrhage\n</tab1><title>Relative Contraindications:</title><tab1>\n• Thrombocytopenia (platelets <50 x 109/L )\n• Active hemorrhage\n• Pulmonary edema\n• Hypotension</tab1>",
            "drug_cards" : [
                {
                    "title" : "<b>Inhaled Epoprostenol (Flolan®)</b>",
                    "drugKey" : "epoprostenol",
                    "loc" : [["ccp", "first"]],
                    "dose_route" : [
                        ["<center>0-50 nanograms (ng)/kg/min nebulized*\n(*FIXED RATE - SHOULD NOT be titrated during transport)</center>"]
                    ]
                }
            ]
        },
        {
            "key" : "adult_prone",
            "title" : "Adult - Transport of Patients in the Prone Position",
            "type" : "medical_directive",
            "indications" : "<tab1>• Severe ARDS (P:F < 150), FiO2 > 0.6, and PEEP > 5 cmH2O with failed supine ventilation</tab1>\n<title>General Principles:</title>\n<tab1>• Mechanically ventilate as per Ornge Clinical Practice Guidelines for ARDS\n• Maintain Sedation and Analgesia as per Ornge Sedation and Pain Management of Ventilated Patients Guidelines to target a sedation score of -4 (i.e., deep sedation)\n• Maintain paralysis during transport (see below)</tab1>",
            "clinical" : "<title>Cardiac Arrest in Prone Position</title><tab1>\n• In the event of cardiac arrest, if the rhythm is shockable, defibrillation should be initiated immediately. Ensure defibrillation pads are applied in an anterior-posterior orientation prior to initiating transport.\n• CPR will not be performed in the prone position and the paramedic team should not attempt to return the patient supine to do chest compressions.\n• The decision of transporting a prone patient will be made in conjunction with the TMP, sending physician, and/or receiving physician and the best attempt made to inform the substitute decision maker of the risks and limitations of the transport.</tab1>",
            "drug_cards" : [
                {
                    "section" : "<b>Prone Transfer:</b>",
                    "title" : "<b>Transport of Patients in Prone Positioning</b>",
                    "loc" : [["ccp", "first"]],
                    "dose_route" : [
                        ["<center>Follow Prone-to-Prone Transfer Process as outlined in the Prone Ventilation Operational and Clinical Guidelines</center>"]
                    ]
                },
                {
                    "section" : "<b>Prone Transfer:</b>",
                    "drug_key" : "rocuronium",
                    "title" : "<b>Rocuronium</b>",
                    "loc" : [["ccp", "none"]],
                    "dose_route" : [
                        ["<center>0.6 mg/kg IV to initiate paralysis\nThen\n0.3 mg/kg IV q 20 minutes\nAND/OR\n10-15 microgram/kg/min to maintain paralysis</center>"]
                    ]
                },
                {
                    "section" : "OR",
                    "drug_key" : "cisatracurium",
                    "title" : "<b>Cisatracurium</b>",
                    "loc" : [["ccp", "none"]],
                    "dose_route" : [
                        ["<center>0.1-0.2 mg/kg IV to initiate paralysis then 0.03 mg/kg IV q 30 minutes\nAND/OR\n1-10 microgram/kg/min to maintain paralysis (usual starting dose 3 microgram/kg/min after initiating paralysis</center>"]
                    ]
                }
            ]
        },
        {
            "key" : "adult_anxiety",
            "title" : "Adult - Pre-Transfer Anxiolysis",
            "type" : "medical_directive",
            "indications" : "For a patient demonstrating or verbalizing the symptoms of transfer anxiety and:\n<tab1>• GCS of 15\n• MAP ≥ 70 mmHg\n• No concurrent sedation or parenteral analgesia being administered</tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication</tab1>",
            "clinical" : "<tab1>• Not applicable</tab1>",
            "drug_cards" : [
                {
                    "title" : "<b>LORazepam (Ativan)</b>",
                    "drugKey" : "lorazepam",
                    "loc" : [["acp", "none"]],
                    "dose_route" : [
                        ["<center>1 mg PO/SL\nMAX dose 1 mg</center>"]
                    ]
                }
            ]
        },
        {
            "key" : "adult_combative",
            "title" : "Adult - Agitated/Combative Patient",
            "type" : "medical_directive",
            "indications" : "<tab1>• In the event that a patient becomes agitated or combative, thereby endangering themselves or crew, ALL Paramedics are expected to: <u>Physically restrain the patient as per MOHLTC Basic Life Support - Patient Care Standards</u>\n• Assess the patient for medical causes of agitation (i.e. hypoxemia, hypoglycemia, etc.)</tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication</tab1>",
            "clinical" : "<tab1>• In patients with a primary psychiatric diagnosis, if time permits, contact TMP for Haloperidol (Haldol TM)\n• Notify the Flight Crew immediately if in an aircraft</tab1>",
            "drug_cards" : [
                {
                    "section" : "<b>Mild-Moderate Agitation</b>",
                    "title" : "<b>Midazolam (Versed)</b>",
                    "drugKey" : "midazolam",
                    "loc" : [["acp", "after"]],
                    "dose_route" : [
                        ["<center>MAP > 70\n0.05 mg/kg IV/IO\n<b>OR</b>\n0.1 mg/kg IM q 5 minutes prn\nMAX dose 0.2 mg/kg IV/IM/IO</center>"]
                    ]
                },
                {
                    "section" : "<b>Severe Agitation/Combativeness</b>",
                    "title" : "<b>Ketamine</b>",
                    "drugKey" : "ketamine",
                    "loc" : [["acp", "after"]],
                    "dose_route" : [
                        ["<center>1-2 mg/kg IV/IO*over 1-3 minutes\n<b>OR<\b>\n3-5 mg/kg IM</center>"]
                    ],
                    "notes" : "*High IV doses of Ketamine should be given slow push (over > 1 minute) to reduce risk of apnea\n<b>*Consider administering using a 50 ml NS bag over 5-10 minutes</b>"
                },
                {
                    "section" : "<b>Primary psychiatric diagnosis</b>",
                    "title" : "<b>Haloperidol (Haldol)</b>",
                    "drugKey" : "haloperidol",
                    "loc" : [["acp", "first"]],
                    "dose_route" : [
                        ["<center>2.5 mg - 5.0 mg IV every 5-10 minutes\nto a Maximum of 30 mg\n or\n10 mg of Haloperidol IM\n(repeat, if required, x1 and patch with TMP)</center>"]
                    ],
                    "notes" : "NOTE: In patients > 65 years of age, start with 2.5 mg"
                }
            ]
        },
        {
            "key" : "adult_awake_analgesia",
            "title" : "Adult - Analgesia: Moderate to Severe Pain",
            "type" : "medical_directive",
            "indications" : "All patients should be assessed fro level of pain using a 10 point scale\n(0 = no pain while 10 = maximum pain)\n\n<i>At least two scores should be documented on all patients and a score must be documented before and after analgesia is provided to the patient</i>",
            "contraindications" : "Allergy or sensitivity to the medication",
            "treatment" : "Patch when maximum amount given or for any other concerns",
            "clinical" : "<tab1>• Total acetaminophen dose is not to exceed the lesser of a total of 75 mg/kg or 4 grams in 24 hours\n• Ketamine for analgesia should be administered slowly using a mini bag or slow IVP if necessary. Adverse events are reduced substantially (46% vs 17%) if given slowly vs IVP.<tab1>",
            "drug_cards" : [
                {
                    "title" : "<b>Ibuprofen (Advil)</b>",
                    "loc" : [["pcp", "none"]],
                    "drugKey" : "ibuprofen",
                    "dose_route" : [
                        ["<center>Contraindication: Impaired renal function, active bleeding, NSAID in the past 4-6 hours</center>"],
                        ["<center><b>≥ 12 years</b>\n400 mg PO</center>"]
                    ]
                },
                {
                    "title" : "<b>Acetaminophen (Tylenol)</b>",
                    "drugKey" : "acetaminophen",
                    "loc" : [["pcp", "none"]],
                    "dose_route" : [
                        ["<center>Contraindication: Acetaminophen within the last 4 hours</center>"],
                        ["<center><b>40 to 60 kg</b>\n15 mg/kg PO/PR q 4 hours prn\n\n<b>≥ 60 kg</b>\n975-1000 mg PO/PR q 4 hours prn\nMAX 75 mg/kg OR 4 grams in 24 hours</center>"]
                    ]
                },
                {
                    "title" : "<b>Toradol (Ketorolac)</b>",
                    "loc" : [["pcp", "none"]],
                    "drugKey" : "ketorolac",
                    "dose_route" : [
                        ["<center>Contraindication: Impaired renal function, active bleeding, NSAID in the past 4-6 hours</center>"],
                        ["<center><b>≥ 12 years</b>\n15 mg IM</center>"]
                    ]
                },
                {
                    "title" : "<b>Toradol (Ketorolac)</b>",
                    "loc" : [["acp", "none"]],
                    "drugKey" : "ketorolac",
                    "dose_route" : [
                        ["<center>Contraindication: Impaired renal function, active bleeding, NSAID in the past 4-6 hours</center>"],
                        ["<center><b>≥ 12 years</b>\n15 mg IV/IM</center>"]
                    ]
                },
                {
                    "section" : "fentaNYL or Morphine or Ketamine",
                    "title" : "<b>fentaNYL (Sublimaze)</b>",
                    "drugKey" : "fentanyl",
                    "loc" : [["acp", "none"]],
                    "dose_route" : [
                        ["<center><b>MAP > 70</b>\nMAP > 80 (high ICP, ischemic stroke or spinal cord injury)\n\n25-50 microgram IV/IO q 10 minutes prn\nMAX 300 microgram</center>"]
                    ]
                },
                {
                    "section" : "OR",
                    "title" : "<b>Morphine</b>",
                    "drugKey" : "morphine",
                    "loc" : [["acp", "none"]],
                    "dose_route" : [
                        [ "<center><b>MAP > 70</b>\nMAP > 80 (high ICP, ischemic stroke or spinal cord injury)\n\n2-4 mg IV/IO q 20 minutes prn\nMAX 10 mg</center>" ]
                    ]
                },
                {
                    "section" : "OR",
                    "title" : "<b>Ketamine</b>",
                    "drugKey" : "ketamine",
                    "loc" : [["acp", "after"]],
                    "dose_route" : [
                        ["<center>Ketamine is <u>not</u> a first line agent for analgesia in normotensive patients but can be considered early for multiple trauma patients or those with concerning hemodynamic status</center>", "<center>0.1 mg/kg IV/IO q 5 minutes PRN\nMAX total dose 0.5 mg/kg\nMAP > 60</center>"]
                    ]
                }
            ]
        },
        {
            "key" : "adult_pain_scale",
            "title" : "Pain Scale For Adult Intubated Patients",
            "type" : "document",
            "content" :
            [
                [
                    ["<section><b>Facial Expression</b>"]
                ],
                [
                    ["<section>Description<width=200>", "Score<width=80>", "<width=20>", "<width=20>"],
                    ["No muscular tension observed", "Balanced, neutral", "0", "<checkbox>"],
                    ["Presence of frowning, brow lowering, orbit tightening and levator contraction", "Tense", "1", "<checkbox>"],
                    ["All of the facial movements plus eyelid tightly closed", "Grimacing", "2", "<checkbox>"]
                ],
                [
                    ["<section><b>Body Movements</b>"]
                ],
                [
                    ["<section>Description<width=200>", "Score<width=80>", "<width=20>", "<width=20>"],
                    ["Does not move at all (does not necessarily mean absence of pain)", "Absence of movements", "0", "<checkbox>"],
                    ["Slow, cautious movements, touching or rubbing the pain site, seeking attention through movements", "Protection", "1", "<checkbox>"],
                    ["Pulling tube, attempting to sit up, moving limbs/thrashing, not following commands, striking at staff, trying to climb out of bed", "Restlessness", "2", "<checkbox>"]
                ],
                [
                    ["<section><b>Muscle tension: Evaluated by passive flexion and extension of upper extremities</b>"]
                ],
                [
                    ["<section>Description<width=200>", "Score<width=80>", "<width=20>", "<width=20>"],
                    ["No resistance to passive movements", "Relaxed", "0", "<checkbox>"],
                    ["Resistance to passive movements", "Tense, rigid", "1", "<checkbox>"],
                    ["Strong resistance to passive movements, inability to complete them", "Very tense or rigid", "2", "<checkbox>"]
                ],
                [
                    ["<section><b>Compliance with the ventilator (intubated patients)\nOR\nVocalization (extubated patients)</b>"]
                ],
                [
                    ["<section>Description<width=200>", "Score<width=80>", "<width=20>", "<width=20>"],
                    ["<b>Intubated patients</b>"],
                    ["Alarms not activated, easy ventilation", "Tolerating ventilator or movement", "0", "<checkbox>"],
                    ["Alarms stop spontaneously", "Coughing but tolerating", "1", "<checkbox>"],
                    ["Asynchrony: blocking ventilation, alarms frequently activated", "Fighting ventilator", "2", "<checkbox>"],
                    ["<b>Extubated patients</b>"],
                    ["Talking in normal tone or no sound", "Talking in normal tone or no sound", "0", "<checkbox>"],
                    ["Sighing, moaning", "Sighing, moaning", "1", "<checkbox>"],
                    ["Crying out, sobbing", "Crying out, sobbing", "2", "<checkbox>"]
                ],
                [
                    ["Total range", "<width=60>0-8"]
                ]
            ]
        },
        {
            "key" : "adult_sedation_scale",
            "title" : "Sedation Scale For Adults (RASS Score)",
            "type" : "document",
            "content" :
            [
                [
                    ["<section><section_width=750><width=40><b>Score</b>", "<width=75><b>Name</b>", "<b>General</b>", "<b>Ventilator Reaction</b>", "<b>ETT Suction Reaction</b>", "<b>Paralyzed Reaction</b>"],
                    ["+4", "Combative", "Danger to staff", "Can't ventilate", "Can't ventilate", "At rest, pupils dilated, ↑↑HR or ↑↑BP"],
                    ["+3", "Very Agitated", "Requires restraints", "Pulls/removes lines, tubes", "Pulls/removes lines, tubes", "At rest, pupils dilated, ↑↑HR or ↑↑BP"],
                    ["+2", "Agitated", "Can be calmed", "Bites ETT, dyssynchrony", "Bites ETT, dyssynchrony", "At rest, pupils dilated, ↑↑HR or ↑↑BP"],
                    ["+1", "Restless", "Apprehensive", "Mild distress", "Prolonged coughing", "At rest, pupils dilated, ↑↑HR or ↑↑BP"],
                    ["0", "Alert, calm", "Awakens easily", "Tolerating ventilator mostly; needs sedation and analgesia when stimulated and moved", "Discomfort, moderate distress, coughing", "At rest, pupils dilated, ↑↑HR or ↑↑BP"],
                    ["-1", "Drowsy", "Wakes > 10s; Follows commands", "Tolerating ventilator mostly; needs sedation and analgesia when stimulated and moved", "Discomfort, moderate distress, coughing", "At rest, pupils dilated, ↑↑HR or ↑↑BP"],
                    ["-2", "Light Sedation", "Wakes < 10s; Eye contact; Simple commands only", "Tolerating ventilator mostly; needs sedation and analgesia when stimulated and moved", "Reaches for ETT, mild distress, coughing", "At rest, pupils dilated, ↑↑HR or ↑↑BP"],
                    ["-3", "Moderate Sedation", "Moves to voice; no eye contact", "Coughing when moved but tolerates ventilation otherwise", "Coughs, mild distress, rapid recovery", "Pupils dilated, ↑↑HR or ↑↑BP with external stimulation (1)"],
                    ["-4", "Deep Sedation", "No response to voice; Moves spontaneously and to physical stimuli", "Tolerates movement well on ventilator", "Coughs, not distressed, eyes closed", "Minimal or no reaction (pupils, HR, BP) with stimulation (1)"],
                    ["-5", "Unarousable", "Minimal or no response to voice or noxious stimuli", "Minimal or no response to ventilator", "No cough, minimal response", "Minimal or no reaction (pupils, HR, BP) with stimulation (1)"]
                ]
            ]
        },
        {
            "key" : "adult_intubated_analgesia",
            "title" : "Adult - Sedation and Pain Management for Intubated and Ventilated Patients",
            "type" : "medical_directive",
            "flowchartkeys" : [["Pain Score", "adult_pain_score_chart"],["Sedation Score", "adult_sedation_score"]],
            "indications" : "<tab1>• When a patient is clinically stable, intubated and mechanically or manually ventilated, the ACP(f), and CCP may administer the following for sedation and analgesia</tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication</tab1>",
            "treatment" : "Infusions are preferred to repeat bolus dosing for sedation and analgesia wherever possible. A bolus dose of sedation or analgesia should only be considered when infusion dosing is increased and rapid therapeutic effect is required. Caution should be used with bolus dosing as this may increase the risk of sedation induced hypotension. All mechanically ventilated patients should receive analgesia with either Ketamine or FentaNYL.<b>ACP(f), CCP, PCCP and PCCN may choose and give ONE analgesic along with ONE of the following sedative agents;</b> patch when maximum amount given, or for any other concerns",
            "clinical" : "<tab1>• <u>All patients</u> (intubated or non-Intubated) receiving analgosedation must be constantly monitored using a continuous ETCO2 gas-sampling device that displays both a value and waveform, and have sedation and pain score documented q 30 minutes throughout transport\n• For recurrent hypotension requiring intervention TMP contact is recommended</tab1>",
            "drug_cards" : [
	            {
	                "section" : "<b>For Analgesia</b>",
	                "title" : "<b>fentaNYL (Sublimaze) if MAP > 70</b>\n(MAP > 80 if high ICP, ischemic stroke or spinal cord injury)",
                    "drugKey" : "fentanyl",
	                "loc" : [["acp", "after"], ["ccp", "none"]],
	                "dose_route" : [
	                    ["<center>50-100 microgram IV/IM prn q 5 minutes\nMaximum cumulative dose for the boluses as above cannot exceed 3 microgram/kg/hr</center>", "<center>Initiate IV infusion 1-3 microgram/kg/hr</center>"]
	                ]
	            },
                {
                    "section" : "<b>For Sedation</b>",
                    "title" : "<b>Midazolam (Versed) if MAP > 70</b>\n(MAP > 80 if high ICP, ischemic stroke or spinal cord injury)",
                    "drugKey" : "midazolam",
                    "loc" : [["acp", "after"], ["ccp", "none"]],
                    "dose_route" : [
                        ["<center>1-2 mg IV prn q 5 minutes\nMAX dose 0.15 mg/kg/hr</center>", "<center>Initiate IV infusion\n0.05-0.15 mg/kg/hr</center>"]
                    ]
                },
                {
                    "section" : "OR",
                    "title" : "<b>Propofol (Diprivan) if MAP > 70\n**Caution in elderly patients **</b>\n(MAP > 80 if high ICP, ischemic stroke or spinal cord injury)",
                    "drugKey" : "propofol",
                    "loc" : [["ccp", "none"]],
                    "dose_route" : [
                        ["<b><center>Bolus</center></b>", "<center>Titration of the infusion is preferred however, may give additional boluses of\n10-20 mg IV q 5 minutes prn if rapid effect is required, and as long as\nMAP > 70 mmHg\n<red>Exercise caution as bolus doses increase risk of hypotension</red></center>"],
                        ["<b><center>Infusion</center></b>", "<center><b>Titration of the infusion is preferred</b>\n1-5 mg/kg/hr\nTitrate in increments of 0.3 mg/kg/hr q 5 minutes\nprn if MAP > 70</center>"]
                    ]
                },
                {
                    "section" : "OR",
                    "title" : "<b>Ketamine if MAP > 60\n(if MAP < 60 Mandatory patch*)</b>\n(MAP > 80 if high ICP, ischemic stroke or spinal cord injury)",
                    "drugKey" : "ketamine",
                    "loc" : [["acp", "after"], ["ccp", "none"]],
                    "dose_route" : [
                        ["<center>1-2 mg/kg IV over 1 minute x 1 dose\nfollowed by 0.5 mg/kg q 20 minutes prn</center>", "<center>Continuous IV infusion of 0.3 to 2.0 mg/kg/hr</center>"]
                    ],
                    "notes" : "*If MAP < 50 patch to consider other therapies"
                },
                {
                    "section" : "<b>Treatment of Hypotension associated with Sedation</b>",
                    "title" : "<b>Phenylephrine (Neosynephrine)</b>",
                    "drugKey" : "phenylephrine",
                    "loc" : [["ccp", "none"]],
                    "dose_route" : [
                        ["<center><b>MAP < 65</b>\nMAP < 80 (high ICP, ischemic stroke or\n spinal cord injury)\n100 microgram IV/IO X 3 q 3 minutes prn\nMAX 300 microgram</center>"]
                    ]
                },
                {
                    "title" : "<b>Norepinephrine (Levophed)</b>",
                    "drugKey" : "norepinephrine",
                    "loc" : [["acp", "after"], ["ccp", "none"]],
                    "dose_route" : [
                        ["<center>0-0.5 microgram/kg/min IV/IO\nTarget MAP > 65</center>"]
                    ]
                }
            ]
        },
        {
            "key" : "adult_paralysis",
            "title" : "Adult - Post Intubation Paralysis",
            "type" : "medical_directive",
            "indications" : "<tab1>• Patients with known difficult airways\n• Facilitate and optimize mechanical ventilation and oxygenation for transport\n• <b>Sedation and Analgesia must be administered in conjunction with muscle relaxation</b></tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication\n• Inadequate sedation/analgesia</tab1>",
            "clinical" : "<tab1>• In patients with known difficult airways, muscle relaxation is strongly recommended post intubation to ensure minimal risk for loss of ETT in transport\n• Complete history and physical examination (including baseline neurologic assessment) must be completed\n• Baseline assessment of vital signs and level of paralysis should be obtained and documented to detect and record the patient’s subsequent response to paralysis\n• Muscle relaxants will hide the motor component of seizures. In cases of status epilepticus or risk of seizures, use paralysis as a last resort and in conjunction with anticonvulsant/sedative infusions. Monitor for autonomic manifestations of seizures\n• Proper securing of the ETT is paramount</tab1>",
            "drug_cards" : [
                {
                    "title" : "<b>Rocuronium (Zemuron)</b>",
                    "drugKey" : "rocuronium",
                    "loc" : [["acp", "after"]],
                    "dose_route" : [["0.6 mg/kg IV/IO\nthen\n0.3 mg/kg IV/IO q 20 minutes prn"]]
                }
            ]
        },
        {
            "key" : "adult_medical_arrest",
            "title" : "Adult - Non-Traumatic Cardiac Arrest",
            "type" : "medical_directive",
            "flowchartkeys" : [["Non-Traumatic Arrest Flowchart", "adult_non_traumatic_arrest_flowchart"]],
            "indications" : "<tab1>• Adult patient is vital signs absent (VSA) due to non-traumatic cause</tab1>",
            "contraindications" : "<tab1>• Not applicable</tab1>",
            "clinical" : "<tab1>• PCP(f) may apply the Medical Directives for the management of cardiac arrest with semi-automated defibrillation\n• TMP patch prior to initiating transport of patient in cardiac arrest for consideration of TOR</tab1>",
            "drug_cards" : [
                {
                    "title" : "",
                    "loc" : [["pcp", "after"]],
                    "dose_route" : [["<center><b>Initiate the appropriate algorithm based upon the presenting ECG rhythm</b></center>"]]
                },
                {
                    "title" : "",
                    "loc" : [["acp", "after"]],
                    "dose_route" : [["<center><b>Initiate the appropriate algorithm based upon the presenting ECG rhythm</b></center>"]]
                },
                {
                    "title" : "",
                    "loc" : [["nil", "nil"]],
                    "dose_route" : [
                        ["<center><b>Shock</b></center>", "<center><b>Zoll X-Adult manual & SAED settings</b></center>"],
                        ["Shock #1", "<center>120J</center>"],
                        ["Shock #2", "<center>150J</center>"],
                        ["Shock #3 and all subsequent shocks", "<center>200J</center>"]
                    ]
                }
            ]
        },
        {
            "key" : "adult_hypothermic_arrest",
            "title" : "Adult - Severe Hypothermic Arrest",
            "type" : "medical_directive",
            "flowchartkeys" : [["Hypothermic Arrest Flowchart", "adult_hypothermic_arrest_flowchart"]],
            "indications" : "<tab1>Adult patient to be vital signs absent (VSA) and Hypothermic defined as temperature < 30°C, or presumed to be so based on environmental circumstances.</tab1>",
            "contraindications" : "<tab1>• Not applicable</tab1>",
            "clinical" : "<tab1>• Not applicable</tab1>",
            "drug_cards" : [
                {
                    "title" : "",
                    "loc" : [["pcp", "after"]],
                    "dose_route" : [["<center><b>Initiate the appropriate algorithm based upon the presenting ECG rhythm</b></center>"]]
                }
            ]
        },
        {
            "key" : "adult_rosc",
            "title" : "Adult - Post Arrest Return of Spontaneous Circulation (ROSC)",
            "type" : "medical_directive",
            "flowchartkeys" : [["ROSC Flowchart", "adult_rosc"]],
            "indications" : "<tab1>• ROSC</tab1>",
            "contraindications" : "<tab1>• Not applicable</tab1>",
            "clinical" : "<tab1>• Reminder that Targeted Temperature Management (TTM) is Mandatory. Temperatures should be maintained between 34°C and 36°C during TTM\n• Document attempts to control temperature\n• Maintain temperature 34-36°C, ETC02 35-40 mmHg, SpO2 94-98%</tab1>",
            "drug_cards" : [
                {
                    "title" : "",
                    "loc" : [["acp", "after"]],
                    "dose_route" : [["<center><b>Initiate the appropriate algorithm based upon the presenting ECG rhythm</b></center>"]]
                }
            ]
        },
        {
            "key" : "adult_acs",
            "title" : "Adult - Acute Coronary Syndrome",
            "type" : "medical_directive",
            "flowchartkeys" : [["ACS Flowchart", "adult_acs_flowchart"]],
            "indications" : "<tab1>• Suspected cardiac ischemia</tab1>\n<title>Conditions for Nitroglycerin Administration</title>\n<tab1>• Patient is ≥ 40 kg\n• MAP ≥ 70 mmHg\n• Heart rate is > 60 beats and < 160 bpm\n• Patient is alert\n• Patients under the age of 18 requires a TMP patch</tab1>\n<title>Contraindications for Nitroglycerin Administration</title>\n<tab1>• Allergy or sensitivity to nitrates\n• Patient has used any phosphodiesterase-5 inhibitors (Sildenafil [Viagra or Revatio], tadalafil [Cialis], or Vardenafil [Levitra]) in the last 48 hours (these agents are commonly used for erectile dysfunction and are also used in pulmonary hypertension)\n• 12 lead ECG compatible with Right Ventricular MI</tab1>",
            "clinical" : "<tab1>• In the setting of acute coronary syndrome fentaNYL is the preferred analgesic\n• Consider Plavix in NSTEMI patients\n• Patch if PTT parameters (above) fall outside norm</tab1>",
            "drug_cards" : [
                {
                    "title" : "<b>Nitroglycerin SL *</b>",
                    "drugKey" : "nitroglycerin",
                    "loc" : [["pcp", "none"]],
                    "dose_route" : [["<center><b>MAP >70</b>\n0.4 mg SL spray q 5 minutes MAX of 6 doses</center>"]],
                    "notes" : "*Single PCP(f): Initiate then patch"
                },
                {
                    "title" : "<b>Initiate Nitroglycerin IV\nMAP > 70</b>",
                    "drugKey" : "nitroglycerin",
                    "loc" : [["acp", "after"]],
                    "dose_route" : [["<center>10 microgram/min\nMAX 100 microgram/min\nTitrate q 5 minutes in 5 microgram/min increments for ischemic chest pain\nMaintain Nitroglycerin infusion during transport</center>"]]
                },
                {
                    "title" : "<b>Maintain Nitroglycerin IV</b>",
                    "drugKey" : "nitroglycerin",
                    "loc" : [["acp", "after"], ["ccp", "none"]],
                    "dose_route" : [["<center>Maintain nitroglycerin infusion during transport under conditions listed below\n• The infusion was initiated by the sending facility\n• The infusion rate is ≤ 100 microgram/min IV\n• No change in patient condition during transport</center>"]]
                },
                {
                    "title" : "<b>Acetylsalicylic Acid (ASA)</b>",
                    "drugKey" : "asa",
                    "loc" : [["pcp", "none"]],
                    "dose_route" : [
                        ["<center>160 mg PO, chewed and swallowed (two 80 mg chewable tablets)</center>", "<tab1>• No allergy to ASA\n• No current active bleeding\n• No evidence of CVA or head injury within 24 hours prior to onset of chest pain\n• No history of asthma exacerbation from ASA ingestion</tab1>"]
                    ]
                },
                {
                    "section" : "Fentanyl is the preferred analgesic for ischemic chest pain.",
                    "title" : "<b>fentaNYL (Sublimaze)</b>",
                    "drugKey" : "fentanyl",
                    "loc" : [["acp", "none"]],
                    "dose_route" : [
                        ["<center><b>MAP ≥ 70</b>\n25-50 microgram IV/IO q 5 minutes prn\nMAX 300 microgram</center>"]
                    ]
                },
                {
                    "title" : "<b>Plavix (Clopidogrel)</b>",
                    "drugKey" : "clopidogrel",
                    "loc" : [["acp", "first"]],
                    "dose_route" : [
                        ["<center>300-600 mg PO</center>"]
                    ]
                },
                {
                    "section" : "OR",
                    "title" : "<b>Ticagrelor</b>",
                    "drugKey" : "ticagrelor",
                    "loc" : [["acp", "first"]],
                    "dose_route" : [
                        ["<center>180 mg PO</center>"]
                    ]
                },
                {
                    "title" : "<b>Metoprolol</b>",
                    "drugKey" : "metoprolol",
                    "loc" : [["acp", "first"]],
                    "dose_route" : [
                        ["<center>5 mg IV/IO q 5 minutes\nMAX 15 mg\nIf the patient is hypertensive or tachycardic</center>"]
                    ]
                },
                {
                    "title" : "<b>Maintain Heparin*</b>",
                    "drugKey" : "heparin",
                    "loc" : [["acp", "none"]],
                    "dose_route" : [
                        ["<center>Maintain Heparin infusion rate from sending if last PTT within therapeutic range of Ornge or sending hospital nomogram,\nOR\nif infusion initiated and no post-initiation PTT available yet</center>"]
                    ]
                },
                {
                    "title" : "<b>Initiate Heparin*</b>",
                    "drugKey" : "heparin",
                    "loc" : [["acp", "first"]],
                    "dose_route" : [
                        ["<center>60 units/kg IV bolus\nMAX 5,000 units\nthen\nINITIATE Infusion 12 units/kg/hr IV\nTitrate dose relative to aPTT</center>"]
                    ]
                },
                {
                    "title" : "<bg=#ffc001ff><b><orange>Heparin Nomogram for Patients NOT Receiving Thrombolytics or Glycoprotein IIb/IIIa Inhibitors</orange></b>",
                    "loc" : [["nil", "nil"]],
                    "dose_route" : [
                        ["<center>aPTT\n(seconds)</center>", "<center>Heparin Bolus\n(units)</center>", "<center>Hold infusion\n(Minutes)</center>", "<center><b>Rate Change (units/hr)</b>\n*** using 50 units/mL concentration***</center>", "<center>Next aPTT\n(from the time rate was changed)</center>"],
                        ["<center>Less than 50</center>", "<center>3,000</center>", "<center>0</center>", "<center>↑ 2.4 mL/120 units/ hr</center>", "<center>4 hours later (STAT)</center>"],
                        ["<center>50-59</center>", "<center>0</center>", "<center>0</center>", "<center>↑ 2.4 mL/120 units/ hr</center>", "<center>6 hours later</center>"],
                        ["<center>60-85</center>", "<center>0</center>", "<center>0</center>",  "<center>0</center>", "<center>Next AM</center>"],
                        ["<center>86-95</center>", "<center>0</center>", "<center>0</center>", "<center>↓1.6 mL/80 units/hr</center>", "<center>Next AM</center>"],
                        ["<center>96-120</center>", "<center>0</center>", "<center>30</center>", "<center>↓1.6 mL/80 units/hr</center>", "<center>6 hours after restarting</center>"],
                        ["<center>Greater than 120</center>", "<center>0</center>", "<center>60</center>", "<center>↓3.2 mL/160 units/hr</center>",  "<center>4 hours after restarting (STAT)</center>"],
                        ["If aPTT is greater than 120 OR less than 50 x 2 consecutive blood samples, patch TMP"]
                    ],
                    "notes" : "<b>*Contraindications to Heparin:</b>\n<tab1>• Active bleeding\n• History of Heparin induced thrombocytopenia</tab1>"
                }
            ]
        },
        {
        "key" : "adult_stemi",
        "title" : "Adult - ST Elevation MI (STEMI)",
        "type" : "medical_directive",
        "flowchartkeys" : [["STEMI Flowchart", "adult_stemi_flowchart"]],
        "indications" : "<tab1>• STEMI as defined by ECG changes</tab1>",
        "contraindications" : "<tab1>• See TNK Checklist</tab1>",
        "treatment" : "In patients being transported for acute cardiac intervention (emergent PCI) initiate Medical Directive and load and go. Initiate patch in transport or pre-patch prior to arrival whenever possible.",
        "clinical" : "<tab1>• No thrombolysis will be administered unless the TMP confirms diagnosis based on clinical and ECG findings and gives the order to proceed. It is preferred that the TMP reviews the ECG but if not possible and paramedic is confident of positive ECG criteria then a verbal confirmation on patch with TMP is adequate\n• Obtain 12 Lead ECG every 15 minutes or prn for duration of transport\n• Consider Plavix, Ticagrelor\n• Patch if PTT parameters (above) fall outside norm</tab1>",
        "drug_cards" : [
                {
                    "title" : "",
                    "loc" : [["acp", "none"]],
                    "dose_route" : [["<center><b>Initiate appropriate treatment based on algorithm below</b></center>"]]
                },
                {
                    "section" : "<b>Thrombolytics (TNKase and Heparinization)</b>",
                    "title" : "<b>TNKase</b>",
                    "drugKey" : "tenecteplase",
                    "loc" : [["acp", "first"]],
                    "dose_route" : [["<center><b>Patient’s Weight (kg)</b>\n< 60 kg\n≥ 60 to < 70 kg\n≥ 70 to < 80 kg\n≥ 80 to < 90 kg\n> 90 kg</center>", "<center><b>Tenecteplase (mg)</b>\n30\n35\n40\n45\n50</center>", "<center><b>Volume (mL)</b>\n6 ml\n7 ml\n8 ml\n9 ml\n10 ml</center>"]
                    ]
                },
                {
                    "title" : "<b>Initiate Heparin*</b>\nConcurrent Use When Thrombolytics Given:",
                    "drugKey" : "heparin",
                    "loc" : [["acp", "first"]],
                    "dose_route" : [
                        ["<center>60 units/kg IV bolus\nMAX 4,000 units\nthen\nINITIATE Infusion 12 units/kg/hr IV\nMAX 1,000 units/hr\nTitrate infusion using Heparin Nomogram</center>"]
                    ]
                },
                {
                    "title" : "<bg=#ffc001ff><b><orange>Heparin Nomogram for Patients NOT Receiving Thrombolytics or Glycoprotein IIb/IIIa Inhibitors</orange></b>",
                    "loc" : [["nil", "nil"]],
                    "dose_route" : [
                        ["<center>aPTT\n(seconds)</center>", "<center>Heparin Bolus\n(units)</center>", "<center>Hold infusion\n(Minutes)</center>", "<center><b>Rate Change (units/hr)</b>\n*** using 50 units/mL concentration***</center>", "<center>Next aPTT\n(from the time rate was changed)</center>"],
                        ["<center>Less than 40</center>", "<center>3,000</center>", "<center>0</center>", "<center>↑ 2.4 mL/120 units/ hr</center>", "<center>4 hours later (STAT)</center>"],
                        ["<center>40-49</center>", "<center>0</center>", "<center>0</center>", "<center>↑ 0.8 mL/40 units/ hr</center>", "<center>6 hours later</center>"],
                        ["<center>50-70</center>", "<center>0</center>", "<center>0</center>", "<center>0</center>", "<center>Next AM</center>"],
                        ["<center>71-85</center>", "<center>0</center>", "<center>0</center>", "<center>0</center>", "<center>Next AM</center>"],
                        ["<center>86-100</center>", "<center>0</center>", "<center>30</center>", "<center>↓2.4 mL/120 units/hr</center>", "<center>6 hours after restarting</center>"],
                        ["<center>101-150</center>", "<center>0</center>", "<center>60</center>", "<center>↓3.2 mL/160 units/hr</center>", "<center>6 hours after restarting</center>"],
                        ["<center>Greater than 150</center>", "<center>0</center>", "<center>60</center>", "<center>↓6.4 mL/320 units/hr</center>", "<center>4 hours after restarting (STAT)</center>"],
                        ["<center><b>If aPTT is greater than 120 OR less than 50 x 2 consecutive blood samples, patch TMP</b></center>"]
                    ],
                    "notes" : "<b>*Contraindications to Heparin:</b>\n<tab1>• Active bleeding\n• History of Heparin induced thrombocytopenia</tab1>"
                }
            ]
        },
        {
            "key" : "adult_tnk_checklist",
            "title" : "Contraindications to Thrombolytics",
            "type" : "document",
            "content" :
            [
                [
                    ["<section><width=30><center><b>YES</b>", "<width=30><center><b>NO</b>", "<b>Absolute Contraindications Criteria</b>"],
                    ["<checkbox>", "<checkbox>", "Suspected Aortic Dissection"],
                    ["<checkbox>", "<checkbox>", "Any prior intracranial hemorrhage, hemorrhagic stroke, or stroke of unknown origin"],
                    ["<checkbox>", "<checkbox>", "Known structural cerebral vascular lesion (i.e. arteriovenous malformation)"],
                    ["<checkbox>", "<checkbox>", "Known intracranial neoplasm (primary or metastatic)"],
                    ["<checkbox>", "<checkbox>", "Ischemic stroke > 3 hours or < 3 months"],
                    ["<checkbox>", "<checkbox>", "Suspected pericarditis"],
                    ["<checkbox>", "<checkbox>", "Active bleeding or bleeding diathesis (excluding menses)"],
                    ["<checkbox>", "<checkbox>", "Gastrointestinal bleeding within the last month"],
                    ["<checkbox>", "<checkbox>", "Major trauma/surgery/head injury within three months"]
                ],
                [
                    ["<b>* Must be 'No' to all Absolute Criteria to proceed"]
                ],
                [
                    ["<section><width=30><center><b>YES</b>", "<width=30><center><b>NO</b>", "<b>Relative Contraindications Criteria</b>"],
                    ["<checkbox>", "<checkbox>", "Patient within 90 minutes of PCI centre from scene, consider direct transport for PCI\n<b>OR</b>\n120 minutes from PCI centre if in a community hospital"],
                    ["<checkbox>", "<checkbox>", "History of chronic, severe, poorly controlled hypertension"],
                    ["<checkbox>", "<checkbox>", "Severe uncontrolled hypertension on presentation (SBP greater than 180 mmHg or DBP > than 110 mmHg)†"],
                    ["<checkbox>", "<checkbox>", "History of prior ischemic stroke or transient ischemic attack within six months, dementia, or known intracranial pathology not covered in contraindications"],
                    ["<checkbox>", "<checkbox>", "Traumatic or prolonged CPR (> than ten minutes)"],
                    ["<checkbox>", "<checkbox>", "Recent internal bleeding (within two to four weeks)"],
                    ["<checkbox>", "<checkbox>", "Noncompressible vascular punctures"],
                    ["<checkbox>", "<checkbox>", "Advanced liver disease"],
                    ["<checkbox>", "<checkbox>", "Pregnancy or within one week postpartum"],
                    ["<checkbox>", "<checkbox>", "Infective endocarditis"],
                    ["<checkbox>", "<checkbox>", "Active peptic ulcer"],
                    ["<checkbox>", "<checkbox>", "Current use of anticoagulants: the higher the INR, the higher the risk of bleeding"]
                ],
                [
                    ["<b>* Must have this information available for the TMP to help weigh risk/benefit of thrombolytic therapy</b>"]
                ],
                [
                    ["<section><b>Legend</b>"],
                    ["SBP = systolic blood pressure"],
                    ["DBP = diastolic blood pressure"],
                    ["INR = international normalized ratio"],
                    ["MI = myocardial infarction"],
                    ["†Could be an absolute contraindication in low-risk patients with MI"]
                ]
            ]
        },
        {
            "key" : "adult_chf",
            "title" : "Adult - Cardiogenic Pulmonary Edema",
            "type" : "medical_directive",
            "flowchartkeys" : [["Cardiogenic Pulmonary Edema Flowchart", "adult_chf_flowchart"]],
            "indications" : "<tab1>• Initial MAP ≥ 70 mmHg and SBP > 100\nAND\n• Heart Rate is ≥ 60 but < 160 bpm</tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication\n• No IV\n• Nitroglycerin: Any phosphodiesterase-5 inhibitors use (Sildeafil [Viagra or Revatio], Tadalafil [Cialis], or Vardenafil [Levitra]) in the last 48 hours (these agents are commonly used for erectile dysfunction and are also used in pulmonary hypertension)</tab1>",
            "clinical" : "<tab1>• If a patient presents with moderate to severe respiratory distress and the Paramedic suspects the patient is in acute pulmonary edema\n• Reassess & document vitals between doses\n• Discontinue Nitroglycerin if the BP or heart rate parameters for Nitroglycerin are no longer met\n• Check blood pressure before administering each subsequent dose of Nitroglycerin</tab1>",
            "drug_cards" : [
                {
                    "title" : "<b>CPAP/NPPV</b>",
                    "loc" : [["acp", "after"]],
                    "dose_route" : [["<center><b>Initial Setting</b>\niPAP 10 cmH2O/ePAP 5 cmH2O\nMAX iPAP 20 cmH2O/ePAP 10 cmH2O</center>"]]
                },
                {
                    "title" : "<b>Nitroglycerin*</b>",
                    "loc" : [["pcp", "none"]],
                    "drugKey" : "nitroglycerin",
                    "dose_route" : [["<center>0.4 mg SL spray\nq 5 minutes prn\nMAX of 6 doses</center>"]],
                    "notes" : "*Single PCP(f): Initiate then patch"
                },
                {
                    "title" : "<b>Nitroglycerin (Tridil)\nIV Infusion (for severe pulmonary edema)</b>",
                    "loc" : [["acp", "first"]],
                    "drugKey" : "nitroglycerin",
                    "dose_route" : [["<center>Initiate 10 microgram/min IV\ntitrate in 5 microgram/min increments q 5 minutes\nMAX 200 microgram/min</center>"]]
                },
                {
                    "title" : "<b>Furosemide (Lasix)</b>",
                    "loc" : [["acp", "first"]],
                    "drugKey" : "furosemide",
                    "dose_route" : [["<center>40 mg IV or double patients usual total daily dose\nMAX of 160 mg</center>"]]
                }
            ]
        },
        {
            "key" : "adult_cardiogenic_shock",
            "title" : "Adult - Cardiogenic Shock",
            "type" : "medical_directive",
            "flowchartkeys" : [["Cardiogenic Shock Flowchart", "adult_cardiogenic_shock_flowchart"]],
            "indications" : "<tab1>• Cardiogenic shock</tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication</tab1>",
            "clinical" : "<tab1>• In general, titration of Norepinephrine should be based upon MAPs whereas response to DOBUTamine should be based on perfusion and clinical parameters such as urine output\n• MAP parameters in cardiogenic shock should be targeted to low normal levels, MAP 60-65 and less than 80 provided there are signs of adequate perfusion</tab1>",
            "drug_cards" : [
                {
                    "title" : "<b>Normal Saline or Ringers Lactate</b>",
                    "loc" : [["acp", "none"]],
                    "dose_route" : [["<center>250 mL IV/IO bolus PRN, MAX 10 ml/kg\nTarget MAP > 65</center>"]]
                },
                {
                    "title" : "<b>Norepinephrine (Levophed)</b>",
                    "loc" : [["acp", "after"]],
                    "drugKey" : "norepinephrine",
                    "dose_route" : [["<center>0-0.5 microgram/kg/min IV/IO\nTarget MAP > 65</center>"]]
                },
                {
                    "title" : "<b>DOBUTamine (Dobutrex)</b>",
                    "loc" : [["ccp", "first"]],
                    "drugKey" : "dobutamine",
                    "dose_route" : [["<center>5-20 microgram/kg/min IV/IO\nInitiate at 5 microgram/kg/min\nMinimum MAP 60 prior to initiating</center>"]]
                }
            ]
        },
        {
            "key" : "adult_iabp",
            "title" : "Adult - Intra-Aortic Balloon Pump (IABP) Auxiliary Medical Directive",
            "type" : "medical_directive",
            "indications" : "<tab1>• A CCP may provide the treatment prescribed in this auxiliary medical directive if certified and authorized\n• Patient > 18 years old\n• Patient > 40 kg\n• Patient must already be on Intra-Aortic Balloon Pump (IABP) at the sending hospital</tab1>",
            "contraindications" : "<tab1>• Not applicable</tab1>",
            "treatment" : "<tab1>• Paramedics are required to perform IABP specific assessments\n</tab1><tab2>o Verify balloon position and size\no Identify balloon tip on x-ray\no Assess for distal pulses in insertion limb\no Assess for urine output\no Identify if catheter is fiber optic\no Identify trigger being used\no Assess IABP waveform\no Ensure catheter is sutured securely in place</tab2>\nParamedics are required to Patch to obtain orders when providing IABP care.",
            "clinical" : "<tab1>• 1 IABP certified paramedic with CCP partner\n• Paramedics are not permitted to advance or remove IABP catheters\n• Paramedics are required to ensure transport IABP is in ready state, fully charged, appropriate helium levels, paper role, and appropriate cables\n• Document sending facility IABP parameters</tab1>",
            "drug_cards" : [
                {
                    "title" : "",
                    "loc" : [["ccp", "first"]],
                    "dose_route" : [
                        ["<center><b>Transition</b></center>"],
                        ["<tab1><left>• Both paramedics at the bedside for transition to transport IABP\n• Put IABP in 1:2 ratio\n• Select trigger\n• Assess and adjust 3 rules of timing to achieve ideal waveform and augmentation\n• Run a recording strip\n• Maintain head of bed no higher than 30 degrees\n• Keep insertion limb straight\n• Ensure no blood is present in the catheter\n• Return IABP ratio to 1:1 or 1:2 matching setting from sending</left></tab1>"],
                        ["<center><b>Transport</b></center>"],
                        ["<tab1><left>• Exercise caution to protect IABP catheter from being pulled.\n• Continuously monitor the patient and the performance of the IABP, make adjustments as required to maintain good augmentation\n• Run a recorder strip at the start of transport and again at the end of transport\n• Plug IABP into vehicle power source to conserve IABP internal battery</left></tab1>"],
                        ["<center><b>Transfer of Care</b></center>"],
                        ["<tab1><left>• Paramedics to ensure safe transfer of IABP care with accepting hospital staff\n• Run final strip prior to transfer\n• Document as required on ACR among other care the specifics of the IABP</left></tab1>"]]
                }
            ]
        },
        {
            "key" : "adult_ecmo",
            "title" : "Adult - Extracorporeal Membrane Oxygenation (ECMO) Auxiliary Medical Directive",
            "type" : "medical_directive",
            "indications" : "<tab1>• Veno-venous (VV) or Veno-arterial (VA) Extracorporeal Membrane Oxygenation (ECMO)/Extracorporeal Life Support (ECLS)\n• Accompanied by ECMO team including ECMO physician\n• A CCP may provide the treatment prescribed in this auxiliary medical directive if certified and authorized\n• Age > 16\n• Successful cannula placement and ECMO initiation</tab1>",
            "contraindications" : "<tab1>• Not applicable</tab1>",
            "clinical" : "<tab1>• The CCP must patch with the TMP if medications are required beyond those provided for in these Medical Directives; if medication doses are required beyond those provided for in these medical directives; or in the case of ECMO failure requiring use of emergency medical directives (as soon as practical and safe to do so taking into account workload to stabilize patient)\n• The CCP may also provide all additional care covered by routine CCP level medical directives</tab1>",
            "drug_cards" : [
                {
                    "title" : "<b>Mechanical ventilation*</b>",
                    "loc" : [["ccp", "none"]],
                    "dose_route" : [["<tab1>• Pressure Control Ventilation\n• RR 10 breaths/min**\n• Pressure control 10 cmH20**\n• PEEP 10 cmH20**\n• FiO2 0.3\n• Protective lung strategy Vt 4-5 ml/kg IBW, RR 10/min, Ti 1.0 sec</tab1>\n\n** or to an initial maximum of 20-20-20 (RR-PC-PEEP) as requested by the ECMO physician", "Keep plateau pressures less than 30 cm H20 with adjustments unless ECMO failure (see ECMO failure emergency medical directives)\nMay titrate FiO2 up to 1.0 and PEEP up to 20 if requested by ECMO physician\n Given that PaCO2 and PaO2 determined by ECMO rather than mechanical ventilation, there is no need to titrate mechanical ventilation during transport (please refer to the Emergency Medical Directive for ECMO/ECLS Failure portion at the end of the Medical Directive for orders in the event of ECMO failure)"]],
                    "notes" : "*Confirm ETT placement on chest X-ray from sending facility"
                },
                {
                    "section" : "<b>Circulation and Fluids</b>\nContinue any of the following medications being administered at the time of initiation of ECMO and/or add/titrate at the request of the ECMO physician within the prescribed ranges below. Match dose from sending facility as starting dose.",
                    "title" : "<b>Norepinephrine (Levophed)</b>",
                    "drugKey" : "norepinephrine",
                    "loc" : [["ccp", "none"]],
                    "dose_route" : [["<center>0-0.5 microgram/kg/min IV\nMatch sending facility for starting dose\nTarget MAP > 65</center>"]]
                },
                {
                    "title" : "<b>Vasopressin</b>",
                    "drugKey" : "vasopressin",
                    "loc" : [["ccp", "none"]],
                    "dose_route" : [["<center>0.02-0.1 units/min IV\nMatch sending facility for starting dose\nTarget MAP > 65</center>"]]
                },
                {
                    "title" : "<b>EPINEPHrine</b>\nTarget MAP > 65",
                    "drugKey" : "epinephrine",
                    "loc" : [["ccp", "none"]],
                    "dose_route" : [
                        ["<center>Bolus</center>", "<center>and/or</center>", "<center>Maintenance Infusion</center>"],
                        ["<center>5-20 mcg\n* q 3 minutes prn IV</center>", "<center>0-0.5 microgram/kg/min\nMatch sending facility for starting dose</center>"]
                    ],
                    "notes" : "*to prepare push-dose EPINEPHrine (i.e., 10 microgram/mL concentration)\n<tab1>1. Draw 100 microgram (i.e. 1 mL of 1:10,000) EPINEPHrine and dilute in 9 mL of Normal Saline</tab1>"
                },
                {
                    "title" : "<b>Phenylephrine</b>\nTarget MAP > 65",
                    "drugKey" : "phenylephrine",
                    "loc" : [["ccp", "none"]],
                    "dose_route" : [
                        ["<center>Bolus</center>", "<center>and/or</center>", "<center>Maintenance Infusion</center>"],
                        ["<center>100-200 micrograms q 3 minutes prn IV</center>", "<center>0-500 microgram/min\nMatch sending facility for starting dose</center>"]
                    ]
                },
                {
                    "title" : "<b>Fluids</b>",
                    "loc" : [["ccp", "none"]],
                    "dose_route" : [
                        ["<center>Bolus</center>", "<center>and/or</center>", "<center>Maintenance Infusion</center>"],
                        ["<center>Bolus 20 mL/kg RL or NS q 15 minutes prn to keep MAP > 65 and/or if rising vasopressor requirements\nAssess for signs of fluid overload between each bolus and hold further fluid boluses if signs fluid overload\nMay substitute sodium bicarbonate (3 amps in 850 cc D5W) instead of NS/RL as bolus fluid 20 ml/kg at request of ECMO physician for metabolic acidosis</center>", "<center>Maintenance infusion RL or NS at 0-150 cc/hr (choice as per ECMO physician and/or to match sending facility, RL preferred)\nMay switch to sodium bicarbonate infusion (3 amps in 850 mL D5W) at 0-150 cc/hr</center>"]
                    ]
                },
                {
                    "title" : "<b>Packed Red Blood Cells (PRBC)</b>",
                    "loc" : [["ccp", "none"]],
                    "dose_route" : [
                        ["<center>Transfuse PRBC at request of ECMO physician if Hb < 70 g/L or if active bleeding; medics may bring PRBC from sending facility to have on standby if available and requested by ECMO physician</center>"]
                        
                    ]
                },
                {
                    "section" : "For Sedation",
                    "title" : "<b>fentaNYL (Sublimaze)</b>",
                    "drugKey" : "fentanyl",
                    "loc" : [["ccp", "none"]],
                    "dose_route" : [
                        ["<center>Bolus</center>", "<center>and/or</center>", "<center>Maintenance Infusion</center>"],
                        ["<center>50-100 micrograms IV q 10 minutes prn</center>", "<center>0-500 microgram/hr IV\nTarget MAP > 65</center>"]
                    ]
                },
                {
                    "section" : "AND",
                    "title" : "<b>Propofol (Diprivan</b>",
                    "drugKey" : "propofol",
                    "loc" : [["ccp", "none"]],
                    "dose_route" : [
                        ["<center>0-5 mg/kg/hr\nTarget MAP > 65</center>"]
                    ]
                },
                {
                    "section" : "OR",
                    "title" : "<b>Midazolam (Versed)</b>",
                    "drugKey" : "midazolam",
                    "loc" : [["ccp", "none"]],
                    "dose_route" : [
                        ["<center>Bolus</center>", "<center>and/or</center>", "<center>Maintenance Infusion</center>"],
                        ["<center>2-4 mg IV q 10 minutes prn</center>", "<center>0-0.25 mg/kg/hr IV\nTarget MAP > 65</center>"]
                    ]
                },
                {
                    "section" : "OR",
                    "title" : "<b>Ketamine</b>",
                    "drugKey" : "ketamine",
                    "loc" : [["ccp", "none"]],
                    "dose_route" : [
                        ["<center>Bolus</center>", "<center>and/or</center>", "<center>Maintenance Infusion</center>"],
                        ["<center>10-20 mg IV q 5 minutes prn</center>", "<center>0-4.5 mg/kg/hr IV\nTarget MAP > 50</center>"]
                    ]
                },
                {
                    "section" : "<b>For Paralysis*</b>",
                    "title" : "<b>Cisatracurium</b>",
                    "drugKey" : "cisatracurium",
                    "loc" : [["ccp", "none"]],
                    "dose_route" : [
                        ["<center>Bolus</center>", "<center>and/or</center>", "<center>Maintenance Infusion</center>"],
                        ["<center>0.1-0.2 mg/kg IV to initiate paralysis\n0.03 mg/kg IV q 30 minutes prn</center>", "<center>1-10 microgram/kg/min\n(usual starting dose 3 microgram/kg/min\nafter initiating paralysis)</center>"]
                    ]
                },
                {
                    "section" : "OR",
                    "title" : "<b>Rocuronium (Zemuron)</b>",
                    "drugKey" : "rocuronium",
                    "loc" : [["ccp", "none"]],
                    "dose_route" : [
                        ["<center>Bolus</center>", "<center>and/or</center>", "<center>Maintenance Infusion</center>"],
                        ["<center>0.6 mg/kg IV to initiate paralysis\n0.3 mg/kg IV q 20 minutes</center>", "<center>10-15 microgram/kg/min\nto maintain paralysis</center>"]
                    ],
                    "notes" : "*Must have analgesia (fentaNYL) plus sedation (propofol, midazolam or ketamine) running at all times while paralyzed"
                },
                {
                    "section" : "<b>Additional Medications</b>\nAt request of ECMO physician",
                    "title" : "<b>Unfractionated Heparin</b>",
                    "drugKey" : "heparin",
                    "loc" : [["ccp", "none"]],
                    "dose_route" : [
                        ["<center>Bolus</center>", "<center>and/or</center>", "<center>Maintenance Infusion</center>"],
                        ["<center>May give 5000 units IV bolus upon cannulation;\nrepeat as requested by ECMO physician/perfusionist</center>", "<center>0-3000 units/hr IV, continue dose from sending;\nadjust as requested by ECMO physician based on\nPTT/ACT as directed by ECMO physician/perfusionist\n(target ACT 160-180 sec)</center>"]
                    ]
                },
                {
                    "title" : "<b>Furosemide (Lasix)</b>",
                    "loc" : [["ccp", "none"]],
                    "drugKey" : "furosemide",
                    "dose_route" : [
                        ["<center>Bolus</center>", "<center>and/or</center>", "<center>Maintenance Infusion</center>"],
                        [ "<center>20-160 mg IV x 1 prn</center>", "<center>0-20 mg/hr IV</center>"]
                    ]
                },
                {
                    "title" : "<b>Tranexamic Acid (TXA)</b>",
                    "loc" : [["ccp", "none"]],
                    "drugKey" : "txa",
                    "dose_route" : [
                        ["<center>1 g IV bolus for bleeding</center>"]
                    ]
                },
                {
                    "title" : "<b>Pantoloc (Pantoprazole)</b>",
                    "loc" : [["ccp", "none"]],
                    "drugKey" : "pantoprazole",
                    "dose_route" : [
                        ["<center>Bolus</center>", "<center>and/or</center>", "<center>Maintenance Infusion</center>"],
                        ["<center>40-80 mg bolus IV</center>", "<center>8 mg/hr IV infusion</center>"]
                    ]
                }
            ]
        },
        {
            "key" : "adult_ecmo_failure",
            "title" : "Adult - Emergency Medical Directive for ECMO/ECLS Failure",
            "type" : "medical_directive",
            "indications" : "<tab1>• Cardiac Arrest\n• ECMO/ECLS equipment failure\n• Failure to Oxygenate\n• Uncontrolled bleeding/Volume loss/Exsanguination</tab1>",
            "drug_cards" : [
                {
                    "section" : "May use all above ECMO medical directives, standard CCP Medical Directives, <b>and in addition:</b>",
                    "title" : "<b>Mechanical ventilation</b>",
                    "loc" : [["ccp", "after"]],
                    "dose_route" : [["<tab1>• FiO2 1.0 and titrate down for O2 saturation > 95%\n• PEEP 5-20, may increase settings to aim for Vt 6-8 ml/kg\n• PIP < 30 (may increase to 40 if unable to achieve targets with settings otherwise)\n• Titrate RR to achieve EtCO2 50-60 target\n• I:E 1:1 if possible for oxygenation failure</tab1>"]],
                    "notes" : "**Mandatory TMP patch if ECMO failure as soon as possible after initiation of ECMO failure orders taking into account immediate patient care needs"
                },
                {
                    "title" : "<b>ECMO Failure</b>",
                    "loc" : [["ccp", "first"]],
                    "dose_route" : [["<tab1>• Cardiac arrest\n• ECMO/ECLS equipment failure\n• Failure to oxygenate\n• Uncontrolled bleeding/volume loss/exsanguination</tab1>"]]
                }
            ]
        },
        {
            "key" : "adult_bradycardia",
            "title" : "Adult - Symptomatic Bradycardia",
            "type" : "medical_directive",
            "flowchartkeys" : [["Flowchart", "adult_bradycardia_flowchart"]],
            "indications" : "<tab1>• Symptomatic Bradycardia with a pulse</tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication</tab1>",
            "drug_cards" : [
                {
                    "title" : "<b>Atropine</b>",
                    "drugKey" : "atropine",
                    "loc" : [["acp","after"]],
                    "dose_route" : [["<center>0.5 mg IV/IO initial dose (repeat q 3-5 minutes to max total dose 3 mg)</center>"]]
                },
                {
                    "title" : "<b>Dopamine</b>",
                    "drugKey" : "dopamine",
                    "loc" : [["acp","after"]],
                    "dose_route" : [["<center>5-20 microgram/kg/min IV\nTarget MAP > 65\nHR > 50</center>"]],
                    "notes" : "Patients with bradycardia requiring transcutaneous (TC) pacing who are conscious and aware of their surroundings may require sedation and analgesia prior to TC pacing."
                },
                {
                    "title" : "<b>Transcutaneous Cardiac Pacing</b>",
                    "loc" : [["acp","after"]],
                    "dose_route" : [["<center>Set pacing rate at 70\nStart output at 10 milliamps (mA) and increase to achieve electrical capture with a pulse (mechanical capture)\nOnce mechanical capture has been confirmed increase mA by 10%\nConfirm the presence of a pulse and assess blood pressure and perfusion</center>"]]
                },
                {
                    "title" : "<b>Procedural Sedation</b>",
                    "loc" : [["acp","first"], ["ccp", "after"]],
                    "dose_route" : [["<center><b>MAP ≥ 65</b>\n<a href=\"drugKey=ketamine\">Ketamine</a> 0.1 mg/kg, MAX 0.5 mg/kg\n<b>OR</b>\n<a href=\"drugKey=midazolam\">Versed</a> 0.05 mg/kg\n<a href=\"drugKey=fentanyl\">fentaNYL</a>\n1 micgrogram/kg</center>", "<center><b>MAP < 65</b>\n<a href=\"drugKey=ketamine\">Ketamine</a> 0.1 mg/kg, MAX 0.5 mg/kg</center>"]]
                }
            ]
        },
        {
            "key" : "adult_tvp",
            "title" : "Adult - Transvenous Cardiac Pacing",
            "type" : "medical_directive",
            "indications" : "<tab1>• Transvenous pacing, if initiated at the sending facility</tab1>",
            "contraindications" : "<tab1>• Not applicable</tab1>",
            "clinical" : "<tab1>• Monitor the cardiac rhythm and ensure the catheter/cable is carefully secured to prevent inadvertent tension or traction on the line\n• Ideal capture threshold is < 1. High outputs are an indication of misplaced wires or more serious pathology that can be more prone to capture failure and need for TCP vs other interventions</tab1>",
            "drug_cards" : [
                {
                    "title" : "",
                    "loc" : [["ccp","after"]],
                    "dose_route" : [["<center><b>Maintain transvenous pacing if initiated at sending facility\n(Initial pacing settings will reflect sending facility settings)</b></center>"
                    ]]
                },
                {
                    "title" : "",
                    "loc" : [["ccp","first"]],
                    "dose_route" : [["<center><b>Any alteration of settings to be discussed with TMP</b></center>"
                    ]]
                }
            ]
        },
        {
            "key" : "adult_afib",
            "title" : "Adult - Symptomatic Atrial Fibrillation/Flutter",
            "type" : "medical_directive",
            "flowchartkeys" : [["Flowchart", "adult_atrial_fib_flowchart"]],
            "indications" : "<tab1>• Symptomatic Atrial Flutter\n• Symptomatic Atrial Fibrillation</tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication</tab1>",
            "treatment" : "Patients with Atrial Fibrillation/Flutter where emergency synchronized cardioversion is indicated who are conscious and aware of their surroundings may require sedation and analgesia first. Below are medical directives for sedation and analgesia for cardioversion. Patients that are peri-arrest or hemodynamically unstable can be immediately managed with synchronized cardioversion without sedation or analgesia",
            "drug_cards" : [
                {
                    "loc" : [["acp","after"]],
                    "dose_route" : [["<center><b>Synchronized Cardioversion</b></center>"]]
                },
                {
                    "title" : "<b>Procedural Sedation</b>",
                    "loc" : [["acp","first"], ["ccp", "after"]],
                    "dose_route" : [["<center><b>MAP ≥ 65</b>\n<a href=\"drugKey=ketamine\">Ketamine</a> 0.1 mg/kg, MAX 0.5 mg/kg\n<b>OR</b>\n<a href=\"drugKey=midazolam\">Versed</a> 0.05 mg/kg\n<a href=\"drugKey=fentanyl\">fentaNYL</a>\n1 micgrogram/kg</center>", "<center><b>MAP < 65</b>\n<a href=\"drugKey=ketamine\">Ketamine</a> 0.1 mg/kg, MAX 0.5 mg/kg</center>"]]
                }
            ]
        },
        {
            "key" : "adult_svt",
            "title" : "Adult - Paroxysmal Supraventricular Tachycardia (PSVT)",
            "type" : "medical_directive",
            "flowchartkeys" : [["Flowchart", "adult_svt_flowchart"]],
            "indications" : "<tab1>• Paroxysmal Supraventricular Tachycardia (PSVT)</tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication</tab1>",
            "treatment" : "Patients with PSVT with a pulse who are conscious and aware of their surroundings may require sedation and analgesia prior to cardioversion. Below are directives for sedation and analgesia for cardioversion. Patients that are peri-arrest or hemodynamically unstable can be immediately cardioverted with synchronized cardioversion (without sedation or analgesia).",
            "clinical" : "<tab1>• Adenosine dose should be decreased if patient taking dipyridamole or carbamazepine, dose should be decreased if given by central line; caution in asthma</tab1>",
            "drug_cards" : [
                {
                    "loc" : [["acp","after"]],
                    "dose_route" : [["<center><b>Synchronized Cardioversion</b></center>"]]
                },
                {
                    "title" : "<b>Procedural Sedation</b>",
                    "loc" : [["acp","first"], ["ccp", "after"]],
                    "dose_route" : [["<center><b>MAP ≥ 65</b>\n<a href=\"drugKey=ketamine\">Ketamine</a> 0.1 mg/kg, MAX 0.5 mg/kg\n<b>OR</b>\n<a href=\"drugKey=midazolam\">Versed</a> 0.05 mg/kg\n<a href=\"drugKey=fentanyl\">fentaNYL</a>\n1 micgrogram/kg</center>", "<center><b>MAP < 65</b>\n<a href=\"drugKey=ketamine\">Ketamine</a> 0.1 mg/kg, MAX 0.5 mg/kg</center>"]]
                },
                {
                    "title" : "<b>Adenosine</b>",
                    "drugKey" : "adenosine",
                    "loc" : [["acp","after"]],
                    "dose_route" : [["<center>6 mg rapid IV/IO with 20 mL NS flush\nRepeat at 12 mg x 1 prn</center>"]]
                }
            ]
        },
        {
            "key" : "adult_vtach",
            "title" : "Adult - Ventricular Tachycardia with Perfusion",
            "type" : "medical_directive",
            "flowchartkeys" : [["Flowchart", "adult_vtach_pulse_flowchart"]],
            "indications" : "<tab1>• Ventricular Tachycardia (VT) with a pulse</tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication</tab1>",
            "treatment" : "Patients with VT with a pulse who are conscious and aware of their surroundings may require sedation and analgesia prior to cardioversion. Below are directives for sedation and analgesia for cardioversion. Patients that are peri-arrest or hemodynamically unstable can be immediately cardioverted with synchronized cardioversion without sedation or analgesia.",
            "clinical" : "<tab1>• Consider early Magnesium IV for polymorphic VT\n• Polymorphic VT should prompt consideration if clinically appropriate for toxicologic exposure which have specific antidote therapies (Ex: Beta blockers in hydrocarbon toxicity). Emergent TMP consultation is indicated\n• Consider hyperkalemia medical directive (167) for wide complex tachycardia/lethal arrythmias</tab1>",
            "drug_cards" : [
                {
                    "loc" : [["acp","after"]],
                    "dose_route" : [["<center><b>Synchronized Cardioversion</b></center>"]]
                },
                {
                    "title" : "<b>Procedural Sedation</b>",
                    "loc" : [["acp","first"], ["ccp", "after"]],
                    "dose_route" : [["<center><b>MAP ≥ 65</b>\n<a href=\"drugKey=ketamine\">Ketamine</a> 0.1 mg/kg, MAX 0.5 mg/kg\n<b>OR</b>\n<a href=\"drugKey=midazolam\">Versed</a> 0.05 mg/kg\n<a href=\"drugKey=fentanyl\">fentaNYL</a> 1 micgrogram/kg</center>", "<center><b>MAP < 65</b>\n<a href=\"drugKey=ketamine\">Ketamine</a> 0.1 mg/kg, MAX 0.5 mg/kg</center>"]]
                },
                {
                    "title" : "<b>Amiodarone (Cordarone)</b>",
                    "drugKey" : "amiodarone",
                    "loc" : [["acp","none"]],
                    "dose_route" : [["<center>150 mg IV over 10 minutes\n(may repeat x1 as adjunct to cardioversion)</center>"]]
                }
            ]
        },
        {
            "key" : "adult_iv_start",
            "title" : "Adult - Intravenous Line Initiation",
            "type" : "medical_directive",
            "indications" : "<tab1>• Actual or potential need for intravenous or fluid therapy</tab1>",
            "contraindications" : "<tab1>• Suspected fracture proximal to the IV site</tab1>",
            "clinical" : "<tab1>• *A PCP(f) may provide the treatment prescribed in this auxiliary medical directive if certified and authorized</tab1>",
            "drug_cards" : [
                {
                    "title" : "<b>Initiate IV</b>",
                    "loc" : [["acp","none"]],
                    "dose_route" : [["<center>MAX of 2 peripheral IV lines may be established</center>"]]
                }
            ]
        },
        {
            "key" : "adult_io_start",
            "title" : "Adult - Intraosseous Initiation and Maintenance",
            "type" : "medical_directive",
            "indications" : "<tab1>• Inadequate intravenous access for <b>resuscitation</b>\n• Unable to obtain intravenous access after two (2) attempts or 90 seconds</tab1>",
            "contraindications" : "<tab1>• Known or suspected fracture, injury, deformity, or infection overlying the proposed insertion site\n• Absence of adequate anatomic landmarks\n• Previous IO insertion in the bone in the past 48 hours\n• Known or suspected fracture of affected limb</tab1>",
            "clinical" : "<tab1>• Resuscitation indicates the process of correcting physiological disorders in the acutely unwell patient. The patient need not be in cardiac arrest to qualify for IO insertion</tab1>",
            "drug_cards" : [
                {
                    "loc" : [["acp","after"]],
                    "dose_route" : [["<center><b>Initiate the appropriate intervention based upon the presenting condition</b></center>"]]
                }
            ]
        },
        {
            "key" : "adult_io_analgesia",
            "title" : "Adult - Intraosseous Vascular Access Analgesia",
            "type" : "medical_directive",
            "indications" : "<tab1>• Patient requiring intraosseous (IO) needle access and responsive to pain</tab1>",
            "contraindications" : "<tab1>• Sino-atrial disorders\n• All grades of AV block, Stokes-Adams syndrome, Wolff-Parkinson-White syndrome\n• Acute porphyria\n• Hypersensitivity to another local anesthetic of the amide type</tab1>",
            "clinical" : "<tab1>• After the second lidocaine dose is given, medication or fluids may be administered under pressure as required\n• Can consider administering again in 45 minutes later at the lower of the two previous doses given if discomfort re-occurs\n• If extravasation occurs insert a new IO needle\n• Cimetidine or beta-blockers (e.g. propranolol) may interact and cause lidocaine toxicity</tab1>",
            "drug_cards" : [
                {
                    "title" : "<b>Lidocaine 2% without epinephrine</b>",
                    "loc" : [["acp","after"]],
                    "drugKey" : "lidocaine",
                    "dose_route" : [
                        ["", "<center><b>1st Dose</b></center>", "<center><b>2nd Dose</b></center>"],
                        ["40 - 60 kg", "30 mg (1.5 mL)", "15 mg (0.75 mL)"],
                        ["61 - 70 kg", "35 mg (1.75 mL)", "17.5 mg (0.9 mL)"],
                        ["71 kg +", "40 mg (2 mL)", "20 mg (1 mL)"]
                    ],
                    "notes" : "*Administer <b>first dose</b> over 2 minutes then allow lidocaine to dwell for 1 minute in IO space and flush with 5-10 mL 0.9% saline\nFollowed by <b>second dose</b> of lidocaine over 1 minute"
                }
            ]
        },
        {
            "key" : "adult_iv_pcp",
            "title" : "Adult - Intravenous Line Maintenance Standard: PCP(f)",
            "type" : "medical_directive",
            "indications" : "<tab1>• Initiated by sending facility</tab1>",
            "contraindications" : "<tab1>• Not applicable</tab1>",
            "clinical" : "<tab1>• To keep the vein open (TKVO)</tab1><tab2>\no The minimum flow rate to maintain IV patency for a patient ≥12 years of age is 30 mL/hr of any isotonic fluid (Normal saline or ringers lactate); or\n</tab2><tab1>\n• For fluid replacement\n</tab1><tab2>o A maximum flow rate infused of up to 2 mL/kg/hr to a MAX of 200 mL/hr,\no Thiamine, multivitamin preparations,\no Drugs within his/her level of certification, or\no Potassium chloride (KCl) for patients ≥18 years of age, to a MAX of 10 mEq in a 250 mL or 40 mEq in a 1000 mL bag</tab2>",
            "drug_cards" : [
                {
                    "title" : "<b>Maintain IV</b>",
                    "loc" : [["pcp","none"]],
                    "dose_route" : [["<center>May transport a patient with a saline IV infusion containing thiamine, multivitamin preparations and KCl to a MAX of <b>40 mEq</b>/Litre as initiated by the sending hospital and maintain at the rate set by the sending facility up to a MAX of 200 mL/hr</center>"]]
                }
            ]
        },
        {
            "key" : "adult_blood_sampling",
            "title" : "Adult - Blood Sampling and Lab Value Interpretation",
            "type" : "medical_directive",
            "indications" : "<tab1>• To establish baseline respiratory, cardiovascular, hematological status prior to or during transport\n• To monitor changes and/or deterioration in clinical status</tab1>",
            "contraindications" : "<tab1>• Not applicable</tab1>",
            "clinical" : "<tab1>• Management based on these results will be via patch with the TMP\n• These tests should only be completed if absolutely essential to patient management en route and will not cause unnecessary delays in transport</tab1>",
            "drug_cards" : [
                {
                    "loc" : [["acp","after"]],
                    "dose_route" : [["<center><b>Perform venipuncture, venous blood sampling and utilize iSTAT if available\nPerform arterial blood sampling and utilize iSTAT if available</b></center>"]]
                }
            ]
        },
        {
            "key" : "adult_central_venous_lines",
            "title" : "Adult - Maintaining and Accessing Central Venous Lines",
            "type" : "medical_directive",
            "indications" : "<tab1>• Actual or potential need for intravenous medication / fluid therapy\nAND\n• Central venous access is available</tab1>\nYou may access the following types of devices:\n<tab1>• Hickman\n• PICC (Peripherally Inserted Central Catheter)\n• Central Venous Line</tab1>",
            "contraindications" : "<tab1>• Not applicable</tab1>",
            "clinical" : "<tab1>• Every lumen of a capped central line must be flushed prior to transport to ensure that they are patent and functional as per the Ornge Medical Procedure Manual\n• Venous devices that are located subcutaneously, i.e. PortaCath or similar devices MAY NOT to be accessed</tab1>",
            "drug_cards" : [
                {
                    "loc" : [["pcp","none"]],
                    "dose_route" : [["<center><b>Must be capped for transport</b>\nDevices <b>must not</b> be accessed by the PCP(f)</center>"]]
                },
                {
                    "loc" : [["acp","none"]],
                    "dose_route" : [["<center><b>Access established CVAD for utilization</b></center>"]]
                }
            ]
        },
        {
            "key" : "adult_arterial_lines",
            "title" : "Adult - Arterial Line Maintenance and Monitoring",
            "type" : "medical_directive",
            "indications" : "<tab1>• Established arterial line</tab1>",
            "contraindications" : "<tab1>• Not applicable</tab1>",
            "clinical" : "<tab1>• NS is the preferred solution for arterial lines with flush / pressure bag / transducer system unless sending facility has it heparinized in which case, one should continue as per sending\n• Arterial lines are not to be capped or locked due to the risk of thrombosis. Instead, it must be removed if not transduced\n• Arterial lines are calibrated (zeroed) with any changes in level of bed &/or position of head of bed to transducer, if waveform changes and with IV tubing changes\n• Ensure all connections are tight , line is secured (ie arm board) and limb properly restrained as required\n• Blood backing up the transducer tubing from the patient may indicate a leak, crack or loose connections</tab1>",
            "drug_cards" : [
                {
                    "loc" : [["acp","after"]],
                    "dose_route" : [["<center><b>Perform blood sampling and utilize iSTAT if available</b></center>"]]
                },
                {
                    "loc" : [["acp","none"]],
                    "dose_route" : [["<center><b>Monitor and transduce an established arterial line</b></center>"]]
                }
            ]
        },
        {
            "key" : "adult_pulmonary_artery_catheters",
            "title" : "Adult - Pulmonary Artery Catheters Auxiliary Medical Directive",
            "type" : "medical_directive",
            "indications" : "<tab1>• A CCP may provide the treatment prescribed in this auxiliary medical directive if certified and authorized</tab1>",
            "contraindications" : "<tab1>• Not applicable</tab1>",
            "clinical" : "<tab1>• If the arterial line and PA catheter cannot be simultaneously monitored then the arterial line will be monitored and the PA line will be removed. Authorized CCPs may remove the PA catheters prior to transport if required. The catheter must be completely removed, not just pulled back into the right atrium or SVC. The introducer (cordis) should be left in-situ and a plug inserted so that a new PA line may be inserted at the receiving facility\n• If the patient must be transported with a PA catheter in place, and no authorized CCP is available, the sending facility must send an appropriate escort with the responsibility for care and monitoring of the PA catheter under the sending facility staff</tab1>",
            "drug_cards" : [
                {
                    "loc" : [["ccp","first"]],
                    "dose_route" : [["<center><b>Transport and monitor PA Catheters</b></center>"]]
                }
            ]
        },
        {
            "key" : "adult_stroke",
            "title" : "Adult - Stroke",
            "type" : "medical_directive",
            "indications" : "<tab1>• Acute stroke</tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication\n• Traumatic head injury\n• Blood glucose < 4 mmol</tab1>",
            "flowchartkeys" : [["Flowchart", "adult_stroke_flowchart"]],
            "clinical" : "<tab1>• Not applicable</tab1>",
            "drug_cards" : [
                {
                    "title" : "<b>Labetalol</b>\nHold if HR < 60 bpm\nMAX dose 300 mg/day",
                    "loc" : [["acp","first"]],
                    "drugKey" : "labetalol",
                    "dose_route" : [["<center>10-20 mg slow IV push q 20 minutes prn\nuntil desired MAP achieved</center>", "<center>Infusion 0.5-2 mg/min</center>"]]
                },
                {
                    "title" : "<b>Hypertonic Saline (3%)</b>",
                    "loc" : [["acp","first"]],
                    "drugKey" : "3%_saline",
                    "dose_route" : [["<center>3 mL/kg IV/IO\nMAX rate of 20 mL/min\nConsider if MAP < 80 mmHg</center>"]]
                },
                {
                    "title" : "<b>Mannitol</b>",
                    "drugKey" : "mannitol",
                    "loc" : [["acp","first"]],
                    "dose_route" : [["<center>1 g/kg IV/IO bolus\nMAP >80 mmHg</center>"]]
                }
            ]
        },
        {
            "key" : "adult_seizure",
            "title" : "Adult - Seizures",
            "type" : "medical_directive",
            "indications" : "<tab1>• Active Seizure</tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication\n• If blood glucose level ≤ 4 mmol/L, proceed with protocol for “Hypoglycemic Emergencies”.</tab1>",
            "treatment" : "If, on assessment, a patient is determined to be having a seizure, management of airway, breathing and circulation remain the first priority: adequate oxygenation and ventilation must be ensured.",
            "flowchartkeys" : [["Flowchart", "adult_seizure_flowchart"]],
            "clinical" : "<tab1>• 0.2 micron filter must be used when administering phenyTOIN</tab1>",
            "drug_cards" : [
                {
                    "title" : "<b>Midazolam (Versed) for Seizures</b>",
                    "drugKey" : "midazolam",
                    "loc" : [["acp","after"]],
                    "dose_route" : [["<center>5 mg IV/IO doses repeated every 5 minutes, until seizure termination or MAX dose of 0.2 mg/kg IV/IO in total\n<b>OR</b>\n10 mg IM if no IV/IO access</center>"]]
                },
                {
                    "title" : "<b>phenyTOIN (Dilantin)</b>",
                    "drugKey" : "phenytoin",
                    "loc" : [["acp","first"]],
                    "dose_route" : [["<center>20 mg/kg add to 250 mL NS IV/IO\nInfusion should be no faster than 25 mg/min\n\n<b>USE NORMAL SALINE ONLY</b>\nphenyTOIN will precipitate in dextrose solutions</center>"]]
                },
                {
                    "title" : "<b>Propofol</b>",
                    "drugKey" : "propofol",
                    "loc" : [["ccp","first"]],
                    "dose_route" : [["<center>50 mg IV/IO q 5 minutes prn if MAP > 70\nPrepare to intubate\nFollowed by infusion at 0-5 mg/kg/hr</center>"]]
                }
            ]
        },
        {
            "key" : "adult_traumatic_arrest",
            "title" : "Adult - Traumatic Cardiac Arrest",
            "type" : "medical_directive",
            "indications" : "<tab1>• Adult patient is vital signs absent (VSA) due to trauma</tab1>",
            "contraindications" : "<tab1>• Not applicable.</tab1>",
            "flowchartkeys" : [["Flowchart", "adult_trauma_arrest_flowchart"]],
            "clinical" : "<tab1>• If this is inter-facility then a STAT patch to the TMP is indicated for further management decision making\n• Routinely bind pelvis if MOI suggests potential for pelvic injury\n• Perform bilateral needle thoracostomy in acute traumatic arrest</tab1>",
            "drug_cards" : [
                {
                    "loc" : [["pcp","after"]],
                    "dose_route" : [["<center><b>Initiate the Traumatic Cardiac arrest algorithm</b></center>"]]
                }
            ]
        },
        {
            "key" : "adult_tbi",
            "title" : "Adult - Traumatic Brain Injury",
            "type" : "medical_directive",
            "indications" : "<tab1>• Traumatic brain injury</tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication</tab1>",
            "flowchartkeys" : [["Flowchart", "adult_tbi_flowchart"]],
            "clinical" : "<tab1>• Trauma patients should be kept warm with temperature > 35 degrees</tab1>",
            "drug_cards" : [
                {
                    "title" : "<b>Norepinephrine (Levophed)</b>",
                    "drugKey" : "norepinephrine",
                    "loc" : [["acp","after"]],
                    "dose_route" : [["<center>0-0.5 microgram/kg/min IV/IO\nTarget MAP > 80</center>"]]
                },
                {
                    "title" : "<b>Hypertonic Saline (3%)</b>",
                    "drugKey" : "3%_saline",
                    "loc" : [["acp","first"]],
                    "dose_route" : [["<center>3 mL/kg IV/IO\nMAX rate of 20 mL/min\n\nConsider if MAP < 80 mmHg</center>"]]
                },
                {
                    "section" : "OR",
                    "title" : "<b>Mannitol</b>",
                    "drugKey" : "mannitol",
                    "loc" : [["acp","first"]],
                    "dose_route" : [["<center>1 g/kg IV/IO bolus\n\nMAP > 80 mmHg</center>"]]
                }
            ]
        },
        {
            "key" : "adult_sci",
            "title" : "Adult - Spinal Cord Injury",
            "type" : "medical_directive",
            "indications" : "<tab1>• Spinal cord injury</tab1>",
            "contraindications" : "<tab1>• Not applicable</tab1>",
            "flowchartkeys" : [["Flowchart", "adult_sci_flowchart"]],
            "clinical" : "<tab1>• Not applicable</tab1>",
            "drug_cards" : [
                {
                    "dose_route" : [["<center><b>See flowchart</b></center>"]]
                }
            ]
        },
        {
            "key" : "adult_neurogenic_shock",
            "title" : "Adult - Neurogenic Shock",
            "type" : "medical_directive",
            "indications" : "<tab1>• Neurogenic shock</tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication</tab1>",
            "flowchartkeys" : [["Flowchart", "adult_neurogenic_shock_flowchart"]],
            "clinical" : "<tab1>• In neurogenic shock (if not also hypovolemic) there is sufficient alpha activity at low doses of levophed that significant reflex bradycardia may arise due to unopposed vasoconstriction and carotid body stimulation/vagal tone. In this situation, dopamine may be considered</tab1>",
            "drug_cards" : [
                {
                    "title" : "<b>Normal Saline or Ringers Lactate</b>",
                    "loc" : [["acp","none"]],
                    "dose_route" : [["<center>20-40 mL/kg IV/IO bolus\nTarget MAP > 80</center>"]]
                },
                {
                    "title" : "<b>Norepinephrine (Levophed)</b>",
                    "drugKey" : "norepinephrine",
                    "loc" : [["acp","after"]],
                    "dose_route" : [["<center>0-0.5 microgram/kg/min IV/IO\nTarget MAP > 80</center>"]]
                },
                {
                    "title" : "<b>Atropine Sulfate (Atropine)</b>",
                    "drugKey" : "atropine",
                    "loc" : [["acp","after"]],
                    "dose_route" : [["<center>0.5 mg IV/IO q 3-5 minutes prn\nTotal MAX dose 3 mg (whichever is less)</center>"]]
                },
                {
                    "title" : "<b>DOPamine</b>",
                    "drugKey" : "dopamine",
                    "loc" : [["acp","after"]],
                    "dose_route" : [["<center>5-20 microgram/kg/min IV\nTarget MAP > 80</center>"]]
                },
                {
                    "title" : "<b>EPINEPHrine (Adrenalin)</b>",
                    "drugKey" : "epinephrine",
                    "loc" : [["ccp","first"]],
                    "dose_route" : [["<center>0-0.5 microgram/kg/min IV/IO\nTarget MAP > 80</center>"]]
                }
            ]
        },
        {
            "key" : "adult_hemorrhagic_shock",
            "title" : "Adult - Traumatic Hemorrhagic Shock",
            "type" : "medical_directive",
            "indications" : "<tab1>• Hemorrhagic shock MAP < 65 mmHg with active, ongoing and significant bleeding</tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication</tab1>",
            "flowchartkeys" : [["Flowchart", "adult_hemorrhagic_shock_flowchart"]],
            "clinical" : "<tab1>• Avoid hypothermia. Keep patient’s temperature above 35ºC</tab1>",
            "drug_cards" : [
                {
                    "title" : "<b>Normal Saline or Ringers Lactate</b>",
                    "loc" : [["acp","none"]],
                    "dose_route" : [["<center>20-40 mL/kg IV/IO bolus\nTarget MAP > 65</center>"]]
                },
                {
                    "title" : "<b>Consider PRBCs and TXA</b>",
                    "loc" : [["acp","after"]],
                    "dose_route" : [["<center><b><a href=\"directive=adult_blood_product\">See Blood Product Administration Medical Directive</a>\nand <a href=\"directive=adult_txa\">TXA Medical Directive</a></b></center>"]]
                }
            ]
        },
        {
            "key" : "adult_blood_product",
            "title" : "Adult - Blood Product Administration",
            "type" : "medical_directive",
            "indications" : "<tab1>• Hemorrhagic shock MAP < 65 mmHg with active, ongoing and significant bleeding\n• Hemoglobin < 70 grams/litre with evidence of circulatory compromise\n• TMP judgement</tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication</tab1>",
            "clinical" : "<tab1>• Contact the TMP to request Packed Red Blood Cells (PRBCs) at the scene. This would only be indicated in very rare individual circumstances i.e. uncontrolled hemorrhagic shock despite adequate crystalloid resuscitation, prolonged out-of-hospital time (i.e. prolonged extrication) and no significant delay to arrival to patient caused by waiting to retrieve the blood\n• Ensure all available identifiers (i.e. name, blood type, patient number, etc) are checked to ensure correct blood product transfusion\n• Once any of the above products are administered, the blood product form must be completed and submitted to the receiving institution, so that they are aware\n• Informed consent for blood product administration must be obtained if Ornge initiates the blood product (please refer to the consent form in the Clinical Affairs P&P manual) except in life threatening circumstances\n• Please note, if immediate PRBCs are required for an unstable patient request Type O blood if available (O Negative for women of child bearing age)</tab1>",
            "drug_cards" : [
                {
                    "loc" : [["acp","first"]],
                    "dose_route" : [
                        ["<center><b>Packed Red Blood Cells (PRBC)</b></center>", "<center><b>Fresh Frozen Plasma (FFP)</b></center>"],
                        ["<center>1-2 PRBC to maintain\nMAP > 65 mm Hg or Hgb > 70 as directed</center>", "<center>2 U for every 2 U PRBC delivered</center>"]
                    ]
                },
                {
                    "loc" : [["ccp", "after"]],
                    "dose_route" : [
                        ["<center><b>Packed Red Blood Cells (PRBC)</b></center>", "<center><b>Fresh Frozen Plasma (FFP)</b></center>"],
                        ["<center>1-2 PRBC to maintain\nMAP > 65 mm Hg or Hgb > 70 as directed</center>", "<center>2 U for every 2 U PRBC delivered</center>"]
                    ]
                }
            ]
        },
        {
            "key" : "adult_warfarin_reversal",
            "title" : "Adult - Reversal of Warfarin/Coumadin",
            "type" : "medical_directive",
            "indications" : "<tab1>• Prothrombin Complex Concentrate (PCC) if emergency reversal of Warfarin therapy (intracranial bleed, emergency surgery, life threatening bleed) AND INR >1.5\n• Life-threatening hemorrhage (i.e., ICH, major trauma, GI bleed requiring RBC transfusion)\n• Emergency surgery</tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication</tab1>",
            "clinical" : "<tab1>• The most commonly used Prothrombin Complex Concentrate (PCC) is Octaplex but some facilities may also use Beriplex</tab1>",
            "drug_cards" : [
                {
                    "title" : "<b>Prothrombin Complex Concentrate (PCC)*</b>",
                    "loc" : [["acp","first"]],
                    "dose_route" : [
                        ["<center>Initiate or maintain the administration of PCC</center>", "<center>10 mg of IV Vitamin K\n(via slow IV infusion ≤ 1 mg/min)\nMUST be administered either before or during the infusion of PCC for maintenance</center>"]
                    ]
                },
                {
                    "title" : "The usual dose of <b>Octaplex</b> is",
                    "loc" : [["acp","first"]],
                    "dose_route" : [
                        ["<center>50-90 kg</center>", "<center>INR 1.5 - 3.0</center>", "<center>1000 IU (40 mL)</center>"],
                        ["<center>50-90 kg</center>", "<center>INR > 3.0</center>", "<center>2000 IU (80 mL)</center>"],
                        ["<center>> 90 kg</center>", "<center>INR > 1.5</center>", "<center>2000 IU (80 mL)</center>"]
                    ],
                    "notes" : "<b>*PCC is a blood product and requires transfusion consent</b>"
                }
            ]
        },
        {
            "key" : "adult_doac_reversal",
            "title" : "Adult - Direct Oral Anticoagulant/Novel Oral Anticoagulants Reversal",
            "type" : "medical_directive",
            "indications" : "<tab1>• Life-threatening hemorrhage (i.e., ICH, major trauma, GI bleed requiring RBC transfusion)\n• Emergency surgery</tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication</tab1>",
            "clinical" : "<tab1>• Not applicable</tab1>",
            "drug_cards" : [
                {
                    "title" : "<b>Idarucizumab</b>",
                    "loc" : [["acp","first"]],
                    "dose_route" : [
                        ["<center>For Dabigatran (Pradaxa) only</center>","<center>5 grams (2 x 2.5 vials) in 100 mL over 10 minutes by bolus infusion\nCompatible with NS</center>"]
                    ]
                },
                {
                    "title" : "<b>Prothrombin Complex Concentrate (PCC)*</b>",
                    "drugKey" : "pcc",
                    "loc" : [["acp","first"]],
                    "dose_route" : [
                        ["<center>For Rivaroxaban (Xarelto) / Apixaban (Eliquis) only</center>", "<center>2000 IU and repeat\n2000 IU at 1 hour\nif ongoing bleeding</center>"]
                    ],
                    "notes" : "<b>*PCC is a blood product and requires transfusion consent</b>"
                },
                {
                    "title" : "<b>Tranexamic Acid (TXA)</b>",
                    "drugKey" : "txa",
                    "loc" : [["acp","first"]],
                    "dose_route" : [
                        ["<center>For Rivaroxaban (Xarelto) / Apixaban (Eliquis) only</center>", "<center>1 g and repeat in 1 hours (2nd bolus of 1g in 1 hour)</center>"]
                    ]
                }
            ]
        },
        {
            "key" : "adult_txa",
            "title" : "Adult - Tranexamic Acid (TXA) Administration",
            "type" : "medical_directive",
            "indications" : "<tab1>• Treatment of trauma-associated hemorrhage, management of massive bleeding, or prophylaxis of systemic or local hyperfibrinolysis</tab1>",
            "contraindications" : "<tab1>• Known hypersensitivity to TXA\n• Greater than 3 hours from time of injury to drug administration (for traumatic injury)</tab1>",
            "clinical" : "<tab1>• If active bleeding persists, additional 1 gram bolus doses of TXA may be indicated. Discuss with TMP.</tab1>",
            "drug_cards" : [
                {
                    "title" : "<b>Tranexamic Acid (TXA)</b>",
                    "drugKey" : "txa",
                    "loc" : [["acp","after"]],
                    "dose_route" : [
                        ["<center>Initiate if the following indications are met:\n<tab1>• Administration is limited to definite knowledge of <3 hours from time of injury\n• HR > 100 bpm or SBP < 100 mmHg</center>"],
                        ["<center>1 gram loading dose (over 10 minutes)\nrepeat 1g bolus in 1 hour</center>"]
                    ]
                }
            ]
        },
        {
            "key" : "adult_push_dose_epi",
            "title" : "Adult - Push Dose EPINEPHrine (10 mcg/ml = 1: 100 000)",
            "type" : "medical_directive",
            "indications" : "<tab1>• Temporary improvement of circulation in peri-arrest or shock states with severe hypotension and/or bradycardia</tab1>",
            "contraindications" : "<tab1>• Patients in cardiac arrest</tab1>",
            "clinical" : "<tab1>• Epinephrine 1: <b>100</b> 000 may provide temporary stabilization while other therapies are added or adjusted/titrated</tab1>\n\n<b>Preparation of Push Dose Epinephrine - 10 mcg/ml concentration</b>\n1. Using a 10 mL syringe, draw 100 microgram (i.e. 1 mL of 1:10,000) EPINEPHrine and dilute in 9 mL of Normal Saline</tab1>",
            "drug_cards" : [
                {
                    "title" : "<b>EPINEPHrine (Adrenalin) 10 mcg/ml - 1: 100 000</b>",
                    "drugKey" : "epinephrine",
                    "loc" : [["ccp","first"]],
                    "dose_route" : [
                        ["<center>5-20 mcg IV/IO q 2-5 minutes PRN\nTarget MAP >65</center>"]
                    ]
                }
            ]
        },
        {
            "key" : "adult_hypovolemic_shock",
            "title" : "Adult - Hypovolemic Shock",
            "type" : "medical_directive",
            "flowchartkeys" : [["Flowchart", "adult_hypovolemic_shock_flowchart"]],
            "indications" : "<tab1>• Hypotensive as defined by a MAP < 65 mmHg as a result of hypovolemia</tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication</tab1>",
            "clinical" : "<tab1>• Following consultation with the TMP, volume replacement therapy, can be continued by the ACP(f), CCP and PCCP/PCCN with the intent of keeping the patient’s MAP within a normotensive range (i.e. ≥ 65 mmHg). Severe hypovolemia from blood loss should prompt consideration for early use of blood products including both packed red blood cells and fresh frozen plasma in cases of massive transfusion (see Blood Product Administration Medical Directive)\n• In setting of hemorrhage consider early blood component therapy (BCT) and limit crystalloid to 1L - use NS for BCT\n• Avoid crystalloid in large doses in hemorrhagic shock particularly in trauma\n• Crystalloids are indicated in hemorrhagic shock if delay for blood with hypotension and altered mentation\n• Consider TXA if severe hemorrhagic shock</tab1>",
            "drug_cards" : [
                {
                    "title" : "<b>Normal Saline or Ringers Lactate</b>",
                    "loc" : [["acp","after"]],
                    "dose_route" : [
                        ["<center>20 mL/kg IV/IO bolus\nMAX 1 Litre\nREPEAT bolus if patient continues to be symptomatically hypotensive\nTarget MAP > 65</center>"]
                    ]
                },
                {
                    "title" : "<b>Norepinephrine (Levophed)</b>",
                    "drugKey" : "norepinephrine",
                    "loc" : [["acp","after"]],
                    "dose_route" : [
                        ["<center>0-0.5 microgram/kg/min IV/IO\nTarget MAP > 65</center>"]
                    ]
                },
                {
                    "title" : "<b>Consider PRBCs and FFP</b>",
                    "loc" : [["acp","blank"]],
                    "dose_route" : [
                        ["<center><b><a href=\"directive=adult_blood_product\">See Blood Product Administration Medical Directive</a></b></center>"]
                    ]
                }
            ]
        },
        {
            "key" : "adult_sepsis",
            "title" : "Adult - Septic Shock",
            "type" : "medical_directive",
            "flowchartkeys" : [["Flowchart", "adult_sepsis_flowchart"]],
            "indications" : "<tab1>• Septic shock (MAP < 65)</tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication</tab1>",
            "clinical" : "<tab1>• Consider 1 g CaCl in 100 mL NS/1 hour if ionized Ca < 1 or Ca < 2.0 (corrected if available)\n• For patients that are profoundly hypotensive with MAP <50 or pre-arrest consider emergent TMP patch to discuss epinephrine 1: 100 000 and start Norepinephrine infusion at minimum 0.3 mcg/kg/min. Crystalloid bolus should be given concurrently with push dose pressors and/or Norepinephrine infusion initiation\n• If Hydrocortisone not available consider Methylprednisolone 125 mg IV/IO</tab1>",
            "drug_cards" : [
                {
                    "title" : "<b>Normal Saline or Ringers Lactate</b>",
                    "loc" : [["acp","none"]],
                    "dose_route" : [
                        ["<center>30 mL/kg IV/IO bolus\nTarget MAP > 65</center>"]
                    ]
                },
                {
                    "title" : "<b>Norepinephrine (Levophed)</b>",
                    "drugKey" : "norepinephrine",
                    "loc" : [["acp","after"]],
                    "dose_route" : [
                        ["<center>0-0.5 microgram/kg/min IV/IO\nTarget MAP > 65</center>"]
                    ]
                },
                {
                    "title" : "<b>Vasopressin</b>",
                    "drugKey" : "vasopressin",
                    "loc" : [["ccp","first"]],
                    "dose_route" : [
                        ["<center>0-0.04 units/min IV/IO\nTarget MAP > 65</center>"]
                    ]
                },
                {
                    "title" : "<b>EPINEPHrine (Adrenalin)</b>",
                    "drugKey" : "epinephrine",
                    "loc" : [["ccp","first"]],
                    "dose_route" : [
                        ["<center>0-0.5 microgram/kg/min IV/IO\nTarget MAP > 65</center>"]
                    ]
                },
                {
                    "title" : "<b>Hydrocortisone</b>",
                    "drugKey" : "hydrocortisone",
                    "loc" : [["acp","first"]],
                    "dose_route" : [
                        ["<center>100 mg IV/IO</center>"]
                    ]
                }
            ]
        },
        {
            "key" : "adult_extravasation_vasopressors",
            "title" : "Adult - Extravasation of Vasopressors from Peripheral IV Infusion",
            "type" : "medical_directive",
            "indications" : "<tab1>• Extravasation of norepinephrine, epinephrine, dopamine, DOBUTamine, vasopressin, or phenylephrine from peripheral IV site</tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication</tab1>",
            "clinical" : "<tab1>• Extravasation of vasopressors may potentially cause necrosis of tissue around the IV site or possibly compartment syndrome. Whenever possible, a central line should be used. If peripheral IV access is the only route available, try to avoid the hand or wrist whenever possible. Any IV pressor site should be kept visible and examined q 15 minutes to assess for extravasation\n• The phentolamine may cause systemic hypotension, but should be addressed if the secondary IV site is running the original pressor</tab1>",
            "drug_cards" : [
                {
                    "title" : "<b>Phentolamine</b>\n(within 12 hour of extravasation)",
                    "drugKey" : "phentolamine",
                    "loc" : [["acp","after"]],
                    "dose_route" : [
                        ["<center>0.1 mg/kg to a max of 10 mg in 9 mL of NS (using a different syringe should be injected) half through the problematic IV catheter over 60 seconds and half as a Sub Q injection around the site using a 25G – 30G needle into any area where tissue discoloration or swelling is seen</center>"]
                    ]
                }
            ]
        },
        {
            "key" : "adult_nausea",
            "title" : "Adult - Nausea, Vomiting and Motion Sickness",
            "type" : "medical_directive",
            "indications" : "<tab1>• Nausea, vomiting, or prevention of motion sickness</tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication\n• Received dimenhyDRINATE or Ondansetron within the last 4 hours\n• Prolonged QT interval or concomitant use of other drugs that may prolong the QT interval (specific to Ondansetron)</tab1>",
            "clinical" : "<tab1>• dimenhyDRINATE should be administered SLOW IV push to prevent vertigo, weakness and dizziness</tab1>",
            "drug_cards" : [
                {
                    "title" : "<b>dimenhyDRINATE (Gravol)</b>",
                    "drugKey" : "dimenhydrinate",
                    "loc" : [["pcp","none"]],
                    "dose_route" : [
                        ["<center>50 mg IM/PO</center>"]
                    ]
                },
                {
                    "title" : "<b>dimenhyDRINATE (Gravol)</b>",
                    "drugKey" : "dimenhydrinate",
                    "loc" : [["acp","none"]],
                    "dose_route" : [
                        ["<center>50 mg IM/PO\nOR\n50 mg/10 mL NS over ≥ 5 minutes</center>"]
                    ]
                },
                {
                    "section" : "OR",
                    "title" : "<b>Ondansetron (Zofran)*</b>",
                    "drugKey" : "ondansetron",
                    "loc" : [["acp","none"]],
                    "dose_route" : [
                        ["<center>4 mg IM q 4-8 hours prn\nOR\n4 mg IV in 50-100 mL NS over ≥ 15 minutes q 4-8 hours prn</center>"]
                    ],
                    "notes" : "<b>*Black box warnings due to risk of prolonged QT</b>\n<tab1>• All IV doses must be diluted in 50–100 mL of saline or other compatible fluid\n• All IV doses must be infused over no less than 15 minutes</tab1>"
                }
            ]
        },
        {
            "key" : "adult_gastric_tubes",
            "title" : "Adult - Gastric (NG or OG) Tubes",
            "type" : "medical_directive",
            "indications" : "<tab1>• Actual or anticipated need to evacuate gastric contents\n• Intubated and ventilated patients or SGA being used for transport</tab1>",
            "contraindications" : "<tab1>• Nasogastric -Patients presenting with facial smash or suspected basal skull fracture</tab1>",
            "clinical" : "<tab1>• Insertion should not delay transport</tab1>",
            "drug_cards" : [
                {
                    "loc" : [["pcp","none"]],
                    "dose_route" : [
                        ["<center><b>Maintenance Only</b>\nEnsure the gastric tube is appropriately located via auscultation</center>"]
                    ]
                },
                {
                    "loc" : [["acp","none"]],
                    "dose_route" : [
                        ["<center><b>Insertion and/or Maintenance</b>\nEnsure the gastric tube is appropriately located via auscultation\nConfirm by partner prior to departure</center>"]
                    ]
                }
            ]
        },
        {
            "key" : "adult_gi_bleed",
            "title" : "Adult - Gastrointestinal Bleed",
            "type" : "medical_directive",
            "flowchartkeys" : [["Flowchart", "adult_gi_bleed_flowchart"]],
            "indications" : "<tab1>• Treatment of gastrointestinal bleed</tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication</tab1>",
            "clinical" : "<tab1>• Consider <a href=\"drugKey=ceftriaxone\">Ceftrixone</a> 1 g IV/IO</tab1>",
            "drug_cards" : [
                {
                    "title" : "<b>Normal Saline or Ringers Lactate</b>",
                    "loc" : [["acp","none"]],
                    "dose_route" : [
                        ["<center>20 mL/kg IV/IO bolus\nTarget MAP > 65</center>"]
                    ]
                },
                {
                    "title" : "<b>Consider PRBC</b>",
                    "loc" : [["acp","blank"]],
                    "dose_route" : [
                        ["<center><b><a href=\"directive=adult_blood_product\">See Blood Product Administration Medical Directive</a></b></center>"]
                    ]
                },
                {
                    "loc" : [["acp","none"]],
                    "dose_route" : [
                        ["<center>The paramedic may continue a <b>Pantoprazole</b> and/or <b>Octreotide</b> infusion from sending facility</center>"]
                    ]
                },
                {
                    "title" : "<b>Pantoprazole</b>",
                    "loc" : [["acp", "first"]],
                    "drugKey" : "pantoprazole",
                    "dose_route" : [
                        ["<center>Bolus</center>", "<center>Infusion</center>"],
                        ["<center>80 mg IV/IO\nfollowed by infusion</center>", "<center>8 mg/hr IV/IO</center>"]
                    ]
                },
                {
                    "title" : "<b>Octreotide</b>",
                    "drugKey" : "octreotide",
                    "loc" : [["acp", "first"]],
                    "dose_route" : [
                        ["<center>Bolus</center>", "<center>Infusion</center>"],
                        ["<center>50 microgram IV/IO over 3 minutes\nfollowed by infusion</center>", "<center>50 microgram/hr IV/IO</center>"]
                    ]
                }
            ]
        },
        {
            "key" : "adult_blakemore_tube",
            "title" : "Adult - Gastroesophageal Balloon Tamponade Devices (Blakemore Tube)",
            "type" : "medical_directive",
            "indications" : "<tab1>• Patients who have a gastroesophageal balloon tamponade device (i.e. Sengstaken-Blakemore Tube) in place</tab1>",
            "contraindications" : "<tab1>• Not applicable</tab1>",
            "clinical" : "<tab1>• Ideally the patient should be intubated and sedated to increase patient tolerance and comfort\n• Maintain 1 kg of traction with BVM mask and forceps\n• Esophageal balloon pressure should be monitored and should remain between 25-45 mmHg. (35-60 cmH2O) Conversion of mmHg to cm H2O = multiply X 1.36</tab1>",
            "drug_cards" : [
                {
                    "loc" : [["ccp","first"]],
                    "dose_route" : [
                        ["<center>If the patient is not intubated, scissors should be readily available to cut the port for balloon deflation should the tube and balloon be pulled back into the pharynx, resulting in a hypopharyngeal occlusion</center>"]
                    ]
                }
            ]
        },
        {
            "key" : "adult_esophageal_probe",
            "title" : "Adult - Esophageal Temperature Probes",
            "type" : "medical_directive",
            "indications" : "<tab1>• Continuous monitoring of core body temperature for any intubated patient with a temperature outside normal range (36.5 to 37.5oC)\n• Temperature monitoring during active rewarming measures\n• Continuous monitoring may be ordered by the TMP at their discretion\n• Required for targeted temperature management in ROSC</tab1>",
            "contraindications" : "<tab1>• Esophageal strictures\n• Esophageal varices\n• Esophageal perforation\n• Congenital anomalies such as tracheal esophageal fistula\n• Post-Operative tonsil and adenoidectomy patients\n• Facial trauma\n• Patients receiving Anticoagulants. Anticoagulants include but are not limited to: IV Heparin, Warfarin (Coumadin), Enoxaparin (Lovenox)</tab1>",
            "clinical" : "<tab1>• It is preferable to assess position of probe using a CXR but should not delay transport</tab1>",
            "drug_cards" : [
                {
                    "loc" : [["acp","none"]],
                    "dose_route" : [
                        ["<center><b>Insert and monitor core temperature with Esophageal Temperature probe</b></center>"]
                    ]
                }
            ]
        },
        {
            "key" : "adult_urinary_catheter",
            "title" : "Adult - Urinary Catheter Insertion and Maintenance",
            "type" : "medical_directive",
            "indications" : "<tab1>• For monitoring urine output\n• For urinary tract obstruction</tab1>",
            "contraindications" : "<tab1>• Blood at the urethral meatus\n• Perineal or scrotal hematoma\n• Suspected urethral tear\n• High riding prostate</tab1>",
            "clinical" : "<tab1>• Urinary catheter removal can only be performed by the ACP(f), CCP and PCCP/PCCN\n• If during transport the catheter becomes obstructed contact the TMP</tab1>",
            "drug_cards" : [
                {
                    "loc" : [["pcp","none"]],
                    "dose_route" : [
                        ["<center><b>Maintenance Only</b></center>"]
                    ]
                },
                {
                    "loc" : [["acp","none"]],
                    "dose_route" : [
                        ["<center><b>Insertion and/or Maintenance</b></center>"]
                    ]
                }
            ]
        },
        {
            "key" : "adult_fever",
            "title" : "Adult - Fever",
            "type" : "medical_directive",
            "indications" : "<tab1>• Fever - temperature >38oC</tab1>",
            "contraindications" : "<tab1>• Acetaminophen within the last 4 hours\n• Ibuprofen:</tab1><tab2>\n• NSAID or Ibuprofen use within previous 6 hours\n• Patient on anticoagulation therapy\n• Current active bleeding\n• Hx of peptic ulcer disease or GI bleed\n• Pregnant\n• If asthmatic, no prior use of ASA or other NSAIDs\n• CVA or TBI in the previous 24 hours\n• Known renal impairment\n• Active vomiting\n• Unable to tolerate oral medication</tab2>",
            "clinical" : "<tab1>• Total acetaminophen dose in 24 hours is not to exceed the lesser of 75 mg/kg or 4 grams</tab1>",
            "drug_cards" : [
                {
                    "title" : "<b>Acetaminophen (Tylenol)</b>",
                    "drugKey" : "acetaminophen",
                    "loc" : [["pcp","none"]],
                    "dose_route" : [
                        ["<center>40 - 60 kg</center>", "<center>15 mg/kg PO every 4 hours</center>"],
                        ["<center>≥ 60 kg</center>", "<center>975-1000 mg PO/PR every 4 hours</center>"]
                    ]
                },
                {
                    "title" : "<b>Ibuprofen (Advil)</b>",
                    "drugKey" : "ibuprofen",
                    "loc" : [["pcp","none"]],
                    "dose_route" : [
                        ["<center>≥ 40 kg</center>", "<center>400 mg</center>"]
                    ]
                }
            ]
        },
        {
            "key" : "adult_anaphylaxis",
            "title" : "Adult - Anaphylaxis",
            "type" : "medical_directive",
            "indications" : "<tab1>• Confirmed or suspected history of exposure to an allergen\nAND\n• Signs and symptoms of a severe life-threatening anaphylactic reaction</tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication</tab1>",
            "clinical" : "<tab1>• May need EPINEPHrine infusion for refractory anaphylaxis\n• Consider histamine antagonists such as Ranitidine</tab1>",
            "drug_cards" : [
                {
                    "title" : "<b>EPINEPHrine (Adrenaline) 1:1000 Solution</b>",
                    "loc" : [["pcp","after"]],
                    "drugKey" : "epinephrine",
                    "dose_route" : [
                        ["<center>0.01 mg/kg IM in anterolateral thigh\n(min 0.1 mg to max 0.5 mg)\nMay repeat x 1 after 5 minutes\nUse caution in elderly and those with CAD</center>"]
                    ]
                },
                {
                    "title" : "<b>Salbutamol (Ventolin) Solution\nVia Nebulized Aerosol (2.5 mg/2.5 mL)</b>",
                    "loc" : [["pcp","after"]],
                    "drugKey" : "salbutamol",
                    "dose_route" : [
                        ["<center>5 mg q 5-15 minutes x 3 prn</center>"]
                    ],
                    "notes" : "*Total volume of Salbutamol and Normal Saline should be 5.0 mL"
                },
                {
                    "title" : "<b>Salbutamol (Ventolin) MDI\n(100 microgram/puff)</b>",
                    "loc" : [["pcp","after"]],
                    "drugKey" : "salbutamol",
                    "dose_route" : [
                        ["<center>8 puffs\n(4 breaths or 45 seconds between each administration)\nmay repeat x 3 q 5-15 minutes prn</center>"]
                    ],
                    "notes" : "*Total volume of Salbutamol and Normal Saline should be 5.0 mL"
                },
                {
                    "title" : "<b>diphenhyDRAMINE (Benadryl)</b>",
                    "loc" : [["pcp","none"]],
                    "drugKey" : "diphenhydramine",
                    "dose_route" : [
                        ["<center>1 mg/kg/dose IM\nMAX of 50 mg/dose</center>"]
                    ]
                },
                {
                    "title" : "<b>diphenhyDRAMINE (Benadryl)</b>",
                    "loc" : [["acp","none"]],
                    "drugKey" : "diphenhydramine",
                    "dose_route" : [
                        ["<center>1 mg/kg/dose IV/IM\nMAX of 50 mg/dose</center>"]
                    ]
                },
                {
                    "title" : "<b>methylPREDNISolone Sodium Succinate (Solumedrol)</b>",
                    "loc" : [["acp","first"]],
                    "drugKey" : "methylprednisolone",
                    "dose_route" : [
                        ["<center>125 mg IV/IO</center>"]
                    ]
                },
                {
                    "section" : "<b>For Persistent Hypotension with MAP <65 mm Hg</b>",
                    "title" : "<b>Normal Saline or Ringers Lactate</b>",
                    "loc" : [["acp","after"]],
                    "dose_route" : [
                        ["<center>20 mL/kg IV/IO bolus\nMAX 1 Litre\nREPEAT bolus if patient continues to be symptomatically hypotensive\nTarget MAP > 65</center>"]
                    ]
                },
                {
                    "title" : "<b>EPINEPHrine (Adrenalin)</b>",
                    "loc" : [["ccp","first"]],
                    "drugKey" : "epinephrine",
                    "dose_route" : [
                        ["<center>0-0.5 microgram/kg/min IV/IO\nTarget MAP > 65</center>"]
                    ]
                }
            ]
        },
        {
            "key" : "adult_hypoglycemia",
            "title" : "Adult - Hypoglycemic Emergencies",
            "type" : "medical_directive",
            "indications" : "<tab1>• Altered level of consciousness (GCS <14)\n• Blood glucose < 4 mmol</tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication\n• Pheochromocytoma is a contraindication to glucagon</tab1>",
            "clinical" : "<tab1>• Not applicable</tab1>",
            "drug_cards" : [
                {
                    "title" : "<b>Glucagon for Hypoglycemia</b>",
                    "loc" : [["pcp","after"]],
                    "drugKey" : "glucagon",
                    "dose_route" : [
                        ["<center>1 mg IM\n(1 mL)</center>", "<center><b>Repeat blood glucose measurement\n20 minutes after the administration of Glucagon</b>\n\nFollow with oral carbohydrates ASAP if LOC permits\n(i.e. a meal or snack)</center>"]
                    ]
                },
                {
                    "title" : "<b>50% Dextrose for Hypoglycemia</b>",
                    "loc" : [["acp","after"]],
                    "drugKey" : "d50w",
                    "dose_route" : [
                        ["<center>25 g of D50W IV\n(50 mL D50W)</center>", "<center>Repeat blood glucose measurement\n10 minutes after the administration of\nDextrose IV\n\nFollow with oral carbohydrates <b>ASAP</b> if LOC permits</center>"]
                    ]
                },
                {
                    "section" : "After the administration of Glucagon and/or Dextrose, if an IV is present, the ACP(f), and CCP should begin an infusion of D10W or D10NS at 100 mL/hr (the accompanying preparation table identifies the process for creating a 10% Dextrose solution).\n",
                    "title" : "<b>10% Dextrose Solution</b>",
                    "loc" : [["nil","nil"]],
                    "dose_route" : [
                        ["<center><b>IF YOU HAVE:</b></center>", "<center><b>REMOVE FROM THE BAG:</b></center>", "<center><b>ADD TO THE BAG:</b></center>"],
                        ["<center>250 mL Normal Saline</center>", "<center>50 mL</center>", "<center>1 prefilled syringe of D50W (50 mL)</center>"],
                        ["<center>250 mL D5W</center>", "<center>25 mL</center>", "<center>25 mL of 1 prefilled syringe of D50W</center>"]
                    ]
                },
                {
                    "title" : "<b>Thiamine (Vitamin B1)</b>",
                    "loc" : [["acp","none"]],
                    "drugKey" : "thiamine",
                    "dose_route" : [
                        ["<center>When alcoholism or malnutrition are suspected</center>", "<center>100 mg IV\n(mini bag or push)\nor\n100 mg IM</center>"]
                    ]
                }
            ]
        },
        {
            "key" : "adult_hyperkalemia",
            "title" : "Adult - Hyperkalemia",
            "type" : "medical_directive",
            "flowchartkeys" : [["Flowchart", "adult_hyperkalemia"]],
            "indications" : "<tab1>• Patient exhibiting signs and symptoms of hyperkalemia</tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication</tab1>",
            "clinical" : "<tab1>• Not applicable</tab1>",
            "drug_cards" : [
                {
                    "title" : "<b>Normal Saline or Ringers Lactate</b>",
                    "loc" : [["acp","none"]],
                    "dose_route" : [
                        ["<center>10 mL/kg IV/IO bolus\nTarget MAP > 65</center>"]
                    ]
                },
                {
                    "title" : "<b>Calcium Gluconate (10%)</b>",
                    "loc" : [["acp","after"]],
                    "drugKey" : "calcium_gluconate",
                    "dose_route" : [
                        ["<center>20 mg/kg IV/IO (Max single dose 1g) - q 5 minutes PRN\nMax TOTAL dose 40 mg/kg or 2g (lesser of)\nAdminister over 2-3 minutes\nAdditional doses may be required, discuss with TMP</center>"]
                    ],
                    "notes" : "OR - if patient in cardiac arrest/pre-arrest"
                },
                {
                    "title" : "<b>Calcium Chloride (Calcijet)</b>",
                    "loc" : [["acp","after"]],
                    "drugKey" : "calcium_chloride",
                    "dose_route" : [
                        ["<center>20 mg/kg IV/IO q 5 minutes prn\nSingle MAX dose 1g over 20 minutes PIV (5 minutes if central line)\nTotal MAX dose 40 mg/kg or 2g (lesser of)\nSlow IVP is appropriate in the setting of cardiac arrest/pre-arrest</center>"]
                    ]
                },
                {
                    "title" : "<b>Sodium Bicarbonate (NaHCO3)</b>",
                    "loc" : [["acp","after"]],
                    "drugKey" : "sodium_bicarbonate",
                    "dose_route" : [
                        ["<center>1 mEq/kg dose (typically 50 mEq) IV/IO</center>"]
                    ]
                },
                {
                    "title" : "<b>Dextrose</b>",
                    "loc" : [["acp","after"]],
                    "drugKey" : "d50w",
                    "dose_route" : [
                        ["<center>25 g IV/IO - Repeat X 1 if required</center>"]
                    ]
                },
                {
                    "title" : "<b>Humulin R (Insulin)</b>",
                    "loc" : [["acp","after"]],
                    "drugKey" : "insulin",
                    "dose_route" : [
                        ["<center>10 units IV/IO</center>"]
                    ]
                },
                {
                    "title" : "<b>Salbutamol (Ventolin) MDI\n(100 microgram/puff)</b>",
                    "loc" : [["acp","after"]],
                    "drugKey" : "salbutamol",
                    "dose_route" : [
                        ["<center>16 puffs x 2 q 5-15 minutes prn\n(45 seconds between each administration)</center>"]
                    ]
                },
                {
                    "section" : "OR",
                    "title" : "<b>Salbutamol (Ventolin) Solution\nVia Nebulized Aerosol (2.5 mg/2.5 mL)</b>",
                    "loc" : [["acp","after"]],
                    "drugKey" : "salbutamol",
                    "dose_route" : [
                        ["<center>10 mg x 2 q 5-15 minutes prn</center>"]
                    ],
                    "notes" : "*Total volume of Salbutamol and Normal Saline should be 3 mL"
                }
            ]
        },
        {
            "key" : "adult_tylenol_od",
            "title" : "Adult - Suspected Acetaminophen Overdose",
            "type" : "medical_directive",
            "flowchartkeys" : [["Flowchart", "adult_tylenol_od_flowchart"]],
            "indications" : "Suspected Acetaminophen toxicity",
            "contraindications" : "Allergy or sensitivity to the medication",
            "drug_cards" : [
                {
                    "title" : "<b>3% Mucomyst (Acetylcysteine)*\nDosage Guide and Preparation for IV Administration (reference CPS)</b>",
                    "drugKey" : "acetylcysteine",
                    "loc" : [["acp", "none"]],
                    "dose_route" : [
                        ["", "Initial Infusion\n60 mg/kg/hr x 4 hrs", "Maintenance Infusion\n6 mg/kg/hr", "*High Risk*\nMaintenance Infusion\n12 mg/kg/hr"],
                        ["<b>Body Weight (kg)</b>", "Dose\n(ml/hr)", "Dose\n(ml/hr)", "Dose\n(ml/hr)"],
                        ["40", "80", "8", "16"],
                        ["50", "100", "10", "20"],
                        ["60", "120", "12", "24"],
                        ["70", "140", "14", "28"],
                        ["80", "160", "16", "32"],
                        ["90", "180", "18", "36"],
                        ["100", "200", "20", "40"],
                        ["110", "220", "22", "44"],
                        ["120", "240", "24", "48"]
                    ],
                    "notes" : "*Please refer to MucomystTM (acetylcysteine) Drug Monographs profile"
                }
            ],
            "clinical" : "<tab1>• *If local reaction or rash occurs: Stop the infusion temporarily, treat with antihistamines, ventolin prn, then restart infusion at ½ the rate\n• <b>Mandatory Patch</b> required to initiate an acetylcysteine infusion\n• The ACP(f), CCP and PCCP/PCCN may maintain the administration of a MucomystTM (acetylcysteine) infusion as per the above table for an Acetaminophen overdose <b>in the following circumstances:</b>\n</tab1><tab2>◦ The infusion was initiated by the sending facility\n◦ Ingested or suspected ingestion of Acetaminophen dose is greater or equal to:\n</tab2><tab3>• 10 g TOTAL\n <b> OR </b> \n• 200 mg/kg ideal body weight\n</tab3><tab2>◦ The rate of infusion is in accordance with the accompanying dosage table and preparation guide\n◦ The rate of infusion cannot be altered by the Paramedic unless ordered by the Transport Medicine Physician</tab2>\n\n<title>Guidelines to Prepare a 3% Intravenous N-Acetylcysteine Bag</title>\nAs part of the Poison Centre’s treatment recommendations for the acetaminophen-poisoned patient, a 3 % nacetylcysteine solution will need to be prepared. The following are instructions on how to prepare this solution in <b>D5W.</b>\nPatient is > 40 kg\n<tab1>• Remove 150 ml from a 1000 ml bag of D5W\n• Add 150 ml of 20% IV N-Acetylcysteine to the remaining 850 ml in the D5W bag\n</tab1><tab2>◦ 150 ml X 200 mg/ml = 30 000 mg of N-Acetylcysteine\n◦ 30 000 mg in 1000 ml yields a final solution with 30 mg/ml or 3%\n</tab2>NOTES:<tab1>\n 1. 20% IV N-Acetylcysteine is equivalent to 200 mg/ml\n 2. The 3% solution is slightly hyperosmolar but still within the safety margin for administration via a peripheral vein\n 3. It is recognized that any particular bag of IV fluid could have excessive fluid more than advertised. It is of little consequence when making this 3% solution. Assume a finished volume as advertised on the bag\n</tab1>Mixing is important to ensure uniform distribution of N-Acetylcysteine in infusion solution"
        },
        {
            "key" : "adult_opioid_od",
            "title" : "Adult - Suspected Opioid Overdose",
            "type" : "medical_directive",
            "flowchartkeys" : [["Flowchart", "adult_opioid_od_flowchart"]],
            "indications" : "<tab1>• GCS of < 12\nAND\n• Respiratory rate < 10\nAND\n• Suspected acute opioid overdose</tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication</tab1>",
            "drug_cards" : [
                {
                    "title" : "<b>Normal Saline or Ringers Lactate</b>",
                    "loc" : [["acp", "none"]],
                    "dose_route" : [["<center>10-20 ml/kg IV/IO bolus\nTarget MAP > 65</center>"]]
                },
                {
                    "title" : "<b>Naloxone (Narcan)</b>",
                    "drugKey" : "naloxone",
                    "loc" : [["pcp", "after"]],
                    "dose_route" : [["<center>0.8 mg IM\nrepeat q 5 minutes prn\nMAX 10 mg</center>"]]
                },
                {
                    "title" : "<b>Naloxone (Narcan)</b>",
                    "loc" : [["acp", "after"]],
                    "drugKey" : "naloxone",
                    "dose_route" : [["<center>0.4-1.0 mg slow IV, repeat q 3 minutes prn\nMAX 10 mg\nIf increased LOC consider continuous IV infusion initially at ½ total waking dose per hour, titrate according to patient response</center>"]]
                }
            ],
            "clinical" :
                "<tab1>• Should be cautious when dealing with a suspected opioid overdose patient as naloxone (Narcan) can have dramatic effect on a chronic opioid user, causing withdrawals and possible violent behaviors</tab1>"
        },
        {
            "key" : "adult_sedative_od",
            "title" : "Adult - Sedative Overdose",
            "type" : "medical_directive",
            "flowchartkeys" : [["Flowchart", "adult_sedative_od_flowchart"]],
            "indications" : "<tab1>• Known sedative overdose</tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication</tab1>",
            "drug_cards" : [
                {
                    "title" : "<b>Normal Saline or Ringers Lactate</b>",
                    "loc" : [["acp", "none"]],
                    "dose_route" : [["<center>10-20 ml/kg IV/IO bolus\nTarget MAP > 65</center>"]]
                },
                {
                    "title" : "<b>Norepinephrine (Levophed)</b>",
                    "loc" : [["acp", "after"]],
                    "drugKey" : "norepinephrine",
                    "dose_route" : [["<center>0-0.5 microgram/kg/min IV/IO\nTarget MAP > 65</center>"]]
                }
            ],
            "clinical" :
                "<tab1>• Not applicable</tab1>"
        },
        {
            "key" : "adult_betablocker_od",
            "title" : "Adult - Beta Blocker Overdose",
            "type" : "medical_directive",
            "flowchartkeys" : [["Flowchart", "adult_betablocker_od_flowchart"]],
            "indications" : "<tab1>• Known overdose to beta blocker medication</tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication</tab1>",
            "clinical" : "<tab1>• Consider Vasopressors (Norepinephrine/EPINEPHrine/DOPamine)</tab1>",
            "drug_cards" : [
                {
                    "title" : "<b>Normal Saline or Ringers Lactate</b>",
                    "loc" : [["acp", "none"]],
                    "dose_route" : [["<center>10-20 ml/kg IV/IO bolus\nTarget MAP > 65</center>"]]
                },
                {
                    "title" : "<b>Atropine Sulfate (Atropine)</b>",
                    "loc" : [["acp", "after"]],
                    "drugKey" : "atropine",
                    "dose_route" : [["<center>0.5 mg IV/IO q 3-5 minutes prn\nTotal MAX dose 3 mg</center>"]]
                },
                {
                    "title" : "<b>Humulin R (Insulin)</b>",
                    "loc" : [["acp", "first"]],
                    "drugKey" : "insulin",
                    "dose_route" : [
                        ["<center>Bolus*</center>", "<center>IV Infusion</center>"],
                        ["<center>1 unit/kg IV/IO\n(followed by IV infusion)</center>", "<center>0.5 - 2.0 units/kg/hr</center>"]
                    ],
                    "notes" : "*with Dextrose as below"
                },
                {
                    "title" : "<b>Dextrose*</b>",
                    "loc" : [["acp", "first"]],
                    "drugKey" : "d50w",
                    "dose_route" : [
                        ["<center>25 g, Repeat Dextrose X 1 q 60\nmin PRN\nObtain BGL q 15 min</center>"]
                    ],
                    "notes" : "*with Humulin R bolus dose as above"
                },
                {
                    "title" : "<b>Intralipid (Fat Emulsion 20%)</b>",
                    "loc" : [["ccp", "first"]],
                    "drugKey" : "intralipid",
                    "dose_route" : [
                        ["<center>1.5 mL/kg IV/IO over 5 minutes; may repeat X 1\nthen\n0.25 mL/kg/min infusion\nMAX total dose: 12 mL/kg</center>"]
                    ]
                },
                {
                    "title" : "<b>Sodium Bicarbonate (NaHCO3)</b>",
                    "loc" : [["acp", "first"]],
                    "drugKey" : "sodium_bicarbonate",
                    "dose_route" : [
                        ["<center>1-2 mEq/kg IV/IO q 5 minutes prn</center>"]
                    ]
                }
            ]
        },
        {
            "key" : "adult_cchannel_od",
            "title" : "Adult - Calcium Channel Blocker Overdose",
            "type" : "medical_directive",
            "flowchartkeys" : [["Flowchart", "adult_cchannel_od_flowchart"]],
            "indications" : "<tab1>• Known overdose to calcium channel blocker medication</tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication</tab1>",
            "clinical" : "<tab1>• Consider vasopressors</tab1>",
            "drug_cards" : [
                {
                    "title" : "<b>Normal Saline or Ringers Lactate</b>",
                    "loc" : [["acp", "none"]],
                    "dose_route" : [["<center>10-20 ml/kg IV/IO bolus\nTarget MAP > 65</center>"]]
                },
                {
                    "section" : "For refractory hypotension and unstable bradydysrhythmias",
                    "title" : "<b>Calcium Gluconate (10%)</b>",
                    "drugKey" : "calcium_gluconate",
                    "loc" : [["acp", "after"]],
                    "dose_route" : [["<center>20 mg/kg (MAX 1g/10 mL) IV/IO - Repeat q 5 minutes prn\nMAX 100 mg/kg up to 5g</center>"]],
                    "notes" : "OR - if patient in cardiac arrest/pre-arrest"
                },
                {
                    "title" : "<b>Calcium Chloride (CaCl2)</b>",
                    "loc" : [["acp", "after"]],
                    "drugKey" : "calcium_chloride",
                    "dose_route" : [["<center>20 mg/kg (MAX 1 g/10 mL) IV/IO over 5 minutes if central line* (over 20 minutes if peripheral IV)\nRepeat q 5 minutes prn\nMAX 100 mg/kg up to 5 g</center>"]],
                    "notes" : "* Preferred route is central line"
                },
                {
                    "title" : "<b>Atropine Sulfate (Atropine)</b>",
                    "loc" : [["acp", "after"]],
                    "dose_route" : [["<center>0.5 mg IV/IO q 3-5 minutes prn\nTotal MAX dose 3 mg</center>"]]
                },
                {
                    "title" : "<b>Humulin R (Insulin)</b>",
                    "loc" : [["acp", "first"]],
                    "drugKey" : "insulin",
                    "dose_route" : [
                        ["<center>Bolus*</center>", "<center>IV Infusion</center>"],
                        ["<center>1 unit/kg IV/IO\n(followed by IV infusion)</center>", "<center>0.5 - 2.0 units/kg/hr</center>"]
                    ],
                    "notes" : "*with Dextrose as below"
                },
                {
                    "title" : "<b>Dextrose*</b>",
                    "loc" : [["acp", "first"]],
                    "drugKey" : "d50w",
                    "dose_route" : [
                        ["<center>25 g, Repeat Dextrose X 1 q 60\nmin PRN\nObtain BGL q 15 min</center>"]
                    ],
                    "notes" : "*with Humulin R bolus dose as above"
                },
                {
                    "title" : "<b>Intralipid (Fat Emulsion 20%)</b>",
                    "loc" : [["ccp", "first"]],
                    "drugKey" : "intralipid",
                    "dose_route" : [
                        ["<center>1.5 mL/kg IV/IO over 5 minutes; may repeat X 1\nthen\n0.25 mL/kg/min infusion\nMAX total dose: 12 mL/kg</center>"]
                    ]
                }
            ]
        },
        {
            "key" : "adult_cholinesterase_od",
            "title" : "Adult - Cholinesterase Inhibitor Poisoning",
            "type" : "medical_directive",
            "flowchartkeys" : [["Flowchart", "adult_cholinesterase_flowchart"]],
            "indications" : "<tab1>• Known overdose/exposure to a cholinesterase inhibitor</tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication</tab1>",
            "clinical" : "<tab1>• Tachycardia is NOT a contraindication to atropine, often tachycardic due to hypoxia\n• Standard PPE should be worn when treating patients with cholinesterase inhibitors unless the exposure is the result of nerve agent used in bioterrorism which require high level PPE</tab1>",
            "drug_cards" : [
                {
                    "title" : "<b>Atropine Sulfate (Atropine)</b>",
                    "loc" : [["acp", "after"]],
                    "drugKey" : "atropine",
                    "dose_route" : [["<center>2-5 mg IV/IO q 5 minutes prn\nTitrate to the drying of secretions</center>"]]
                },
                {
                    "title" : "<b>Normal Saline or Ringers Lactate</b>",
                    "loc" : [["acp", "none"]],
                    "dose_route" : [["<center>20 ml/kg IV/IO bolus\nTarget MAP > 65</center>"]]
                },
                {
                    "title" : "<b>Norepinephrine (Levophed)</b>",
                    "loc" : [["acp", "after"]],
                    "drugKey" : "norepinephrine",
                    "dose_route" : [
                        ["<center>0-0.5 microgram/kg/min IV/IO\nTarget MAP > 65</center>"]
                    ]
                },
                {
                    "title" : "<b>Pralidoxime* (2-PAM)</b>",
                    "loc" : [["acp", "first"]],
                    "drugKey" : "pralidoxime",
                    "dose_route" : [
                        ["<center>1-2 g IV/IO over 15-20 minutes q 1 hr prn</center>"]
                    ],
                    "notes" : "*Not indicated for carbamate poisoning"
                }
            ]
        },
        {
            "key" : "adult_tca_od",
            "title" : "Adult - Cyclic Antidepressant Overdose",
            "type" : "medical_directive",
            "flowchartkeys" : [["Flowchart", "adult_tca_od_flowchart"]],
            "indications" : "<tab1>• Treatment of a cyclic antidepressant overdose</tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication</tab1>",
            "clinical" : "<tab1>• Not applicable</tab1>",
            "drug_cards" : [
                {
                    "title" : "<b>Normal Saline or Ringers Lactate</b>",
                    "loc" : [["acp", "none"]],
                    "dose_route" : [["<center>10-20 ml/kg IV/IO bolus\nTarget MAP > 65</center>"]]
                },
                {
                    "title" : "<b>Sodium Bicarbonate (NaHCO3)</b>",
                    "loc" : [["acp", "after"]],
                    "drugKey" : "sodium_bicarbonate",
                    "dose_route" : [["<center>1-2 mEq/kg IV/IO\nq 5 minutes; may repeat X 1\nfor MAP < 65 or wide complex tachycardia*</center>"]],
                    "notes" : "*Stop sodium bicarbonate boluses if QRS < 0.12 sec or pH > 7.55"
                },
                {
                    "title" : "<b>Magnesium Sulfate</b>",
                    "loc" : [["acp", "first"]],
                    "drugKey" : "magnesium",
                    "dose_route" : [["<center>MAX 2 g IV/IO over 15 minutes\nfor Torsades de Pointes</center>"]]
                },
                {
                    "title" : "<b>Intralipid (Fat Emulsion 20%)</b>",
                    "loc" : [["ccp", "first"]],
                    "dose_route" : [
                        ["<center>1.5 mL/kg IV/IO over 5 minutes; may repeat X 1\nthen\n0.25 mL/kg/min infusion\nMAX total dose: 12 mL/kg</center>"]
                    ]
                },
                {
                    "section" : "<b>For refractory hypotension",
                    "title" : "<b>Norepinephrine (Levophed)</b>",
                    "drugKey" : "norepinephrine",
                    "loc" : [["acp", "after"]],
                    "dose_route" : [
                        ["<center>0-0.5 microgram/kg/min IV/IO\nTarget MAP > 65</center>"]
                    ]
                }
            ]
        },
        {
            "key" : "adult_salicylate_od",
            "title" : "Adult - Salicylate Overdose",
            "type" : "medical_directive",
            "flowchartkeys" : [["Flowchart", "adult_salicylate_od_flowchart"]],
            "indications" : "<tab1>• Known salicylate overdose</tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication</tab1>",
            "clinical" : "<tab1>• Not applicable</tab1>",
            "drug_cards" : [
                {
                    "title" : "<b>Normal Saline or Ringers Lactate</b>",
                    "loc" : [["acp", "none"]],
                    "dose_route" : [["<center>10-20 ml/kg IV/IO bolus\nTarget MAP > 65</center>"]]
                },
                {
                    "title" : "<b>Sodium Bicarbonate (NaHCO3)</b>",
                    "loc" : [["acp", "first"]],
                    "drugKey" : "sodium_bicarbonate",
                    "dose_route" : [
                        ["<center>Bolus</center>", "<center>Infusion</center>"],
                        ["<center>2 mEq/kg IV/IO</center>", "<center>3 mL/kg/hr IV/IO\n(Remove 150 mL of fluid from 1000 mL of D5W\nand add 150 mEq of Sodium Bicarbonate)</center>"]
                    ]
                },
                {
                    "title" : "<b>Dextrose</b>",
                    "loc" : [["acp", "first"]],
                    "drugKey" : "d50w",
                    "dose_route" : [["<center>Dextrose 0.5 g/kg IV/IO\nto single MAX dose of 25 g\nfollowed by a D1OW infusion at maintenance rate of 2 ml/kg/hr</center>"]]
                }
            ]
        },
        {
            "key" : "adult_stimulant_od",
            "title" : "Adult - Stimulant Overdose",
            "type" : "medical_directive",
            "flowchartkeys" : [["Flowchart", "adult_stimulant_od_flowchart"]],
            "indications" : "<tab1>• Stimulant overdose</tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication</tab1>",
            "clinical" : "<tab1>• Not applicable</tab1>",
            "drug_cards" : [
                {
                    "title" : "<b>Midazolam (Versed)</b>",
                    "loc" : [["acp", "after"]],
                    "drugKey" : "midazolam",
                    "dose_route" : [["<center>0.05 - 0.1 mg/kg IV/IO q 5 minutes prn\n<b>MAP > 65</b></center>"]]
                },
                {
                    "title" : "<b>Nitroglycerin (Tridil)</b>",
                    "loc" : [["acp", "first"]],
                    "drugKey" : "nitroglycerin",
                    "dose_route" : [["<center>10-200 microgram/min IV/IO\ntitrate in 5 microgram/min increments q 5 minutes to effect\nMAX 200 microgram/min</center>"]]
                },
                {
                    "title" : "<b>Sodium Bicarbonate (NaHCO3)</b>\nFor QRS > 0.12 sec or arrhythmias",
                    "loc" : [["acp", "first"]],
                    "drugKey" : "sodium_bicarbonate",
                    "dose_route" : [
                        ["<center>1-2 mEq/kg IV/IO bolus prn</center>"]
                    ]
                },
                {
                    "title" : "<b>Phentolamine</b>",
                    "loc" : [["acp", "first"]],
                    "drugKey" : "phentolamine",
                    "dose_route" : [["<center>1-5 mg IV/IO q 5 minutes prn</center>"]]
                }
            ]
        },
        {
            "key" : "adult_alcohol_od",
            "title" : "Adult - Toxic Alcohol Poisoning",
            "type" : "medical_directive",
            "flowchartkeys" : [["Flowchart", "adult_alcohol_od_flowchart"]],
            "indications" : "<tab1>• Ingestion of toxic alcohol</tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication</tab1>",
            "clinical" : "<tab1>• Not applicable</tab1>",
            "drug_cards" : [
                {
                    "title" : "<b>Normal Saline or Ringers Lactate</b>",
                    "loc" : [["acp", "none"]],
                    "dose_route" : [["<center>10-20 ml/kg IV/IO bolus\nTarget MAP > 65</center>"]]
                },
                {
                    "title" : "<b>Norepinephrine (Levophed)</b>",
                    "loc" : [["acp", "after"]],
                    "drugKey" : "norepinephrine",
                    "dose_route" : [
                        ["<center>0-0.5 microgram/kg/min IV/IO\nTarget MAP > 65</center>"]
                    ],
                    "notes" : "OR"
                },
                {
                    "title" : "<b>Sodium Bicarbonate (NaHCO3)</b>",
                    "loc" : [["acp", "first"]],
                    "drugKey" : "sodium_bicarbonate",
                    "dose_route" : [
                        ["<center>1-2 mEq/kg IV/IO bolus prn</center>"]
                    ]
                },
                {
                    "title" : "<b>Fomepizole (Antizol)</b>",
                    "loc" : [["acp", "first"]],
                    "drugKey" : "fomepizole",
                    "dose_route" : [["<center>15 mg/kg IV/IO (to a single MAX dose of 1 g) in 100 mL Normal Saline infused over 30 minutes\nRepeat at 10 mg/kg IV/IO (to single MAX dose of 1 g) q 12 hours\nMAX dose of 55 mg/kg</center>"]]
                },
                {
                    "title" : "<b>Pyridoxine</b>",
                    "loc" : [["acp", "first"]],
                    "drugKey" : "pyridoxine",
                    "dose_route" : [["<center>1 mg/kg IV/IO\nSingle MAX dose of 50 mg q 6 hours</center>"]]
                },
                {
                    "title" : "<b>Thiamine (Vitamin B1)</b>",
                    "loc" : [["acp", "first"]],
                    "drugKey" : "thiamine",
                    "dose_route" : [["<center>1 mg/kg IV/IO\nSingle MAX dose of 50 mg q 8 hours</center>"]]
                },
                {
                    "title" : "<b>Folic Acid</b>",
                    "loc" : [["acp", "first"]],
                    "drugKey" : "folic_acid",
                    "dose_route" : [["<center>1 mg/kg IV/IO\nSingle MAX dose of 50 mg q 4 hours</center>"]]
                }
            ]
        },
        {
            "key" : "adult_obs_complications",
            "title" : "Obstetrics - Pre-Term Obstetrical Complications",
            "type" : "medical_directive",
            "flowchartkeys" : [["Flowchart", "adult_obs_preterm_flowchart"]],
            "indications" : "<tab1>• Patients at high risk of preterm birth</tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication</tab1>",
            "clinical" : "<tab1>• Use caution in administering a tocolytic to someone with an antepartum hemorrhage</tab1>",
            "drug_cards" : [
                {
                    "section" : "<b>Tocolytics</b>",
                    "title" : "<b>Indomethacin (<30 weeks only)</b>",
                    "loc" : [["acp", "first"]],
                    "drugKey" : "indomethacin",
                    "dose_route" : [["<center>100 mg PR\nfollowed by 25-50 mg every 6 hours for 48 hours max</center>"]]
                },
                {
                    "section" : "OR",
                    "title" : "<b>niFEDIPine (Adalat)</b>\nContraindicated with MAP < 70\nTablets should not be crushed",
                    "loc" : [["acp", "first"]],
                    "drugKey" : "nifedipine",
                    "dose_route" : [
                        ["<center>20 mg PO</center>", "<center>Initial dose of 10-20 mg PO, then 10 mg PO q 20 minutes if contractions persist to MAX dose of 40 mg in the first hour of treatment</center>", "<center>May continue treatment of 10-20 mg q 4h if contractions persist to MAX dose of 120 mg/day</center>"]
                    ]
                },
                {
                    "section" : "Other",
                    "title" : "<b>Glucocorticoids</b>",
                    "loc" : [["acp", "first"]],
                    "dose_route" : [
                        ["<center><b><a href=\"drugKey=dexamethasone\">Dexamethasone</a></b></center>", "<center><b>Betamethasone</b></center>"],
                        ["<center>6 mg IM q 12 hours x 4\nif 24 - < 35 weeks</center>", "<center>12 mg IM q 24 hours x 2\nif 24 - < 35 weeks</center>"]
                    ],
                    "notes" : "<b>Clinical Considerations</b>\n<tab1>• Antenatal glucocorticoid therapy may be administered between 35+0 to 36 + 6 weeks gestation in select clinical situations in discussion with Obstetrician</tab1>"
                },
                {
                    "title" : "<b>Antibiotics</b>",
                    "loc" : [["acp", "first"]],
                    "dose_route" : [
                        ["<center><a href=\"drugKey=ampicillin\">Ampicillin</a> 2 g IV q 6 hours</center>", "<center><red>and</red></center>", "<center>Erythromycin 250 mg IV q 6 hours for 48 hours</center>"]
                    ]
                },
                {
                    "title" : "<b>Magnesium Sulfate (MgSO4)</b>",
                    "loc" : [["acp", "first"]],
                    "drugKey" : "magnesium",
                    "dose_route" : [
                        ["<center>IV loading dose of 4 g: (over 27 minutes or 150 mg/min MAX)\nMaintenance infusion: 1 g/hr</center><tab1>\n• Dose should not exceed 30-40 g/24 hours or 20 g/48 hours in renal insufficiency\n• Dilute to a ≤ 20% solution for IV infusion</tab1>"]
                    ]
                }
            ]
        },
        {
            "key" : "adult_obs_eclampsia",
            "title" : "Obstetrics - Pre-eclampsia / Eclampsia",
            "type" : "medical_directive",
            "flowchartkeys" : [["Flowchart", "adult_obs_eclampsia_flowchart"]],
            "indications" : "<tab1>• Symptoms of pre-eclampsia/eclampsia and pregnant or post—partum within 28 days\n• Pre-eclampsia with severe features is defined as including Proteinuria, Platelets <100,000, a doubling of the serum creatinine, LFT 2x normal, pulmonary edema, or cerebral or visual symptoms</tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication</tab1>",
            "treatment" : "If, on assessment, a patient is determined to be having a seizure, management of airway, breathing and circulation remain the first priority: adequate oxygenation and ventilation must be ensured.",
            "clinical" : "<tab1>• Eclamptic seizures are almost always self-limiting and seldom last longer than three to four minutes (usual duration 60 to 75 seconds). Magnesium loading dose is used to prevent recurrent seizures\n• The magnesium dosage regimen should not cause toxicity in normal renal function\n• In event of magnesium toxicity (i.e. respiratory depression/paralysis, severe hypotension) give calcium chloride\n• Magnesium sulphate is recommended as prophylaxis against eclampsia in women with severe preeclampsia\n• Routine monitoring of serum magnesium levels is not recommended\n• Phenytoin and benzodiazepines should not be used for eclampsia prophylaxis or treatment, unless there is a contraindication to magnesium sulphate or it is ineffective</tab1>",
            "drug_cards" : [
                {
                    "section" : "<b>For severe signs and symptoms of pre-eclampsia</b>",
                    "title" : "<b>Magnesium Sulfate (MgSO4)</b>",
                    "drugKey" : "magnesium",
                    "loc" : [["acp", "first"]],
                    "dose_route" : [
                        ["<center>IV loading dose of 4 g: (over 27 minutes or 150 mg/min MAX)\nMaintenance infusion: 1 g/hr</center><tab1>\n• Dose should not exceed 30-40 g/24 hours or 20 g/48 hours in renal insufficiency\n• Dilute to a ≤ 20% solution for IV infusion</tab1>"]
                    ]
                },
                {
                    "section" : "<b>Labetalol or Hydralazine</b>",
                    "title" : "<b>Labetalol (Trandate)</b>",
                    "drugKey" : "labetalol",
                    "loc" : [["acp", "first"]],
                    "dose_route" : [
                        ["<center>10-20 mg IV/IO q 20 minutes prn OR 1-2 mg/min infusion</center>"]
                    ]
                },
                {
                    "section" : "OR",
                    "title" : "<b>Hydralazine (Apresoline)</b>",
                    "drugKey" : "hydralazine",
                    "loc" : [["ccp", "first"]],
                    "dose_route" : [
                        ["<center>Hydralazine 5-10 mg IV/IO over 2 minutes\nq 20 minutes prn</center>"]
                    ]
                },
                {
                    "section" : "<b>For Seizures</b>",
                    "title" : "<b>Magnesium Sulfate (MgSO4)*</b>",
                    "drugKey" : "magnesium",
                    "loc" : [["acp", "after"]],
                    "dose_route" : [
                        ["<center>IV loading dose of 4 g: (over 27 minutes or 150 mg/min MAX)\nMaintenance infusion: 1 g/hr</center><tab1>\n• Dose should not exceed 30-40 g/24 hours or 20 g/48 hours in renal insufficiency\n• Dilute to a ≤ 20% solution for IV infusion</tab1>"]
                    ],
                    "notes" : "*First-line medication for treatment of seizures as well as prophylaxis after eclampsia"
                },
                {
                    "title" : "<b>Midazolam (Versed)</b>",
                    "loc" : [["acp", "after"]],
                    "drugKey" : "midazolam",
                    "dose_route" : [
                        ["<center>5 mg IV doses repeated every 5 minutes, until seizure termination\nor MAX dose of 0.2 mg/kg IV in total\nor\n10 mg IM if no IV access</center>"]
                    ]
                },
                {
                    "section" : "<b>For treatment of Magnesium Toxicity</b>",
                    "title" : "<b>Calcium Gluconate (10%)</b>",
                    "loc" : [["acp", "after"]],
                    "drugKey" : "calcium_gluconate",
                    "dose_route" : [
                        ["<center>20 mg/kg IV/IO (Max single dose 1g) - q 5 minutes PRN\nMax TOTAL dose 40 mg/kg or 2g (lesser of)\nAdminister over 2-3 minutes\nAdditional doses may be required, discuss with TMP</center>"]
                    ],
                    "notes" : "OR - if patient in cardiac arrest/pre-arrest"
                },
                {
                    "title" : "<b>Calcium Chloride (Calcijet)</b>",
                    "loc" : [["acp", "after"]],
                    "drugKey" : "calcium_chloride",
                    "dose_route" : [
                        ["<center>20 mg/kg IV/IO q 5 minutes prn\nSingle MAX dose 1g over 20 minutes PIV (5 minutes if central line)\nTotal MAX dose 40 mg/kg or 2g (lesser of)\nSlow IVP is appropriate in the setting of cardiac arrest/pre-arrest</center>"]
                    ],
                    "notes" : "<b>* Preferred route central line or antecubital fossa IV</b>"
                }
            ]
        },
        {
            "key" : "adult_obs_emergency_birth",
            "title" : "Obstetrics - Labour and Delivery - Emergency Birth",
            "type" : "medical_directive",
            "flowchartkeys" : [["Normal Delivery", "adult_obs_labor_normal_flowchart"], ["Delivery Complications", "adult_obs_labor_complications_flowchart"]],
            "indications" : "<tab1>• Complicated delivery</tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication</tab1>",
            "clinical" : "<tab1>• Not applicable</tab1>",
            "drug_cards" : [
                {
                    "loc" : [["pcp", "after"]],
                    "dose_route" : [
                        ["<center><b>Treat per the appropriate algorithm for Normal Delivery or Delivery Complications\n\nConsider:</b>\nExternal uterine massage\nGaskin maneuvre\nH.E.L.P.E.R. maneuvers (shoulder dystocia)\nMariceau-Smellie-Veit maneuver (Breech)\nMcRoberts maneuver\nUmbilical cord management</center>"]
                    ]
                },
                {
                    "loc" : [["ccp", "after"]],
                    "dose_route" : [
                        ["<center><b>Reverting Uterine Inversion</b></center>"]
                    ]
                },
                {
                    "title" : "<b>Oxytocin (Syntocin)</b>",
                    "drugKey" : "oxytocin",
                    "loc" : [["acp", "after"]],
                    "dose_route" : [
                        ["<center>10 units IM with anterior shoulder</center>"]
                    ]
                }
            ]
        },
        {
            "key" : "adult_obs_post_birth",
            "title" : "Obstetrics - Post Emergency Birth",
            "type" : "medical_directive",
            "indications" : "<tab1>• Following an emergency birth</tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication</tab1>",
            "clinical" : "<tab1>• Notify the receiving facility ASAP\n• <b>DO NOT</b> administer oxytocin by IV push\n• <b>For postpartum hemorrhage (PPH)</b> consider differential diagnosis and additional pharmacologic therapies (i.e. Ergonovine, Hemabate)</tab1>",
            "drug_cards" : [
                {
                    "title" : "<b>Oxytocin (Syntocin)</b>",
                    "drugKey" : "oxytocin",
                    "loc" : [["acp", "after"]],
                    "dose_route" : [
                        ["<center>Additional 10 units IM after delivery of the placenta\nAND\n40 units in 1000 mL NS at 2.5 units/hr (62.5 mL/hr) if bleeding minimal</center>"]
                    ]
                }
            ]
        },
        {
            "key" : "adult_obs_pph",
            "title" : "Obstetrics - Post-Partum Hemorrhage",
            "type" : "medical_directive",
            "indications" : "<tab1>• Post-Partum Hemorrhage</tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication\n• Ergonovine is contraindicated in presence of hypertension</tab1>",
            "flowchartkeys" : [["Flowchart", "adult_obs_pph_flowchart"]],
            "clinical" : "<tab1>• Not applicable</tab1>",
            "drug_cards" : [
                {
                    "title" : "<b>Oxytocin (Syntocin)</b>",
                    "drugKey" : "oxytocin",
                    "loc" : [["pcp", "none"]],
                    "dose_route" : [
                        ["<center><b>External Uterine Massage</b></center>"]
                    ]
                },
                {
                    "title" : "<b>Oxytocin (Syntocin)</b>",
                    "drugKey" : "oxytocin",
                    "loc" : [["acp", "after"]],
                    "dose_route" : [
                        ["<center>10 units IM with anterior shoulder and + 10 units IM after delivery of the placenta\nAND\n40 units in 1000 mL of Normal Saline at 10units/hr (250 mL/hr)</center>"]
                    ]
                },
                {
                    "loc" : [["ccp", "after"]],
                    "dose_route" : [
                        ["<center><b>Brandt Manoeuvre</b>\nApply firm traction to the (clamped) umbilical cord with one hand\nwhile the other applies suprapubic counter pressure to deliver the placenta</center>"]
                    ]
                },
                {
                    "title" : "<b>Ergonovine (Ergometrine)*</b>",
                    "loc" : [["ccp", "first"]],
                    "drugKey" : "ergonovine",
                    "dose_route" : [
                        ["<center>0.2 mg IV or IM q 2 to 4 hours\nmax 1 mg (total of 5 doses)</center>"]
                    ],
                    "notes" : "*Should not be used prior to delivery of the placenta"
                },
                {
                    "title" : "<b>Hemabate (Carboprost Tromethamine)</b>",
                    "loc" : [["ccp", "first"]],
                    "drugKey" : "carboprost_tromethamine",
                    "dose_route" : [
                        ["<center>250 microgram (1 ml) IM\nDosage may be repeated at 15-90 minute intervals\nuntil therapeutic response or to a max cumulative dose of 2 mg (8 doses)</center>"]
                    ]
                },
                {
                    "loc" : [["ccp", "after"]],
                    "dose_route" : [
                        ["<center><b>Bimanual Uterine Massage</b></center>"]
                    ]
                }
            ]
        },
        {
            "key" : "adult_obs_third_stage",
            "title" : "Obstetrics - Advanced Active Management of the Third Stage",
            "type" : "medical_directive",
            "indications" : "<tab1>• In the event the placenta is not delivered within 15 minutes of delivery of the neonate\nOR\n• If there is life threatening post-partum hemorrhage</tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication</tab1>",
            "flowchartkeys" : [["Flowchart", "adult_obs_pph_flowchart"]],
            "clinical" : "<tab1>• Oxytocin 10 units IM immediately after delivery of baby\n• Delayed cord clamping should occur at least 30 seconds after birth unless the baby requires resuscitation. Further advanced measures for active management of the third stage may be done by the CCP and PCCP/PCCN who has been trained, via contact with the TMP or either prospective or retrospective orders if contact with the TMP is impossible or cannot be obtained quickly</tab1>",
            "drug_cards" : [
                {
                    "loc" : [["ccp", "after"]],
                    "dose_route" : [
                        ["<center><b>Brandt Manoeuvre</b>\nApply firm traction to the (clamped) umbilical cord with one hand while the other applies suprapubic counter pressure to deliver the placenta</center>"]
                    ]
                }
            ]
        },
        {
            "key" : "adult_obs_checklist",
            "title" : "Ornge Emergency Birth Pre-Delivery Checklist",
            "type" : "document",
            "content" :
            [
                [
                    ["<section><left>", "<width=25>"],
                    ["Radiant warmer <b>ON</b> (if available)", "<checkbox>"],
                    ["Room/vehicle heat <b>ON</b>", "<checkbox>"],
                    ["Transwarmer(s) <b>ACTIVATED</b>", "<checkbox>"],
                    ["Neonatal Stethoscope", "<checkbox>"],
                    ["NeoTee with O2 supply connected & tested\n<b>Neo-Tee Pressure Adjustments</b>\n1. Adjust flowmeter to 10 lpm\n2. Adjust PIP, by occluding <b>both</b> patient & PEEP/CPAP outflow ports\n3. Adjust PEEP/CPAP (5 cm H2O) by occluding <b>only</b> the patient outflow port", "<checkbox>"]
                ],
                [
                    ["<section><left><b>Paediatric Airway Equipment</b>", "<width=25>"],
                    ["Infant BVM + PEEP valve + pressure manometer","<checkbox>"],
                    ["Mask sizes neonate & infant", "<checkbox>"],
                    ["Infant OPA size 00, 0", "<checkbox>"],
                    ["Paediatric laryngoscope handle", "<checkbox>"],
                    ["Miller blades 0, 1", "<checkbox>"],
                    ["ETTs 2.5, 3.0, 3.5 mm", "<checkbox>"],
                    ["6 Fr stylet", "<checkbox>"],
                    ["CO2 infant size adapter or infant size colormetric CO2 indicator", "<checkbox>"],
                    ["Suction catheters size 6, 8, 10 Fr", "<checkbox>"],
                    ["Bulb suction", "<checkbox>"],
                    ["Elastoplast tape", "<checkbox>"],
                    ["Scissors", "<checkbox>"],
                    ["Meconium aspirator", "<checkbox>"],
                    ["i-Gel size 1", "<checkbox>"]
                ],
                [
                    ["<section><left>", "<width=25>"],
                    ["Sterile drape", "<checkbox>"],
                    ["Under buttocks drape", "<checkbox>"],
                    ["Absorbent pad", "<checkbox>"],
                    ["2 x Cord clamps (multiple gestations 2 clamps per neonate)", "<checkbox>"],
                    ["Sterile gloves (1 pair)", "<checkbox>"],
                    ["Receiving blanket (minimum 1 per neonate)", "<checkbox>"],
                    ["2 toques per neonate", "<checkbox>"],
                    ["Plastic bag (1 per neonate <32 wks GA)", "<checkbox>"],
                    ["Suction source, LSU or wall (set 80 – 100 mm Hg)", "<checkbox>"]
                ],
                [
                    ["<section><left><b>UVC Kit</b>",  "<width=25>"],
                    ["Chlorhexidine swabs (3 ea)", "<checkbox>"],
                    ["Saline flush (2 ea)", "<checkbox>"],
                    ["UVC line 3.5", "<checkbox>"],
                    ["UVC line 5.0", "<checkbox>"],
                    ["Umbilical tie (2 ea)", "<checkbox>"],
                    ["Needle driver", "<checkbox>"],
                    ["Suture set", "<checkbox>"],
                    ["Tegaderm", "<checkbox>"],
                    ["Tape", "<checkbox>"],
                    ["3 way stopcock (2 ea)", "<checkbox>"],
                    ["Scalpel – straight blade", "<checkbox>"]
                ],
                [
                    ["<section><left><b>If time permits prepare</b>", "<width=25>"],
                    ["Pre-draw 2 doses of 10 u oxytocin in 2 separate 3 ml flashpoint IM syringes", "<checkbox>"],
                    ["Prepare 40 u oxytocin in 1000 ml 0.9% NS", "<checkbox>"],
                    ["Pre-draw 1 ETT dose of Epinephrine 1:10,000 in 3 ml syringe based on GA", "<checkbox>"],
                    ["Pre-draw 3 IV doses of Epinephrine 1:10,000 in 1 ml syringes based on GA", "<checkbox>"],
                    ["Prepare 10% dextrose in water\n<tab1>o Waste 25ml from a 250ml bag of D5W and add 25 ml of D50W</tab1>", "<checkbox>"]
                ],
                [
                    ["<section><b>No chest rise?</b><width=150>", ""],
                    ["<b>M</b>", "Mask adjustment"],
                    ["<b>R</b>", "Reposition Airway"],
                    ["<b>S</b>", "Suction mouth & nose"],
                    ["<b>O</b>", "Open mouth"],
                    ["<b>P</b>", "Pressure increase"],
                    ["<b>A</b>", "Alternative airway"]
                ],
                [
                    ["<section><section_width=1100><b>Gestational age</b>", "<b>Estimated weight</b>", "<b>ETT size (mm)</b>", "<b>ETT depth (cm)</b>", "<b>UVC catheter size (Fr)</b>", "<b>NG/OG Size (Fr)</b>","<b>Epinephrine dose IV/UVC (0.1 ml/kg)</b>", "<b>Epinephrine ETT dose (1 ml/kg)</b>", "<b>BG >3 <10 mmol/L D10W (2 ml/kg)</b>", "<b>Fluid Maintenance</b>"],
                    ["23 - 24 wks", "500 - 600 g", "2.5", "5.5 cm", "3.5", "5", "0.05 ml", "1 ml", "1 ml", "D10W\n80 ml/kg/day"],
                    ["25 - 26 wks", "700 - 800 g", "2.5", "6 cm", "3.5", "5", "0.1 ml", "1 ml", "2 ml", "D10W\n80 ml/kg/day"],
                    ["27 - 29 wks", "900 - 1000 g", "2.5", "6.5 cm", "3.5", "5", "0.1 ml", "1 ml", "2 ml", "D10W\n80 ml/kg/day"],
                    ["30 - 32 wks", "1100 - 1400 g", "3.0", "7 cm", "5.0", "5", "0.2 ml", "2 ml", "3 ml", "D10W\n80 ml/kg/day"],
                    ["33 - 34 wks", "1500 - 1800 g", "3.0", "7.5 cm", "5.0", "5", "0.2 ml", "2 ml", "4 ml", "D10W\n80 ml/kg/day"],
                    ["35 - 37 wks", "1900 - 2400 g", "3.5", "8 cm", "5.0", "5", "0.2 ml", "2 ml", "5 ml", "D10W\n80 ml/kg/day"],
                    ["38 - 40 wks", "2500 - 3100 g", "3.5", "8.5 cm", "5.0", "8", "0.3 ml", "3 ml", "6 ml", "D10W\n80 ml/kg/day"],
                    ["41 - 43 wks", "3200 - 4200 g", "3.5", "9 cm", "5.0", "8", "0.4 ml", "3 ml", "6 ml", "D10W\n80 ml/kg/day"]
                ],
                [
                    ["*If actual weight is known or a scale is available, neonate should be weighed & correct weight based dose administered"]
                ],
                [
                    ["<section><b>Post-delivery time</b>", "<b>Pre-ductal SpO2 (right hand)</b>"],
                    ["1 min", "60 - 65%"],
                    ["2 min", "65 - 70%"],
                    ["3 min", "70 - 75%"],
                    ["4 min", "75 - 80%"],
                    ["5 min", "80 - 85%"],
                    ["10 min", "85 - 95%"]
                ]
            ]
        },
        {
            "key" : "adult_mixing_table",
            "title" : "Adult Mixing and Administration Table for Continuous Infusion Summary",
            "type" : "document",
            "content" :
            [
                [
                    ["<section><section_width=600><left><width=110><bg=#ffc001ff><b>Drug</b>", "<bg=#ffc001ff><center><b>Drug to Add to Diluent</b></center>", "<bg=#ffc001ff><center><b>Diluent (mL)</b></center>", "<bg=#ffc001ff><center><b>BD Library Dose Range</b></center>", "<bg=#ffc001ff><center><b>Standard Concentration</b></center>"],
                    ["<a href=\"drugKey=amiodarone\">Amiodarone</a>\n[Use 0.22 micron In-line filter]", "450 mg", "250 mL D5W", "0.01 - 1 mg/min", "1.8 mg/mL" ],
                    ["<a href=\"drugKey=cisatracurium\">Cisatracurium</a>", "40 mg", "100 mL D5W/NS", "1 - 10 mcg/kg/min", "0.4 mg/mL" ],
                    ["<a href=\"drugKey=diltiazem\">dilTIAZem</a>", "100 mg", "100 mL D5W/NS", "2.5 - 15 mg/hr", "1 mg/mL"],
                    ["<a href=\"drugKey=dobutamine\">DOBUTamine</a>", "250 mg", "250 mL D5W/NS", "0.01 - 30 mcg/kg/min", "1000 mcg/ml"],
                    ["<a href=\"drugKey=dopamine\">DOPamine</a>", "N/A premixed", "200 mg/250 mL premixed D5W\n400 mg/250 mL premixed D5W\n800 mg/250 mL premixed D5W", "0.01 - 30 mcg/kg/min", "800 mcg/mL\n1600 mcg/mL\n3200 mcg/mL"],
                    ["<a href=\"drugKey=epinephrine\">EPINEPHrine</a>", "4 mg", "250 mL D5W/NS", "0.01 - 1.0 mcg/kg/min", "16 mcg/ml"],
                    ["<a href=\"drugKey=esmolol\">Esmolol</a>", "N/A premixed", "2500 mg/250 mL premixed", "50 - 300 mcg/kg/min", "10 mcg/ml"],
                    ["<a href=\"drugKey=fentanyl\">FentaNYL</a>", "500 mcg", "50 mL D5W/NS", "0.01 - 5 mcg/kg/hr", "10 mcg/ml"],
                    ["<a href=\"drugKey=heparin\">Heparin</a>", "25,000 units", "500 mL D5W", "400 - 3000 units/hr", "50 units/mL"],
                    ["<a href=\"drugKey=hydralazine\">HydrALAZINE</a>", "50 mg", "250 mL NS", "0.01 - 5 mcg/kg/min", "200 mcg/mL"],
                    ["<a href=\"drugKey=insulin\">Insulin</a>", "100 units", "100 mL NS", "0.01 - 2 units/kg/hr", "1 unit/mL"],
                    ["<a href=\"drugKey=isoproterenol\">Isoproterenol</a>", "1000 mcg", "250 mL D5W/NS", "0.01 - 20 mcg/min", "4 mcg/mL"],
                    ["<a href=\"drugKey=ketamine\">Ketamine</a>", "500 mg", "100 mL D5W/NS", "0.01 - 4.5 mg/kg/hr", "10 mg/mL"],
                    ["<a href=\"drugKey=labetalol\">Labetalol</a>", "50 mg", "50 mL D5W/NS", "0.01 - 5 mg/min", "5 mg/mL"],
                    ["<a href=\"drugKey=lidocaine\">Lidocaine</a>", "200 mg", "50 mL D5W/NS", "1 - 4 mg/min", "4 mg/mL"],
                    ["<a href=\"drugKey=magnesium\">Magnesium</a>", "5 g", "250 mL D5W/NS", "1000 - 2000 mg/hr", "20 mg/mL"],
                    ["<a href=\"drugKey=midazolam\">Midazolam</a>", "50 mg", "50 mL D5W/NS", "0.01 - 0.25 mg/kg/hr", "1 mg/mL"],
                    ["<a href=\"drugKey=milrinone\">Milrinone</a>", "20 mg", "100 mL D5W/NS", "0.01 - 0.75 mcg/kg/hr", "200 mcg/mL"],
                    ["<a href=\"drugKey=morphine\">Morphine</a>", "50 mg", "50 mL D5W/NS", "0.01 - 25 mg/hr", "1 mg/mL"],
                    ["<a href=\"drugKey=naloxone\">Naloxone</a>", "10 mg", "100 mL D5W/NS", "0.4 - 6 mg/hr", "0.1 mg/mL"],
                    ["<a href=\"drugKey=nitroglycerin\">Nitroglycerin</a>", "50 mg", "250 mL D5W/NS", "5 - 200 mcg/min", "200 mcg/mL"],
                    ["<a href=\"drugKey=nitroprusside\">NitroPRUSSide</a>", "50 mg", "250 mL D5W/NS", "0.01 - 10 mcg/kg/min", "200 mcg/mL"],
                    ["<a href=\"drugKey=norepinephrine\">Norepinephrine (PVL)</a>", "4 mg", "250 mL D5W/NS", "0.01 - 1 mcg/kg/min", "16 mcg/mL"],
                    ["<a href=\"drugKey=norepinephrine\">Norepinephrine (CVL)</a>", "8 mg", "250 mL D5W/NS", "0.01 - 1 mcg/kg/min", "32 mcg/mL"],
                    ["<a href=\"drugKey=norepinephrine\">Norepinephrine (CVL)</a>", "16 mg", "250 mL D5W/NS", "0.01 - 1 mcg/kg/min", "64 mcg/mL"],
                    ["<a href=\"drugKey=octreotide\">Octreotide</a>", "500 mcg", "100 mL D5W/NS", "0.01 - 50 mcg/hr", "5 mcg/mL"],
                    ["<a href=\"drugKey=oxytocin\">Oxytocin</a>", "40 units", "1000 mL D5W/NS", "2.5 - 10 units/hr", "0.04 units/mL"],
                    ["<a href=\"drugKey=pantoprazole\">Pantoprazole</a>", "80 mg", "100 mL D5W/NS", "1 - 8 mg/hr", "0.8 mg/mL"],
                    ["<a href=\"drugKey=phenylephrine\">Phenylephrine</a>", "10 mg", "250 mL D5W/NS", "5 - 200 mcg/min", "40 mcg/mL"],
                    ["<a href=\"drugKey=potassium\">Potassium</a>", "10 mEq", "100 mL D5W/NS", "0 - 10 mEq/hr", "0.1 mEq/mL"],
                    ["<a href=\"drugKey=procainamide\">Procainamide</a>", "1 g", "250 mL D5W/NS", "1 - 6 mg/min", "4 mg/mL"],
                    ["<a href=\"drugKey=propofol\">Propofol</a>", "N/A premixed", "500 mg/50 mL premixed", "0.01 - 8 mg/kg/hr", "10 mg/mL"],
                    ["<a href=\"drugKey=rocuronium\">Rocuronium</a>", "100 mg", "50 mL D5W/NS", "0.01 - 15 mcg/kg/min", "2 mg/mL"],
                    ["<a href=\"drugKey=salbutamol\">Salbutamol</a>", "50 mg", "500 mL D5W/NS", "0.01 - 5 mcg/kg/min", "100 mcg/mL"],
                    ["<a href=\"drugKey=vasopressin\">Vasopressin</a>", "40 units", "100 mL D5W/NS", "0.02 - 0.1 units/min", "0.4 units/mL"],
                    ["<a href=\"drugKey=vecuronium\">Vecuronium</a>", "10 mg", "100 mL D5W/NS", "0.6 - 1.8 mcg/kg/min", "100 mcg/mL"]
                ],
                [
                    ["<center><b>Remove drug volume from diluent to ensure accurate dosing.</center></b>"]
                ]
            ]
        },
        {
            "key" : "adult_medication_list",
            "title" : "Adult Medication List",
            "type" : "document",
            "content" :
            [
                [
                    ["<section><b><left>Medication</left></b>", "<width=50><center><b>PCP(f)</b>", "<width=50><center><b>ACP(f)</b>", "<center><width=40><b>CCP</b>", "<width=60><center><b>PCCP/PCCN</b>"],
                    ["3% Saline", "", "√", "√", "√"],
                    ["Abciximab", "", "√", "√", ""],
                    ["Acetaminophen", "√", "√", "√", "√"],
                    ["Acetylcysteine Sodium", "", "√", "√", "√"],
                    ["Acetylsalicylic Acid", "√", "√", "√", "√"],
                    ["Activated Charcoal", "", "√", "√", "√"],
                    ["Acyclovir", "", "√", "√", "√"],
                    ["Adenosine", "", "√", "√", "√"],
                    ["Amiodarone", "", "√", "√", "√"],
                    ["Ampicillin", "", "√", "√", "√"],
                    ["Atropine", "", "√", "√", "√"],
                    ["Betamethasone", "", "√", "√", "√"],
                    ["Bivalirudin", "", "√", "√", ""],
                    ["Calcium Chloride", "", "√", "√", "√"],
                    ["Calcium Gluconate", "", "√", "√", "√"],
                    ["Cefazolin", "", "√", "√", "√"],
                    ["Ceftriaxone", "", "√", "√", "√"],
                    ["Cisatracurium", "", "", "√", "√"],
                    ["Clopidogrel", "", "√", "√", ""],
                    ["Cyproheptadine", "", "", "√", "√"],
                    ["D10/25/50W", "", "√", "√", "√"],
                    ["Dexamethasone", "", "√", "√", "√"],
                    ["Diazepam (IV & PR)", "", "√", "√", "√"],
                    ["Digitalis", "", "", "√", "√"],
                    ["diLTIazem", "", "", "√", "√"],
                    ["dimenhyDRINATE (IV)", "", "√", "√", "√"],
                    ["dimenhyDRINATE (PO & IM)", "√", "√", "√", "√"],
                    ["diphenyDRAMINE", "√", "√", "√", "√"],
                    ["DOBUTamine", "", "", "√", "√"],
                    ["DOPamine", "", "√", "√", "√"],
                    ["EPINEPHrine (IM & Nebulized)", "√", "√", "√", "√"],
                    ["EPINEPHrine (IV Push ONLY for cardiac arrest -\nACLS and Neonatal Resuscitation)", "", "√", "√", "√"],
                    ["EPINEPHrine (IV Push in Non-Arrest & IV Infusion)", "", "", "√", "√"],
                    ["Epoprostenol", "", "", "√", ""],
                    ["Eptifibatide", "", "√", "√", ""],
                    ["Ergonovine", "", "", "√", "√*"],
                    ["Esmolol HCL", "", "", "√", "√"],
                    ["Etomidate", "", "", "√", "√"],
                    ["fentaNYL", "", "√", "√", "√"],
                    ["Flumazenil", "", "√", "√", "√"],
                    ["Folic Acid", "", "√", "√", "√"],
                    ["Fomepizole", "", "√", "√", "√"],
                    ["Fosphenytoin", "", "√", "√", "√"],
                    ["Furosemide", "", "√", "√", "√"],
                    ["Gentamycin", "", "√", "√", "√"],
                    ["Glucagon (IM)", "√", "√", "√", "√"],
                    ["Glucagon (IV)", "", "√", "√", "√"],
                    ["Haloperidol", "", "√", "√", "√"],
                    ["Hemabate", "", "", "√", "√*"],
                    ["Heparin", "", "√", "√", "√"],
                    ["hydrALAZINE", "", "", "√", "√"],
                    ["Ibuprofen", "√", "√", "√", "√"],
                    ["Insulin", "", "√", "√", "√"],
                    ["Intralipid", "", "", "√", "√"],
                    ["Ipratropium Bromide", "", "√", "√", "√"],
                    ["Isoproterenol", "", "", "√", "√"],
                    ["Kayexalate", "", "√", "√", "√"],
                    ["Ketamine", "", "√", "√", "√"],
                    ["Ketorolac (IM)", "√", "√", "√", "√"],
                    ["Labetalol", "", "√", "√", "√"],
                    ["Lidocaine (IV & Topical)", "", "√", "√", "√"],
                    ["LORazepam", "", "√", "√", "√"],
                    ["Magnesium Sulphate", "", "√", "√", "√"],
                    ["Mannitol 20%", "", "√", "√", "√"],
                    ["methylPREDNISolone ACEtate", "", "√", "√", "√"],
                    ["Metoprolol", "", "√", "√", "√"],
                    ["Metronidazole", "", "√", "√", "√"],
                    ["Midazolam", "", "√", "√", "√"],
                    ["Milrinone", "", "", "√", "√"],
                    ["Morphine Sulphate", "", "√", "√", "√"],
                    ["Naloxone (IM)", "√", "√", "√", "√"],
                    ["Naloxone (IV)", "", "√", "√", "√"],
                    ["niFEDIPine", "", "√", "√", "√"],
                    ["Nitroglycerin (IV & Topical)", "", "√", "√", "√"],
                    ["Nitroglycerin (SL)", "√", "√", "√", "√"],
                    ["Norepinephrine", "", "√", "√", "√"],
                    ["Octaplex", "", "√", "√", "√"],
                    ["Octreotide", "", "√", "√", "√"],
                    ["Ondansetron", "", "√", "√", "√"],
                    ["Oxytocin", "", "√", "√", "√*"],
                    ["Pantoprazole", "", "√", "√", "√"],
                    ["PHENObarbital", "", "", "√", "√"],
                    ["Phentolamine", "", "√", "√", "√"],
                    ["Phenylephrine", "", "", "√", "√"],
                    ["phenyTOIN", "", "√", "√", "√"],
                    ["Potassium Chloride (Premix IV solution ONLY)", "√", "√", "√", "√"],
                    ["Potassium Chloride (added into IV solution)", "", "√", "√", "√"],
                    ["Pralidoxime", "", "√", "√", "√"],
                    ["Procainamide", "", "", "√", "√"],
                    ["Propofol", "", "", "√", "√"],
                    ["Prostaglandin E1", "", "", "", "√"],
                    ["Prothrombin Complex Concentrate / Octaplex", "", "√", "√", ""],
                    ["Pyridoxine", "", "√", "√", "√"],
                    ["Rocuronium", "", "√", "√", "√"],
                    ["Salbutamol (IV)", "", "", "√", "√"],
                    ["Salbutamol (Nebulized & MDI)", "√", "√", "√", "√"],
                    ["Sodium Bicarbonate", "", "√", "√", "√"],
                    ["Succinylcholine", "", "", "√", "√"],
                    ["Thiamine", "", "√", "√", "√"],
                    ["Ticagrelor", "", "√", "√", ""],
                    ["Tirofiban", "", "√", "√", ""],
                    ["TNKase", "", "√", "√", ""],
                    ["Tobramycin", "", "√", "√", "√"],
                    ["Toradol (IM)", "√", "√", "√", "√"],
                    ["Tranexamic Acid (TXA)", "", "√", "√", "√"],
                    ["Vancomycin", "", "√", "√", "√"],
                    ["Vasopressin", "", "", "√", "√"],
                    ["Vecuronium", "", "√", "√", "√"],
                    ["Vitamin K", "", "√", "√", "√"],
                    ["Xylometazoline", "", "√", "√", "√"]
                ],
                [
                    ["<right>*selected PCCPs/PCCNs only"]
                ],
                [
                    ["<b>PCP(f):</b> Primary Care Flight Paramedic"],
                    ["<b>ACP(f):</b> Advanced Care Flight Paramedic"],
                    ["<b>CCP:</b> Critical Care Paramedic"],
                    ["<b>PCCP/PCCN:</b> Paediatric Critical Care Paramedic / Paediatric Critical Care Nurse"]
                ],
                [
                    ["The CCP and PCCP/PCCN may administer any medication under the direction of the TMP provided that they are familiar with the drug and comfortable with managing its administration and potential side effects."]
                ]
            ]
        },
        {
            "key" : "adult_procedure_list",
            "title" : "Adult Procedure List",
            "type" : "document",
            "content" : [
                [
                    ["<section><b>Legend: M - Monitoring, I - Initiation (includes troubleshooting), T - Troubleshooting (includes monitoring)</b>"]
                ],
                [
                    ["<section><section_width=470><b><left>Procedure</b>", "<width=55><center><b>PCP(f)</b>", "<width=55><center><b>ACP(f)</b>", "<width=55><center><b>CCP</b>", "<width=55><center><b>PCCP/PCCN</b>"],
                    ["Arterial line monitoring (transduce & blood sampling)", "", "T", "T", "T"],
                    ["Advanced Airway Management: Bougie, Direct or Video Laryngoscopy (VL)", "", "I", "I", "I"],
                    ["Balloon tamponade of gastroesophageal varices monitoring (Blakemore tubes)", "", "", "M", ""],
                    ["Bimanual uterine massage", "", "", "I", "I*"],
                    ["NPPV", "", "I", "I", "I"],
                    ["Blood analysis (iSTAT)", "", "I", "I", "I"],
                    ["Blood product transfusion", "", "I", "I", "I"],
                    ["Blood sampling-Peripheral venous and capillary", "", "I", "I", "I"],
                    ["Brandt maneuver", "", "", "I", "I*"],
                    ["Cardiac ECG monitoring and interpretation ‐ Lead II, 12-lead STEMI recognition", "I", "I", "I", "I"],
                    ["Cardiac ECG monitoring and interpretation ‐ All leads including 12 & 15", "", "I", "I", "I"],
                    ["Chest drainage systems", "", "T", "T", "T"],
                    ["Chest x‐ray or CXR interpretation", "", "I", "I", "I"],
                    ["Doppler ultrasound assessment", "", "I", "I", "I"],
                    ["ETCO2 capnography (intubated & non‐intubated patients)", "", "I", "I", "I"],
                    ["External defibrillation ‐ Semi‐automatic", "I", "I", "I", "I"],
                    ["External defibrillation ‐ Manual", "", "I", "I", "I"],
                    ["Field extubation", "", "I", "I", "I"],
                    ["Foreign body removal (with McGill forceps)", "", "I", "I", "I"],
                    ["Gastric intubation", "M", "I", "I", "I"],
                    ["Intra‐aortic balloon pump monitoring", "", "", "T*", ""],
                    ["Intraosseous (IO) Initiation", "", "I", "I", "I"],
                    ["Intubation ‐ Nasotracheal", "", "I", "I", "I"],
                    ["Intubation ‐ Orotracheal", "", "I", "I", "I"],
                    ["Intravenous initiation (peripheral, external jugular & infant scalp vein)", "", "I", "I", "I"],
                    ["Lab value interpretation", "", "I", "I", "I"],
                    ["Manometer for positive pressure ventilation", "I", "I", "I", "I"],
                    ["Mechanical ventilation for patients weighing ≤ 5 kg", "", "", "I", "I"],
                    ["Mechanical ventilation for patients weighing > 5 kg", "", "I", "I", "I"],
                    ["Multi‐channel infusion pump/syringe", "", "I", "I", "I"],
                    ["Needle cricothyrotomy", "", "I", "I", "I"],
                    ["Needle thoracostomy", "", "I", "I", "I"],
                    ["Obstetrics:\nExternal uterine massage\nGaskin maneuvre\nH.E.L.P.E.R. maneuvers (shoulder dystocia)\nMariceau-Smellie-Veit maneuvr\nMcRoberts maneuvre\nUmbilical cord management", "I", "I", "I", "I"],
                    ["Pacing - Transcutaneous", "", "I", "I", "I"],
                    ["Pacing - Transvenous", "", "", "T", "T"],
                    ["Pulmonary artery catheter monitoring and/or removal", "", "", "I*", ""],
                    ["Rapid Sequence Intubation or RSI", "", "", "I", "I"],
                    ["Reverting uterine inversion", "", "", "I", "I*"],
                    ["Suctioning (Endotracheal, Tracheostomy)", "I", "I", "I", "I"],
                    ["Supraglottic Airway (SGA)", "I", "I", "I", "I"],
                    ["Synchronized cardioversion", "", "I", "I", "I"],
                    ["Tracheostomy care:\nMaintenance & Emergency Reinsertion/Intervention", "I", "I", "I", "I"],
                    ["Transport Isolette ‐ Care of a neonate", "", "I", "I", "I"],
                    ["Umbilical vein catheterization or UVC", "", "I", "I", "I"],
                    ["Urinary catheterization", "M", "I", "I", "I"],
                    ["Vascular access - Arterial stab", "", "", "", "I*"],
                    ["Vascular access - Central venous catheter", "M", "M", "M", "M"],
                    ["Vascular access - Peripheral venous and Capillary", "", "I", "I", "I"]
                ],
                [
                    ["<b>PCP(f):</b> Primary Care Flight Paramedic"],
                    ["<b>ACP(f):</b> Advanced Care Flight Paramedic"],
                    ["<b>CCP:</b> Critical Care Paramedic"],
                    ["<b>PCCP/PCCN:</b> Paediatric Critical Care Paramedic / Paediatric Critical Care Nurse"]
                ]
            ]
        },
        {
            "key" : "ped_intubation_checklist",
            "title" : "Controlled Intubation Checklist",
            "type" : "document",
            "content" :
            [
                    [
                        ["<section><left><b>Resuscitation</b>", "<width=25>"],
                        ["Hemodynamics Optimized - Hypotension + Metabolic Acidosis Addressed", "<checkbox>"]
                    ],
                    [
                        ["<section><left><b>Preparation</b>", "<width=25>"],
                        ["Patient Positioned - Ear to Sternal Notch", "<checkbox>"],
                        ["Cardiac Monitor - NIBP (q 2 minutes), SpO2, EtCO2", "<checkbox>"],
                        ["O2 Supply Sufficient", "<checkbox>"],
                        ["Mask O2 @ ≥ 15 LPM/NPPV/BVM + PEEP", "<checkbox>"],
                        ["Nasal O2 @ 15 LPM (equipment / patient dependent)", "<checkbox>"],
                        ["Suction Tested", "<checkbox>"]
                    ],
                    [
                        ["<section><left><b>IV/IO Medications</b>", "<width=25>"],
                        ["2 IV/IOs working", "<checkbox>"],
                        ["BP Cuff on opposite Arm", "<checkbox>"],
                        ["Drug/Doses - induce, paralyze, post ETI analgosedation", "<checkbox>"]
                    ],
                    [
                        ["<section><left><b>Team Brief</b>", "<width=25>"],
                        ["MILS assistant briefed, collar Open", "<checkbox>"],
                        ["ELM/Bougie assistant briefed", "<checkbox>"],
                        ["Fail plan briefed", "<checkbox>"],
                        ["SGA", "<checkbox>"]
                    ],
                    [
                        ["<section><left><b>Intubation Equipment</b>", "<width=25>"],
                        ["BVM + PEEP + ETCO2 waveform / colorimetric CO2 (as indicated)", "<checkbox>"],
                        ["OPA + 2 NPAs", "<checkbox>"],
                        ["PPE including mask/face sheild", "<checkbox>"],
                        ["CMAC On + Working/Laryngoscope tested", "<checkbox>"],
                        ["ETT + Stylet", "<checkbox>"],
                        ["Syringe + Cuff Tested", "<checkbox>"],
                        ["Alternate tube(s)", "<checkbox>"],
                        ["Bougie", "<checkbox>"],
                        ["Leukoplast tape (paediatric ETT protocol)", "<checkbox>"],
                        ["SGA", "<checkbox>"],
                        ["Cricothyrotomy Set", "<checkbox>"],
                        ["Cricothyrotomy Assessment if > 12 years of age", "<checkbox>"]
                    ],
                    [
                        ["<left>Check complete - Anaesthetizing at ___________"],
                        ["<left><red>Press CMAC Record Button</red>"]
                    ],
                    [
                        ["<section><left><b>Post Intubation</b>", "<width=25>"],
                        ["Re-assess ABC vitals", "<checkbox>"],
                        ["ETT Secured", "<checkbox>"],
                        ["Tube depth confirmed with ETCO2 waveform, cuff pressure", "<checkbox>"],
                        ["In-line suction ready", "<checkbox>"],
                        ["Analgesia / Sedation", "<checkbox>"],
                        ["Supplies (oxygen, drugs, power)"],
                        ["Ventilator settings", "<checkbox>"],
                        ["HOB Raised to 30 degrees", "<checkbox>"],
                        ["NGT/OGT inserted & Foley PRN", "<checkbox>"],
                        ["Secure all Lines and Tubes", "<checkbox>"],
                        ["Rescue Airway Equipment within Reach", "<checkbox>"]
                    ]
            ]
        },
        {
            "key" : "ped_sga",
            "title" : "Paediatric - Supraglottic Airway",
            "type" : "medical_directive",
            "indications" : "<tab1>• Weight >2 kg\n• Need for ventilatory assistance OR airway control AND\n• Other airway management is inadequate OR ineffective OR unsuccessful</tab1>",
            "contraindications" : "<tab1>• Intact gag reflex\n• Caustic ingestion\n• Active vomiting</tab1>",
            "drug_cards" : [
                {
                    "title" : "<b>Supraglottic Airway</b>",
                    "loc" : [["pcp", "after"]],
                    "dose_route" : [["Insert Airway\nMAX 2 attempts\nFollowing two (2) failed attempts at supraglottic airway insertion, recommended 2 person BVM with oral/nasal pharyngeal airway management"]]
                }
            ],
            "clinical" : "<tab1>• Supraglottic airway should be the initial airway strategy in out of hospital cardiac arrest unless endotracheal intubation is deemed more appropriate by the paramedic\n• Endotracheal intubation is usually preferred for secure airway management in the non cardiac arrest patient. In this setting, SGA is considered a rescue device if BLS airway/ventilation and other advanced airway maneuvers have been unsuccessful\n• Confirm placement with ETCO2</tab1>"
        },
        {
            "key" : "ped_rsi",
            "title" : "Paediatric - Pre-Intubation and Intubation Medications",
            "flowchartkeys" : [["Algorhythm", "ped_universal_airway"], ["Setup", "ped_intubation_positioning"], ["Approach", "ped_intubation_types"]],
            "type" : "medical_directive",
            "indications" : "<tab1>• All Intubation attempts</tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication</tab1>",
            "drug_cards" : [
                {
                    "title" : "<b>Lidocaine Spray (Xylocaine, Xylocard)*</b>",
                    "drugKey" : "lidocaine",
                    "loc" : [["acp", "after"]],
                    "dose_route" : [["<center>< 40 kg</center>", "<center>10 mg/spray onto the pharynx, hypopharynx, and vocal cords\nMAX cumulative dose of 5 mg/kg or 200 mg</center>"]],
                    "notes" : "*Consider Lidocaine for oro-tracheal facilitated and awake intubations"
                },
                {
                    "section" : "<b>For Sedation</b>\nChoose only one sedative agent +/- analgesic",
                    "title" : "<b>Ketamine (Ketalar)</b>",
                    "drugKey" : "ketamine",
                    "loc" : [["acp", "first"]],
                    "dose_route" : [["<center>< 40 kg</center>", "<center><u>Induction</u> dose: 1-2 mg/kg slow IV/IO push\nNot to exceed 0.5 mg/kg/min or not faster than 60 sec</center>"]],
                    "notes" : "*Consider Lidocaine for oro-tracheal facilitated and awake intubations"
                },
                {
                    "section" : "<b>OR</b>",
                    "title" : "<b>Midazolam (Versed)</b>",
                    "drugKey" : "midazolam",
                    "loc" : [["acp", "first"]],
                    "dose_route" : [["<center>< 40 kg</center>", "<center>0.05-0.2 mg/kg IV/IO\n(to a MAX of 4 mg)</center>"]]
                },
                {
                    "section" : "<b>OR</b>",
                    "title" : "<b>Propofol*</b>",
                    "drugKey" : "propofol",
                    "loc" : [["ccp", "first"]],
                    "dose_route" : [["<center>0.5-3 mg/kg IV/IO</center>"]],
                    "notes" : "*Apnea and hypotension may occur with rapid induction\n*Avoid use in hypovolemia or patients with poor cardiovascular reserve"
                },
                {
                    "section" : "<b>For Analgesia</b>",
                    "title" : "<b>FentaNYL (Sublimaze)</b>",
                    "drugKey" : "fentanyl",
                    "loc" : [["acp", "first"]],
                    "dose_route" : [["<center>< 40 kg</center>", "<center>1- 2 microgram/kg/dose IV/IO</center>"]]
                },
                {
                    "section" : "<b>For RSI</b>",
                    "title" : "<b>RSI Dosages:</b>",
                    "loc" : [["ccp", "first"]],
                    "dose_route" : [["<center><a href=\"drugKey=atropine\">Atropine</a></center>", "<center>0.02 mg/kg/dose IV/IO\n(MAX 0.5 mg)</center>"],
                        ["<center><b>Administer atropine prior to the administration of Succinylcholine</b>\nCaution in patients if HR > 180</center>"],
                        ["<center><a href=\"drugKey=succinylcholine\">Succinylcholine*\n(Quelicin)</a></center>", "<center>2 mg/kg/dose IV/IO</center>"],
                        ["<center><a href=\"drugKey=rocuronium\">Rocuronium (Zemuron)</a></center>", "<center>Induction dose 1.2 mg/kg/dose IV/IO</center>"]
                    ],
                    "notes" : "<b>*Contraindications to Succinylcholine:</b>\n<tab1>• Malignant hyperthermia\n• Hyperkalemia (known or concern)\n• Myopathies/Muscular dystrophies\n• Amyotrophic Lateral Sclerosis, Multiple Sclerosis\n• Guillain-Barre Syndrome, botulism\n• Burns ≥ 2nd degree over 10% BSA >5 days until healed\n• Spinal cord injury >5 days until 6 months post injury"
                }
            ],
            "clinical" : "<tab1>• RSI intubation falls under the CCP, PCCP/PCCN scope\n• Rocuronium may be used if Succinylcholine is contraindicated\n• Propofol may be preferred in clinical circumstances such as closed head injury in the absence of hemodynamic instability</tab1>"
        },
        {
            "key" : "ped_bronchoconstriction",
            "title" : "Paediatric - Shortness of Breath/Wheeze/Asthma",
            "type" : "medical_directive",
            "flowchartkeys" : [["Flowchart", "ped_bronchoconstriction_flowchart"]],
            "indications" : "<tab1>• Respiratory distress AND\n• Suspected bronchoconstriction</tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication\n• Allergy to peanuts (i.e. Ipratropium Bromide (Atrovent)</tab1>",
            "drug_cards" : [
                {
                    "title" : "<b>Salbutamol (Ventolin) Solution Via Nebulized Aerosol (2.5 mg/2.5 mL)</b>",
                    "drugKey" : "salbutamol",
                    "loc" : [["pcp", "none"]],
                    "dose_route" : [
                        ["<center>< 10 kg</center>", "<center>1.25 mg* (0.5 mL)</center>"],
                        ["<center>10-20 kg</center>", "<center>2.5 mg* (1.0 mL)\nRepeat q 30 minutes - 4 hours prn</center>"],
                        ["<center>> 20 kg</center>", "<center>5 mg* (2.0 mL)\nRepeat q 30 minutes - 4 hours prn</center>"],
                        ["<center>In acute asthma exacerbations refer to the Asthma Exacerbation Clinical Pathway for Salbutamol dosing</center>"]
                    ],
                    "notes" : "*Dilute Salbutamol dose to 3 mL in Normal Saline. Dose Limit: MAX 1 mL/dose"
                },
                {
                    "title" : "<b>Salbutamol (Ventolin) via MDI\n(100 microgram/puff) with Aerochamber</b>",
                    "drugKey" : "salbutamol",
                    "loc" : [["pcp", "none"]],
                    "dose_route" : [
                        ["<center>Less than 20 kg\nGreater than 20 kg\n\nLess than 20 kg\nGreater than 20 kg</center>", "<center>4 puffs (400 microgram) x1 reassess\n8 puffs (800 microgram) x 1 reassess\n\nAcute asthma:\n4 puffs (400 microgram) q 20 min x 3 doses\n8 puffs (800 microgram) q 20 min x 3 doses</center>"]
                    ]
                },
                {
                    "title" : "<b>Ipratropium Bromide (Atrovent) Solution\nVia Nebulized Aerosol (250 microgram/mL)</b>",
                    "drugKey" : "ipratropium",
                    "loc" : [["acp", "none"]],
                    "dose_route" : [
                        ["<center>1 mL (0.25 mg) mixed with Salbutamol q 20 minutes prn\nMAX 3 doses</center>"]
                    ],
                    "notes" : "*Add Normal Saline to Atrovent and Salbutamol dose to make a final volume of 3 mL as required. Atrovent should not be given alone. Nebulized Atrovent is given with Salbutamol dose."
                },
                {
                    "title" : "<b>Ipratropium Bromide (Atrovent) MDI\n(20 microgram/puff)</b>",
                    "drugKey" : "ipratropium",
                    "loc" : [["acp", "none"]],
                    "dose_route" : [
                        ["<center>4 puffs\n(4 breaths or 45 seconds between each administration)\nmay repeat x 3 every 20 minutes prn\nMAX 3 doses</center>"]
                    ]
                },
                {
                    "section" : "<b>For moderate to severe shortness of breath</b>",
                    "title" : "<b>Dexamethasone (Decadron)</b>",
                    "drugKey" : "dexamethasone",
                    "loc" : [["acp", "after"]],
                    "dose_route" : [
                        ["<center>0-40 kg</center>", "<center>0.3 mg/kg PO/IM/IV\n(MAX 12 mg/dose)</center>"]
                    ]
                },
                {
                    "section" : "OR",
                    "title" : "<b>Prednisone</b>",
                    "loc" : [["acp", "after"]],
                    "dose_route" : [
                        ["<center>0-40 kg</center>", "<center>1-2 mg/kg/dose PO\nOnce daily\n(MAX 60 mg/day)</center>"]
                    ]
                },
                {
                    "section" : "OR",
                    "title" : "<b>Methylprednisolone</b>",
                    "drugKey" : "methylprednisolone",
                    "loc" : [["acp", "after"]],
                    "dose_route" : [
                        ["<center>0-40 kg</center>", "<center>1 mg/kg/dose IV/IM\nEvery 6 hours\n(MAX 60 mg/dose)</center>"]
                    ]
                },
                {
                    "section" : "<b>For severe shortness of breath</b>",
                    "title" : "<b>EPINEPHrine (Adrenaline)</b>",
                    "drugKey" : "epinephrine",
                    "loc" : [["pcp", "first"]],
                    "dose_route" : [
                        ["<center>0-40 kg</center>", "<center>0.01 mg/kg intramuscularly (IM)\nto a MAX of 0.5 mg\nMay repeat in 10 min (MAX 2 doses)\n(For use in pre-arrest patients not responding to conventional therapies)</center>"]
                    ]
                },
                {
                    "title" : "<b>Magnesium Sulfate (MgSO4)</b>",
                    "drugKey" : "magnesium",
                    "loc" : [["acp", "first"]],
                    "dose_route" : [
                        ["<center>0-40 kg</center>", "<center>25–50 mg/kg IV bolus over 20 min (MAX 2 g)</center>"]
                    ]
                },
                {
                    "title" : "<b>Salbutamol (Ventolin) IV</b>",
                    "drugKey" : "salbutamol",
                    "loc" : [["ccp", "first"]],
                    "dose_route" : [
                        ["<center>0-40 kg</center>", "<center>1 microgram/kg/min IV infusion\nTitrate infusion in increments of 1 microgram/kg/min q 15 minutes prn\n(MAX 5 microgram/kg/min)</center>"]
                    ]
                }
            ],
            "clinical" : "<tab1>• Add Normal Saline to Atrovent and Salbutamol dose to make a final volume of 3 mL. Atrovent should not be given alone. Nebulized Atrovent is given with Salbutamol dose.\n• Side effects of Magnesium Sulfate include hypotension, muscle fatigue and acute pulmonary edema; monitor BP and respiratory status closely\n• Consider IV Salbutamol in severe asthma exacerbations; monitor heart rate and rhythm, glucose (hyperglycemia) and electrolytes (hypokalemia)</tab1>"
        },
        {
            "key" : "ped_croup",
            "title" : "Paediatric - Croup – Suspected Cases",
            "type" : "medical_directive",
            "indications" : "<tab1>• A current history of an upper respiratory infection with a “barking” cough\nAND\n• Stridor at rest, or marked accessory muscle use, or an altered level of consciousness, or cyanosis</tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication</tab1>",
            "drug_cards" : [
                {
                    "title" : "<b>EPINEPHrine (Adrenalin) Nebulized (1:1000 solution)</b>",
                    "drugKey" : "epinephrine",
                    "loc" : [["pcp", "after"]],
                    "dose_route" : [
                        ["<center><b>Age and Weight</b></center>", "<center><b>Dose</b></center>"],
                        ["<center>< 1 year of age AND < 5 kg</center>", "<center>0.5 mg/dose\nDilute dose to 3mL in Normal Saline</center>"],
                        ["<center>< 1 year of age AND < 5 kg</center>", "<center>2.5 mg/dose\nDilute dose to 3 mL in Normal Saline</center>"],
                        ["<center>≥ 1 year of age</center>", "<center>5 mg</center>"]
                    ]
                },
                {
                    "title" : "<b>Dexamethasone (Decadron)</b>",
                    "drugKey" : "dexamethasone",
                    "loc" : [["acp", "after"]],
                    "dose_route" : [
                        ["<center>0.6 mg/kg/dose PO, IM, IV\nMAX 12 mg</center>", "<center>Administer orally if patient able to swallow\nor\nIf unable to tolerate oral administration due to respiratory distress and no IV access, administer IM</center>"]
                    ]
                }
            ],
            "clinical" : "<tab1>• Repeat the administration of EPINEPHrine nebulized using the same dose if no improvement is observed in ten minutes following the first treatment\n• For patients with HR > 200/min prior to EPINEPHrine nebulization, continue to monitor heart rate and rhythm; exclude arrhythmias and evaluate need for acute fluid resuscitation</tab1>"
        },
        {
            "key" : "ped_pneumothorax",
            "title" : "Paediatric - Tension Pneumothorax",
            "type" : "medical_directive",
            "indications" : "<tab1>• Severe respiratory distress in the setting of chest trauma with hemodynamic compromise\nOR\n• Traumatic VSA\nOR\n• Severe hemodynamic compromise with positive pressure ventilation particularly with altitude in trauma or asthma\nOR\n• Either chest trauma or severe asthma and hemodynamic instability and one of the following:</tab1>\n<tab2>o Decreased/absent breath sounds\no Altered LOC\no Cyanosis\no JVD (not seen in young children)\no Hyper resonance on affected side\no Tracheal shift (late sign)</tab2>",
            "contraindications" : "<tab1>• Not applicable</tab1>",
            "drug_cards" : [
                {
                    "loc" : [["acp", "after"]],
                    "dose_route" : [
                        ["<center>Consider differential diagnosis and decompress if high probability of tension pneumothorax</center>"]
                    ]
                }
            ],
            "clinical" : "<tab1>• The patient must be seen as soon as possible at an appropriate facility for the insertion of chest tube(s)\n• Consider differential diagnosis:\n</tab1><tab2>o Mainstem intubation\no Pleural effusion\no Hemothorax\no Consolidated pneumonia\no Autopeep\no Dynamic hyperinflation</tab2>"
        },
        {
            "key" : "ped_chest_tubes",
            "title" : "Paediatric - Maintenance of Chest Tubes",
            "type" : "medical_directive",
            "indications" : "<tab1>• Initiated by sending facility</tab1>",
            "contraindications" : "<tab1>• Not applicable</tab1>",
            "drug_cards" : [
                {
                    "title" : "Maintain chest drainage systems during the call to keep the drainage system clear",
                    "loc" : [["acp", "none"]],
                    "dose_route" : [
                        ["<center>If the patient’s chest tube was maintained by suction at the sending facility, the Paramedic may maintain suction to no greater than -20 cm H2O</center>", "<center>If the patient’s chest tube was maintained by gravity drainage, the Paramedic should maintain gravity drainage to underwater seal</center>"]
                    ]
                }
            ],
            "clinical" : "<tab1>• A Heimlich flutter valve is mandatory for transport if no drainage system has been implemented</tab1>"
        },
        {
            "key" : "ped_ventilation",
            "title" : "Paediatric - Initiating or Maintaining Mechanical Ventilation",
            "type" : "medical_directive",
            "indications" : "<tab1>• Need for mechanical ventilation</tab1>",
            "contraindications" : "<tab1>• None</tab1>",
            "drug_cards" : [
                {
                    "loc" : [["acp", "after"]],
                    "dose_route" : [
                        ["<left>Perform leak test on ventilator circuit.\nObtain baseline vital signs, including ETCO2.\nConfirm ETT placement (direct visualization if required, auscultation, and ETCO2) and ETT depth:\n<b>Oral ETT depth(cm)</b>\n<tab1>• 1 month: 9-10 cm\n• 6 months: 10-12 cm\n• 1 year: 12-14\n• 2 to 12 years: ETT size x 3\n</tab1>Check cuff pressure < 20 cm H2O after tube placement, and again in flight.\nReview indications for mechanical ventilation:\n<tab1>• Respiratory failure (apnea/respiratory arrest, inadequate ventilation, inadequate oxygenation)\n• Cardiac insufficiency/shock\n• Neurologic dysfunction – cerebral hypoventilation/frequent apneas, GCS < 8, and inability to protect airway</tab1>\nReview most recent chest film, CXR confirmation reported/ ETT depth & lung fields reviewed if done, or confirm in good position. Review blood gas if available.\nDocument ETT size and depth (distance at the lips).\nKeep bag-valve mask, with peep valve and pressure manometer available for the duration of transport.\nPaediatric ETTs should be secured according to Ornge Policy & Procedures prior to transport.\nEnsure NG/ or OG tubes inserted.</left>"]
                    ]
                },
                {
                    "section" : "<b>Initiation of Ventilation – Normal Lungs</b>",
                    "loc" : [["acp", "first"], ["pccp", "after"]],
                    "dose_route" : [
                        ["Select mode of ventilation for patient (PSV if awake & spontaneously breathing or AC/SIMV if unable to breathe, heavily sedated or high ventilator settings required). \n<b>SIMV PC + PS/AC to achieve</b>\n<tab1>• Target Vt 6-8 mL/kg.</tab1>\n\n<b>SIMV VC + PS/AC to achieve</b>\n<tab1>• Target Vt 6-8 mL/kg.</tab1>\n\n<b>PS general starting point 10 cm H2O</b>\n<tab1>• Range 5-20 cm H2O to achieve\n• Target Vt 6-8 ml/kg.</tab1>\n\n<b>Frequency (breaths per minute):</b>\n<tab1>• 1 month - 1 year 20-30\n• 1 - 6 years 15-25\n• > 6 years 15-20</tab1>\n\n<b>PEEP (cm H2O):</b>\n<tab1>• Minimum PEEP of 5 for all patients.\n• Pulmonary Disease 5-15\n• Abdominal Distention 5-15\n(Ascites, bowel obstruction)</tab1>\n\n<b>Inspiratory time:</b>\n<tab1>• 1 month–1 year 0.50-0.70\n• 1-6 years 0.60-0.90\n• > 6 years 0.70-1.0</tab1>\n\nMay use longer I-time to improve mean airway pressure and subsequently oxygenation. In obstructive airway disease, to increase Te, reduce RR to achieve I:E ratio 1:4 or 1:5. Reduced Ti is not recommended due to the risk of reduced Vt, requiring increased PIP and potential for barotrauma.\nMatch FiO2 requirements from sending facility or target SpO2 >92%\nAdjust sensitivity to trigger with respiratory effort (normally 3).\nPIP < 30 cmH20\nPlateau pressure < 30 cmH20\nIf already well ventilated, consider starting with referral ventilator settings.\ni.e. Pulmonary disease, ETT leaks\ni.e. Head trauma (no ETT leak)\nTarget ETCO2 35-45 (or target ETCO2 as ordered by Paediatric TMP based on clinical diagnosis).\n<center><b>Alarm Guidelines</b></center>\nSet high pressure 5-10 cmH20 above the PIP.\nSet low pressure alarm 5-10 cmH20 below PIP.\nSet minute ventilation alarm at 75% of actual VE."]
                    ]
                },
                {
                    "section" : "<b>Monitoring</b>",
                    "loc" : [["acp", "none"]],
                    "dose_route" : [
                        ["Document and monitor the following ventilator parameters:\n<tab1>• Mode: AC, SIMV or PSV\n• Pressure or Volume control\n• Sensitivity\n• Frequency\n• Tidal volume\n• Minute ventilation\n• PIP\n• PEEP\n• Pressure support\n• Mean airway pressure\n• Inspiratory time\n• I:E ratio\n• FiO2", "Monitor EtCO2 and capnographic waveforms throughout transport.\nMonitor ventilator synchrony, work of breathing, chest rise and fall.\nMonitor mean arterial pressure changes related to potential ventilator changes during transport.\nConsider checking plateau pressure or auto PEEP if concerned about lung compliance or air trapping."]
                    ]
                },
                {
                    "section" : "<b>Cuff Pressures</b>",
                    "loc" : [["acp", "none"]],
                    "dose_route" : [
                        ["<center>Target cuff pressure < 20 cm H2O</center>", "Recommended cuff pressure is just enough to seal the trachea.\nCuff pressure should be carefully adjusted to obtain a leak free seal at a pressure < 20 cm H2O.\nRecheck cuff pressure in flight."]
                    ]
                },
                {
                    "section" : "<b>Asthma Ventilation Strategies</b>",
                    "loc" : [["nil", "nil"]],
                    "dose_route" : [
                        ["Prevent or treat autoPEEP\n<b>Start PEEP at 5 cm H20</b>\nUse low frequency 8-12 breaths/min to a maximum of 16 breaths/min.\nTitrate frequency to maximize I:E ratio 1:4 to 1:5 allowing for long expiratory time.\nAdjust inspiratory time 0.75-1.0 based on age/weight.\nUse low tidal volume 4-6 mL/kg.\nKeep plateau pressure < 30 cmH20.\nTitrate ventilator parameters to achieve SpO2 >92%.", "Intrinsic or autoPEEP can lead to worsening hypoxia, hypercapnia and hypotension.\nSevere airway obstruction may not allow complete expiration prior to the next delivered breath.nMonitor capnographic waveform for sloped expiratory rise indicating airflow obstruction.\n<b>Difficult to ventilate/oxygenate:</b>\nOptimize sedation;\nConsider muscle relaxing the patient\nPermissive Hypercapnia;\nDiscuss with TMP regarding use of PEEP"]
                    ]
                },
                {
                    "section" : "<b>Bronchiolitis Ventilation Strategies</b>",
                    "loc" : [["nil", "nil"]],
                    "dose_route" : [
                        ["Start PEEP at 5 cm H2O and titrate up as needed if FiO2 > 60%.\nUse low frequency half of normal rate for patient age.\nSet proper I-time for age/weight.\nI:E ratio 1:3 to 1:4.\nTidal volumes 6-8 mL/kg.\nKeep plateau pressure < 30 cmH2O.\nTitrate Ventilator parameters to achieve SpO2 >92%.", "Permissive hypercapnia.\nAssess adequacy of expiratory phase.\nAim to avoid or minimize hyperinflation.\nOptimize sedation"]
                    ]
                },
                {
                    "section" : "<b>Acute Lung Injury/ARDS Ventilation Strategies</b>",
                    "loc" : [["nil", "nil"]],
                    "dose_route" : [
                        ["Tidal volumes 6-8 mL/kg. Adjust Vt based on plateau pressures.\nStart PEEP at 8 cm H2O; if FiO2 > 0.60 FiO2, titrate incremental increases in PEEP from 8 to 12 cm H2O to achieve SpO2 > 0.92. If no clinical improvements observed with increasing PEEP (increasing SpO2), STOP increasing PEEP. In severe paediatric ARDS, with no observed clinical improvements & continued SpO2 < 0.92, despite interventions, discuss further vent strategies, permissive hypoxia and hypercapnia parameters with paeds TMP\nKeep plateau pressure < 30 cmH20.\nFiO2 to maintain SpO2 > 90.\nInflamed lungs with decreased compliance and increased dead space are prone to atelectasis, barotrauma and volu-trauma.\nPermissive hypercapnia (if pH > 7.25)\nIncreased I:E ratio can improve oxygenation by increasing mean airway pressure and helping to maintain PEEP. Aim for pH > 7.25 on blood gas\nAvoid pulmonary de-recruitment (disconnections); may require manual recruitments using increased pressure for 30 to 40 seconds to recover.\nOptimize sedation.\nConsider muscle relaxing patient."]
                    ]
                }
            ],
            "clinical" : "<tab1>• When mechanical ventilation is initiated, all settings and patient’s response to treatment must be documented on the Call Report\n• The patient’s end tidal CO2, O2 saturation, and PIPs must be continuously monitored and recorded</tab1>"
        },
        {
            "key" : "ped_nippv",
            "title" : "Paediatric - Non-Invasive Positive Pressure Ventilation (NIPPV)",
            "type" : "medical_directive",
            "indications" : "<tab1>• Conscious patient\n• Obstuctive airway disease; e.g. asthma\n• Cardiac failure\n• Chronic lung disease\n• Acute/Chronic respiratory failure\n• Neuromuscular disease\n• Pneumonia</tab1>",
            "contraindications" : "<tab1>• <b>Paediatric patients < 9 years old</b>\n• Decreased level of consciousness\n• Inability to protect airway\n• Recent gastric or esophageal surgery\n• Immediate need for endotracheal intubation\n• Pneumothorax</tab1>",
            "drug_cards" : [
                {
                    "title" : "<b>CPAP/BiPAP</b>",
                    "loc" : [["acp", "after"]],
                    "dose_route" : [
                        ["<center>Consider initiating CPAP and progressing to BiPAP as required if no improvement\n<b>Initial Setting</b></center><left>\n<tab1>Mild to moderate work of breathing: iPAP 6-8 cm H2O; increase to 10 cm H2O\nModerate work of breathing: iPAP 10 cm H2O; increase to 15-18 cm H2O*\n\n</tab1></left><center><b>PEEP</b>\n</center><left><tab1>If FiO2 is < 0. 40 start ePAP 5-6 cm H2O\nIf FiO2 is > 0.40 to 0.80 start ePAP 8-10 cm H2O\nIf FiO2 is > 0.80 start ePAP 10 cm H2O and increase to 12 cm H2O as tolerated</tab1></left><center>\n\nInvasive ventilation should be considered at these levels of O2 & support requirements</center>"]
                    ]
                }
            ],
            "clinical" : "<tab1>• Titrate iPAP based on disease process requiring NIPPV e.g Asthma verses congestive heart failure (CHF) verses respiratory distress from other causes\n• Start with a ePAP 5 cmH2O in asthmatic patients regardless of FiO2 needs due to air trapping and begin iPAP 8-10 cm H2O, titrating iPAP as tolerated\n• Ensure mask fits securely to ensure adequate seal\n• NGT/OGT to ensure gastric decompression during NIPPV\n• Monitor for for leaks and mask pressure around eyes and refit as required</tab1>"
        },
        {
            "key" : "ped_hfnc",
            "title" : "Paediatric - High Flow Nasal Cannula Therapy (HFNC)",
            "type" : "medical_directive",
            "indications" : "<tab1>• Any patients who would benefit from heated humidity (e.g. bronchiolitis, pneumonia, patients with tenacious secretions, tracheostomy)\n• Hypoxemia, as evidenced by suboptimal oxygen saturations below acceptable patient specific ranges, despite maximum recommended flow rates while receiving traditional O2 therapy (nasal cannula, face mask or hood)\n• To alleviate mild to moderate work of breathing as evidenced by the following signs & symptoms:</tab1>\n<tab2>o Tachypnea, nasal flaring, in-drawing, retractions and accessory muscle use\no Agitation, confusion or anxiety\no Tachycardia and/or heart rate variability</tab2>",
            "contraindications" : "<tab1>• • Acute deterioration in level of consciousness\n• When positive pressure ventilation is required (poor compliance, decreased functional residual capacity).\n• NHFC therapy should not be used as an alternative to positive pressure ventilation or NPPV.\n• Moderate to severe respiratory distress and/or impending cardio-respiratory failure with high partial arterial pressure of carbon dioxide\n• Airway obstruction (e.g. Obstructive Sleep Apnea)\n• Air leak (pneumothorax, pneumomediastinum) is a potential cause for concern and should be monitored closely\n• Recent post-operative esophageal surgery or suspected bowel obstruction – mechanical or functional\n• Suspected or confirmed base of skull fracture\n• Epistaxis</tab1>\n<title>Complications:</title>\n<tab1>• Unmeasured PEEP may result in lung hyperinflation, pneumothorax (rare)\n• Complications of HFNC include abdominal distension, aspiration, barotrauma, and pneumothorax (rare)</tab1>",
            "drug_cards" : [
                {
                    "loc" : [["acp", "after"]],
                    "dose_route" : [
                        ["<center>Initiate treatment at 1.5-2 L/kg/min to achieve SpO2 >92%. Contact TMP if an increase in flow is indicated and/or FiO2 requirements exceed 0.60</center>"]
                    ]
                }
            ]
        },
        {
            "key" : "ped_non_intubated_sedation",
            "title" : "Paediatric - Sedation and Pain Management for Non-Ventilated Patients",
            "type" : "medical_directive",
            "flowchartkeys" : [["FLACC score", "ped_flacc_score"]],
            "clinical" : "<tab1>• FLACC pain scoring / assessment <red>must</red> be completed at the start of normal patient care at a frequency that aligns with the patient’s clinical state\n• Pain assessment should be completed every 30 minutes as well as with significant changes in patient condition and also before and after interventions\n• Use Oral route to administer medications whenever possible\n• IM administration is not acceptable; use the least invasive route whenever possible\n• Match analgesic to the severity of pain\n• Consider using more than one class of analgesic (e.g Acetaminiphen + NSAID) to promote better pain relief; may reduce opioid requirements</tab1>",
            "drug_cards" : [
                {
                    "loc" : [["nil", "nil"]],
                    "dose_route" : [
                        ["<left><b>Pain Severity</b></left>", "<left><b>Medication Choices</b></left>"],
                        ["<left>Mild pain</left>", "<left>Acetaminophen +/NSAID (if not contraindicated)</left>"],
                        ["<left>Moderate to Severe Pain</left>", "<left>Acetaminophen +/NSAID (if not contraindicated) + Opioid</left>"]
                    ],
                    "notes" : "NSAID Non steroidal anti-inflammatory drug"
                },
                {
                    "title" : "<b>Acetaminophen</b>",
                    "drugKey" : "acetaminophen",
                    "loc" : [["pcp", "none"]],
                    "dose_route" : [
                        ["<center><b>Age / Weight</b></center>", "<center><b>Dose</b></center>"],
                        ["<center>12 years or ></center>", "<center>500-650 mg every 4 hours PO\nMax single dose 650 mg</center>"]
                    ]
                },
                {
                    "title" : "<b>Acetaminophen</b>",
                    "drugKey" : "acetaminophen",
                    "loc" : [["acp", "none"]],
                    "dose_route" : [
                        ["<center><b>Age / Weight</b></center>", "<center><b>Dose</b></center>"],
                        ["<center>< 12 years</center>", "<center>15 mg/kg every 4 hours PO or PR\nMax 1 gram\n(Suspension or Suppository)</center>"]
                    ]
                },
                {
                    "title" : "<b>Ibuprofen</b>",
                    "drugKey" : "ibuprofen",
                    "loc" : [["pcp", "none"]],
                    "dose_route" : [
                        ["<center><b>Age / Weight</b></center>", "<center><b>Dose</b></center>"],
                        ["<center>12 years or ></center>", "<center>400 mg every 6 hours PO</center>"]
                    ]
                },
                {
                    "title" : "<b>Ibuprofen</b>",
                    "drugKey" : "ibuprofen",
                    "loc" : [["acp", "none"]],
                    "dose_route" : [
                        ["<center><b>Age / Weight</b></center>", "<center><b>Dose</b></center>"],
                        ["<center>>6 months and <12 years</center>", "<center>10 mg/kg PO\nMax 400 mg</center>"]
                    ]
                },
                {
                    "title" : "<b>Morphine</b>",
                    "drugKey" : "morphine",
                    "loc" : [["acp", "after"]],
                    "dose_route" : [
                        ["<center>0.05-0.1 mg/kg/dose IV (Max 4 mg/dose)</center>"]
                    ]
                },
                {
                    "title" : "<b>24% Sucrose</b>",
                    "loc" : [["acp", "none"]],
                    "dose_route" : [
                        ["<center><b>Age / Weight</b></center>", "<center><b>Dose</b></center>"],
                        ["<center><u>Less</u> than 18 months</center>", "<center>0.1 ml PO\n2 minutes prior to painful procedure</center>"]
                    ],
                    "notes" : "<title>Clinical Consideratons for 24% Sucrose:</title>\n<tab1>• Dose may be repeated at 5 minute intervals for prolonged procedures\n• <b>Contraindicated</b> in short-bowel syndrome, carbohydrate intolerance, unconscious or heavily sedated patients with absent gag reflex; <b>avoid use</b> in patients with gastrointestinal tract abnormalities (e.g. esophageal atresia or tracheal esophageal fistula), in patients at risk for aspiration. Sucrose <b>should not be used</b> for patients requiring ongoing analgesia</tab1>"
                }
            ]
        },
        {
            "key" : "ped_intubated_sedation",
            "title" : "Paediatric - Sedation and Pain Management for Intubated and Ventilated Patients",
            "type" : "medical_directive",
            "flowchartkeys" : [["Sedation score", "ped_sedation_score"]],
            "indications" : "<tab1>• Agitation and lability requiring intubation and ventilation\n• Any patient receiving muscle relaxation\n• Any patient undergoing invasive procedures\n• Any patient who demonstrates positive indications of pain, tachycardia, hypertension or grimacing\n• The patient must have a baseline and continuous assessment of response to the drug with heart rate, respiratory rate and blood pressure</tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication\n• Systolic BP below 70 + (2 x age in years)</tab1>",
            "clinical" : "<tab1>• Observe patient for hemodynamic instability with analgosedation infusions\n• Fentanyl is preferred for procedural pain relief or if low SBP, otherwise morphine preferred for sedation/pain management\n• Systolic BP below 70 + (2 x age in years)</tab1>",
            "drug_cards" : [
                {
                    "section" : "<b>For Analgesia (choose one)</b>",
                    "title" : "<b>FentaNYL (Sublimaze)</b>",
                    "drugKey" : "fentanyl",
                    "loc" : [["acp", "after"]],
                    "dose_route" : [
                        ["<center>Bolus</center>", "<center>Infusion</center>"],
                        ["<center>1-2 microgram/kg/dose slow IV push</center>", "<center>1-4 microgram/kg/hr</center>"]
                    ]
                },
                {
                    "section" : "OR",
                    "title" : "<b>Morphine (MSO4)</b>",
                    "drugKey" : "morphine",
                    "loc" : [["acp", "after"]],
                    "dose_route" : [
                        ["<center>Bolus</center>", "<center>Infusion</center>"],
                        ["<center>0.1 mg/kg/dose IV (MAX 4 mg/dose)</center>", "<center>10-40 microgram/kg/hr</center>"]
                    ]
                },
                {
                    "section" : "OR",
                    "title" : "<b>Ketamine</b>",
                    "drugKey" : "ketamine",
                    "loc" : [["acp", "first"], ["ccp", "after"]],
                    "dose_route" : [
                        ["<center>Bolus</center>", "<center>Infusion</center>"],
                        ["<center>1-2 mg/kg slow IV push\nNot to exceed 0.3-2 mg/kg/hr</center>", "<center>0.3-1.2 mg/kg/hour IV/IO</center>"]
                    ]
                },
                {
                    "section" : "<b>For Sedation (choose one)</b>",
                    "drugKey" : "midazolam",
                    "title" : "<b>Midazolam (Versed)</b>",
                    "loc" : [["acp", "first"], ["ccp", "after"]],
                    "dose_route" : [
                        ["<center>Bolus</center>", "<center>Infusion</center>"],
                        ["<center>0.05-0.1 mg/kg/dose IV/IO</center>", "<center>50-500microgram/kg/hour IV/IO</center>"]
                    ]
                },
                {
                    "section" : "<b>OR</b>",
                    "title" : "<b>Propofol (Diprivan)</b>",
                    "drugKey" : "propofol",
                    "loc" : [["ccp", "first"]],
                    "dose_route" : [
                        ["<center>Additional boluses of 0.5 mg/kg/dose\nq 5 minutes prn\nprovided BP is normal for ag</center>", "<center>0-12 mg/kg/hr titrated\nby increments of 0.3 mg/kg/hr\nq 5 minutes prn</center>"] 
                    ]
                }
            ]
        },
        {
            "key" : "ped_pain_scale",
            "title" : "FLACC (Paediatric) Behavioural Pain Assessment Scale",
            "type" : "document",
            "content" :
            [
                [
                    ["<section><b>Face</b>", "<b>Score</b><width=70>", "<width=25>"],
                    ["No particular expression or smile", "0", "<checkbox>"],
                    ["Occasional grimace or frown, withdrawn, disinterested", "1", "<checkbox>"],
                    ["Frequent to constant frown, clenched jaw, quivering chin", "2", "<checkbox>"]
                ],
                [
                    ["<section><b>Legs</b>", "<b>Score</b><width=70>", "<width=25>"],
                    ["Normal position or relaxed", "0", "<checkbox>"],
                    ["Uneasy, restless, tense", "1", "<checkbox>"],
                    ["Kicking or legs drawn up", "2", "<checkbox>"]
                ],
                [
                    ["<section><b>Activity</b>", "<b>Score</b><width=70>", "<width=25>"],
                    ["Lying quietly, normal position, moves easily", "0", "<checkbox>"],
                    ["Squirming, shifting back and forth, tense", "1", "<checkbox>"],
                    ["Arched, rigid, or jerking", "2", "<checkbox>"]
                ],
                [
                    ["<section><b>Cry</b>", "<b>Score</b><width=70>", "<width=25>"],
                    ["No cry (awake or asleep)", "0", "<checkbox>"],
                    ["Moans or whimpers, occasional complaint, tense", "1", "<checkbox>"],
                    ["Crying steadily, screams or sobs; frequent complaints", "2", "<checkbox>"]
                ],
                [
                    ["<section><b>Consolability</b>", "<b>Score</b><width=70>", "<width=25>"],
                    ["Content, relaxed", "0", "<checkbox>"],
                    ["Reassured by occasional touching, hugging, or being talked to; distractible", "1", "<checkbox>"],
                    ["Difficult to console or comfort", "2", "<checkbox>"]
                ],
                [
                    ["<section><width=70><b>Total</b>", ""],
                    ["0", "Relaxed and comfortable"],
                    ["1-3", "Mild discomfort"],
                    ["4-6", "Moderate pain"],
                    ["7-10", "Severe discomfort or pain or both"]
                ]
            ]
        },
        {
            "key" : "ped_sedation_scale",
            "title" : "Sedation Scale For Paediatrics",
            "type" : "document",
            "content" :
            [
                [
                    ["<section><section_width=750><width=40><b>Score</b>", "<width=75><b>Name</b>", "<b>General</b>", "<width=100><b>Ventilator Reaction</b>", "<width=100><b>ETT Suction Reaction</b>"],
                    ["+2", "Agitated", "Spontaneously pays attention to care provider\nUnsafe (biting endotracheal tube, pulling at catheters, cannot be left alone)\nUnable to console\nIncreased movement (restless, squirming, or thrashing side-to-side, kicking legs)", "May have difficulty breathing with ventilator", "Coughing spontaneously\nNo external stimulus required to elicit response"],
                    ["+1", "Restless and difficult to calm", "Responds to voice/no external stimulus is required to elicit response\nDrifts off/spontaneously pays attention to care provider\nIntermittently unsafe\nDoes not consistently calm, despite 5-min attempt/unable to console\nIncreased movement (restless, squirming)", "Spontaneous effective breathing/having difficulty breathing with ventilator", "Occasional spontaneous cough"],
                    ["0", "Alert & able to calm", "Responds to voice/no external stimulus is required to elicit response\nSpontaneously pays attention to care provider\nDistresses with procedures\nAble to calm with comforting touch or voice when stimulus removed\nOccasional movement of limbs or shifting of position/increased movement (restless, squirming)", "Spontaneous and effective breathing", "Coughs when repositioned/occasional spontaneous cough"],
                    ["-1", "Response to gentle touch or voice", "Responds to touch/voice\nAble to pay attention but drifts off after stimulation\nDistresses with procedures\nAble to calm with comforting touch or voice when stimulus removed\nOccasional movement of limbs or shifting of position; Follows commands", "Spontaneous but ineffective nonsupported breaths", "Coughs with suctioning/repositioning"],
                    ["-2", "Response to noxious stimuli", "Responds to noxious stimuli\nUnable to pay attention to care provider\nWill distress with a noxious procedure\nDoes not move/occasional movement of limbs or shifting of position", "Spontaneous yet supported breathing", "Coughs with suctioning/repositioning"],
                    ["-3", "Unresponsiveness", "No response to noxious stimuli\nUnable to pay attention to care provider\nDoes not distress with any procedure (including noxious)\nDoes not move", "No spontaneous respiratory effort", "No cough or coughs only with suctioning"]
                ]
            ]
        },
        {
            "key" : "ped_intubated_paralysis",
            "title" : "Paediatric - Post Intubation Paralysis",
            "type" : "medical_directive",
            "indications" : "<tab1>• Patients with known difficult airway\n• To facilitate and optimize mechanical ventilation and oxygenation\n• Persistent hypoxia/hypoxemia <b>despite adequate sedation</b>\n• To minimize risk of accidental extubation in transport\n• In labile patients requiring 100% oxygen</tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication\n• Inadequate sedation/analgesia</tab1>",
            "clinical" : "<tab1>• In patients with known difficult airway, muscle relaxation is strongly recommended post intubation to ensure minimal risk for loss of ETT in transport\n• Complete history and physical examination (including baseline neurologic assessment) must be completed prior to medication administration\n• ETT tube confirmed to be in good position on, CXR (if available), auscultation and by EtCO2 tracing confirms ETT placement in the trachea, but does not confirm optimal positioning\n• Resuscitation equipment should be readily available\n• All patients must be on a cardiac, SpO2 and EtCO2 monitor, with frequent blood pressure monitoring (typically every 5-10 minutes unless otherwise indicated)\n• Baseline assessment of patient’s response (heart rate, blood pressure) to paralytic must be obtained and re-evaluated to determine need for further sedation and ongoing muscle relaxation\n• <b>Sedation/analgesia must be administered in conjunction with muscle relaxation</b>\n• Muscle relaxants will hide the motor component of seizures. In cases of status epilepticus or risk of seizures, paralysis should be administered as a last resort and in conjunction with anticonvulsant/sedative infusions. Monitor closely for autonomic manifestations of seizures</tab1>",
            "drug_cards" : [
                {
                    "title" : "<b>Rocuronium (Zemuron)</b>",
                    "drugKey" : "rocuronium",
                    "loc" : [["acp", "first"]],
                    "dose_route" : [
                        ["<center>< 40 kg</center>", "<center>0.6 mg/kg/dose IV/IO</center>"]
                    ]
                }
            ]
        },
        {
            "key" : "ped_medical_arrest_pcp",
            "title" : "Paediatric - Non-Traumatic Cardiac Arrest: PCP(f)",
            "type" : "medical_directive",
            "flowchartkeys" : [["Flowchart", "ped_medical_arrest_pcp"]],
            "indications" : "<tab1>• Vital signs absent (VSA) due to non-traumatic cause</tab1>",
            "contraindications" : "<tab1>• Vital signs present</tab1>",
            "drug_cards" : [
                {
                    "loc" : [["pcp", "after"]],
                    "dose_route" : [["<b>Initiate the appropriate algorithm based upon the presenting ECG rhythm</b>"]]
                },
                {
                    "loc" : [["nil", "nil"]],
                    "dose_route" : [
                        ["Shock", "Zoll X-Paeds SAED settings", "Zoll X-Paeds manual settings"],
                        ["Shock # 1", "50J", "2J/kg"],
                        ["Shock # 2", "70J", "4J/kg"],
                        ["Shock # 3 and all subsequent shocks", "85J", "6J/kg"],
                        ["Shock # 4", "<bg=000000ff>", "8J/kg"],
                        ["Shock # 5", "<bg=000000ff>", "10J/kg"]
                    ]
                }
            ],
            "clinical" : "<tab1>• PCP(f) may apply the Medical Directives for the management of cardiac arrest with semi-automated defibrillation\n• The above chart shows all possible Joule settings based on the two types of monitors currently used by Ornge in both manual and SAED settings\n• Joule settings in the algorithms above are based on the Zoll X MD Manual settings as this is the most prevalent monitor in our system\n• TMP patch prior to initiating transport of patient in cardiac arrest for consideration of TOR</tab1>"
        },
        {
            "key" : "ped_medical_arrest",
            "title" : "Paediatric - Non-Traumatic Cardiac Arrest: ACP(f)",
            "type" : "medical_directive",
            "flowchartkeys" : [["Flowchart", "ped_medical_arrest_flowchart"], ["Notes", "ped_medical_arrest_list"], ["Paediatric Post Arrest ROSC", "ped_nrp_1"]],
            "indications" : "<tab1>• Vital signs absent (VSA) due to non–traumatic cause</tab1>",
            "contraindications" : "<tab1>• Vital signs present\n• Allergy or sensitivity to the medication</tab1>",
            "drug_cards" : [
                {
                    "loc" : [["acp", "after"]],
                    "dose_route" : [["<b>Initiate the appropriate algorithm based upon the presenting ECG rhythm</b>"]]
                },
                {
                    "title" : "EPINEPHrine",
                    "drugKey" : "epinephrine",
                    "loc" : [["acp", "after"]],
                    "dose_route" : [["0.01 mg/kg (0.1 mL/kg of 1:10,000 concentration)\nRepeat q 3-5 min"]]
                },
                {
                    "title" : "Amiodarone",
                    "drugKey" : "amiodarone",
                    "loc" : [["acp", "after"]],
                    "dose_route" : [["0.01 mg/kg (0.1 mL/kg of 1:10,000 concentration)\nRepeat q 3-5 min"]]
                },
                {
                    "title" : "Lidocaine",
                    "drugKey" : "lidocaine",
                    "loc" : [["acp", "after"]],
                    "dose_route" : [["Initial 1 mg/kg loading dose\nMaintenance infusion 20-50 microgram/kg/min\n(repeat bolus dose if infusion initiated > 15 min after initial bolus therapy)"]]
                }
            ],
            "clinical" : "<tab1>• Lidocaine continuous IV infusion: Do not exceed 20 microgram/kg/min in patients with shock, hepatic disease, cardiac arrest or CHF</tab1>"
        },
        {
            "key" : "ped_nrp",
            "title" : "Neonatal Resuscitation (NRP)",
            "type" : "medical_directive",
            "indications" : "• Neonatal vital signs absent",
            "flowchartkeys" : [["Neonatal Resuscitation", "ped_nrp_0"]],
            "contraindications" : "• Allergy or sensitivity to the medication",
            "drug_cards" : [
                {
                    "title" : "",
                    "loc" : [["acp", "after"]],
                    "dose_route" : [["<b>Initiate Neonatal Resuscitation Algorithm"]]
                },
                {
                    "section" : "<b>Neonatal Resuscitation Drug Dosages 0-28 days",
                    "title" : "",
                    "loc" : [["acp", "after"]],
                    "dose_route" : [
                        ["<b>Drug", "<a href=\"drugKey=epinephrine\">EPINEPHrine</a>", "<a href=\"drugKey=epinephrine\">EPINEPHrine</a>", "<a href=\"drugKey=d50w\">Dextrose</a>"],
                        ["<b>Concentration", "1:10,000", "1:10,000", "D₁₀W"],
                        ["<b>Preparation", "1 ml Syringe", "3 mL Syringe", "D₁₀W"],
                        ["<b>Dose", "0.1 mL/kg\n(0.01 mg/kg)", "1 mL/kg\n(0.1 mg/kg)", "2 mL/kg\n(0.2 mg/kg)"],
                        ["<b>Route", "UVC/IV/IO", "ETT*", "UVC/IV/IO"]
                    ],
                    "notes" : "*IV or UVC route is preferred"
                },
                {
                    "title" : "",
                    "loc" : [["acp", "first"]],
                    "dose_route" : [
                        ["<b>Drug", "Volume: Normal Saline and/or Blood as indicated"],
                        ["<b>Dose", "10 mL/kg IV over 5 to 10 minutes"],
                        ["<b>Route", "UVC/IV/IO"]
                    ]
                }
            ],
            "clinical" :
            "<tab1>• Administration of Narcan is not recommended in the initial steps of resuscitation\n• *UVC/IV/IO route preferred. May consider giving one dose of EPINEPHrine via the tracheal tube (ET) while obtaining vascular access. If EPINEPHrine given by ET route and no response, as soon as UVC or IO access obtained do not wait 3-5 minutes after ET dose to administer IV dose\n• Preparation for Transport:\n</tab1><tab2>o Anticipate need for thermoregulation during initial steps of resuscitation, especially in premature infants < 32 weeks GA; all neonates require continuous temperature monitoring during initial resuscitation, stabilization and transport. Target normal temperatures 36.5 to 37.5 ̊C\no Following initial steps of resuscitation, target preductal oxygen saturations 90 to 95%; In neonates with suspected congenital heart disease requiring Alprostadil infusion, review preductal oxygen saturation target with TMP\no In neonates with suspected persistent pulmonary hypertension of the newborn, target preductal oxygen saturations 92% to 95%</tab2>"
        },
        {
            "key" : "ped_bradycardia",
            "title" : "Paediatric - Bradycardia",
            "type" : "medical_directive",
            "flowchartkeys" : [["Flowchart", "ped_bradycardia_flowchart"]],
            "indications" : "Bradycardia",
            "contraindications" : "Allergy or sensitivity to the medication",
            "drug_cards" : [
                {
                    "title" : "",
                    "loc" : [["acp", "after"]],
                    "dose_route" : [["<b>Initiate the appropriate algorithm based upon the presenting ECG rhythm</b>"]]
                },
                {
                    "title" : "<b>EPINEPHrine</b>",
                    "drugKey" : "epinephrine",
                    "loc" : [["acp", "after"]],
                    "dose_route" : [["0.01 mg/kg (0.1 mL/kg of 1:10,000 concentration) IV\nRepeat q 3-5 min"]]
                },
                {
                    "title" : "<b>EPINEPHrine</b>",
                    "drugKey" : "epinephrine",
                    "loc" : [["ccp", "after"]],
                    "dose_route" : [["0.01 mg/kg (0.1 mL/kg of 1:10,000 concentration) IV\nRepeat q 3-5 min\nOR\n0.1 microgram/kg/min IV infusion"]]
                },
                {
                    "title" : "<b>DOPamine</b>",
                    "drugKey" : "dopamine",
                    "loc" : [["acp", "first"]],
                    "dose_route" : [
                        [ "5-20 microgram/kg/min IV infusion"]
                    ]
                },
                {
                    "title" : "<b>Atropine</b>",
                    "drugKey" : "atropine",
                    "loc" : [["acp", "first"]],
                    "dose_route" : [
                        [ "0.02 mg/kg IV/IO\nMAX single dose: Child 0.5 mg; Adolescent 1 mg\nMay repeat dose once"]
                    ]
                }
            ],
            "clinical" :
            "<tab1>• Atropine Dose ETT if no IV/IO access: 0.04- 0.06 mg/kg/dose for symptomatic bradycardia\n• Atropine for Toxins/overdose (i.e. organophosphate, carbamate)</tab1><tab2>\no < 12 years: 0.02- 0.05 mg/kg IV/IO initially; repeat q 20-30 minutes until symptoms are reversed\no > 12 years: 2 mg IV/IO initially; then 1-2 mg IV/IO q 20-30 minutes until symptoms are reversed</tab2>"
        },
        {
            "key" : "ped_tachycardia",
            "title" : "Paediatric - Tachycardia",
            "type" : "medical_directive",
            "flowchartkeys" : [["Flowchart", "ped_tachycardia_flowchart"]],
            "indications" : "<tab1>• Tachycardia</tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication</tab1>",
            "drug_cards" : [
                {
                    "title" : "",
                    "loc" : [["acp", "after"]],
                    "dose_route" : [["Initiate the appropriate algorithm based upon the presenting ECG rhythm"]]
                },
                {
                    "title" : "Adenosine",
                    "drugKey" : "adenosine",
                    "loc" : [["acp", "after"]],
                    "dose_route" : [["Adenosine 0.1 mg/kg rapid IV/IO bolus (MAX 6 mg)\nfollowed by rapid Normal Saline flush 5-10 ml\nRepeat Adenosine at 0.2 mg/kg q 2 min if no change"]]
                },
                {
                    "title" : "",
                    "loc" : [["acp", "first"]],
                    "dose_route" : [["<b>Synchronized Cardioversion</b>"]]
                },
                {
                    "title" : "<b>Procedural Sedation</b>",
                    "loc" : [["acp", "first"]],
                    "dose_route" : [
                        [ "<b>SBP > 70 + (2 x age in years)</b>", "<b>SBP < 70 + (2 x age in years</b>"],
                        [ "<a href=\"drugKey=ketamine\">Ketamine</a> 0.5 mg/kg\n<b>OR</b>\n<a href=\"drugKey=midazolam\">Midazolam</a> 0.05 mg/kg and/or\n<a href=\"drugKey=fentanyl\">FentaNYL</a> 1 microgram/kg",
                        "<a href=\"drugKey=ketamine\">Ketamine</a> 0.5 mg/kg"]
                    ]
                }
            ],
            "clinical" :
            "<tab1>• Adenosine should be administered in peripheral IV site close to patient's heat. Two syringes (one with Adenosine dose and one with NS flush) connected to a T-connector or stopcock is recommended for rapid administration of both medication and flush</tab1>"
        },
        {
            "key" : "ped_iv",
            "title" : "Paediatric - Intravenous Line Initiation and Maintenance",
            "type" : "medical_directive",
            "indications" : "<tab1>• Actual or potential need for intravenous drug or fluid therapy</tab1>",
            "contraindications" : "<tab1>• Suspected fracture proximal to the IV site</tab1>",
            "drug_cards" : [
                {
                    "title" : "<b>Monitor</b>",
                    "loc" : [["pcp", "none"]],
                    "dose_route" : [["Infants and children with an IV in place infusing at a rate of 5-15 mL/hr TKVO"]]
                },
                {
                    "loc" : [["acp", "after"]],
                    "dose_route" : [["<b>Newborn (< 24 hours)</b>", "Calculate IV rate of 80 mL/kg/day\nPreferred solution D10W"],
                        ["<b>Neonate (> 24 hours old)\n(< 28 days or 44 weeks corrected gestational age)</b>", "Calculate IV rate at 100 mL/kg/day\nPreferred solution D10W & 0.2% Saline\n(D5W & 0.9% NaCL) may be indicated in some circumstances"]
                    ]
                },
                {
                    "loc" : [["acp", "none"]],
                    "dose_route" : [
                        ["<b>Paediatric (> 28 days)</b>", "4 mL/hr x (0-10 kg)\n+ 2 mL/hr x (10.1 kg-20 kg)\n+ 1 mL/hr x (20.1 kg and greater)\nD5W & 0.9% NaCL IV\n0.9% normal saline may be indicated for maintenance when blood glucose levels are high"]
                    ]
                }
            ],
            "clinical" :
            "<tab1>• Not applicable</tab1>"
        },
        {
            "key" : "ped_io_initiate",
            "title" : "Paediatric - Intraosseous Initiation and Maintenance",
            "type" : "medical_directive",
            "indications" : "<tab1>• Inadequate intravenous access for resuscitation\n• Unable to obtain intravenous access after two (2) attempts or 90 seconds</tab1>",
            "contraindications" : "<tab1>• Known or suspected fracture of affected limb\n• Known or suspected injury, deformity, or infection overlying the proposed insertion site\n• Absence of adequate anatomic landmarks</tab1>",
            "drug_cards" : [
                {
                    "loc" : [["acp", "after"]],
                    "dose_route" : [["<b>Initiate the appropriate intervention based upon the presenting condition</b>"]]
                }
            ],
            "clinical" :
            "<tab1>• If the patient has hypovolemic shock, extensive burns, or major trauma but not in cardiac arrest or pre-arrest state, attempt to contact the TMP prior to using the IO device\n• For neonates < 10 days of age and less than 3 kg, consider UVC Insertion\n• Paediatric IOs can be placed in the proximal and distal tibia, distal femur and the humerus</tab1><tab2>\no Choosing the site is based on ability to landmark\no Issue with choosing the humerus is ability to landmark the greater tubercle in patients < 6 years old as this site is not yet well developed</tab2>"
        },
        {
            "key" : "ped_io_analgesia",
            "title" : "Paediatric - Intraosseous Vascular Access Analgesia",
            "type" : "medical_directive",
            "indications" : "<tab1>• Patient requiring intraosseous (IO) needle access and responsive to pain</tab1>",
            "contraindications" : "<tab1>• Sino-atrial disorders\n• All grades of AV block, Stokes-Adams syndrome, Wolff-Parkinson-White syndrome\n• Acute porphyria\n• Hypersensitivity to another local anesthetic of the amide type</tab1>",
            
            "drug_cards" : [
                {
                    "title" : "<b>Lidocaine 2% without epinephrine</b>",
                    "loc" : [["acp", "after"]],
                    "drugKey" : "lidocaine",
                    "dose_route" : [
                        ["", "<b>1st Dose</b>", "<b>2nd Dose</b>"],
                        ["30-40 kg", "20 mg (1.0 ml)", "10 mg (0.5 ml)"],
                        ["20-30 kg", "15 mg (0.75 ml)", "7.5 mg (0.4 ml)"],
                        ["10-20 kg", "10 mg (0.5 ml)", "5 mg (0.25 ml)"],
                        ["< 10 kg", "5 mg (0.25 ml)", "2.5 mg (0.15 ml)"]
                    ],
                    "notes" : "*Administer <b>first dose</b> over 2 minutes then allow lidocaine to dwell for 1 minute in IO space and flush with 5-10 ml 0.9% saline\nFollowed by <b>second dose</b> of lidocaine over 1 minute"
                }
            ],
            "clinical" :
            "<tab1>• After the second lidocaine dose is given, medication or fluids may be administered under pressure as required\n• Can consider administering again in 45 minutes later at the lower of the two previous doses given if discomfort re-occurs\n• If extravasation occurs insert a new IO needle\n• Cimetidine or beta-blockers (e.g. propranol) may interact and cause lidocaine toxicity</tab1>"
        },
        {
            "key" : "ped_uvc",
            "title" : "Paediatric - Umbilical Vein Catheterization",
            "type" : "medical_directive",
            "indications" : "<tab1>• No parenteral access is available in a newborn that requires IV therapy emergently (i.e. during neonatal resuscitation)\n• When IV access cannot be obtained\n• To treat hypoglycemia when IV dextrose concentration is greater than D12.5W</tab1>",
            "contraindications" : "<tab1>• Not applicable</tab1>",
            "drug_cards" : [
                {
                    "loc" : [["acp", "after"]],
                    "dose_route" : [
                        ["Recommended sizes for procedure are:\n# 3.5 Fr for infants < 26+6 weeks gestation\n# 5 Fr for infants > 27 weeks gestational age"]
                    ]
                }
            ],
            "clinical" :
            "<tab1>• Initiate the appropriate intervention based upon the presenting condition\n• The umbilical vein is usually the most accessible vein in a newborn\n• UVCs inserted with the catheter tip below the liver, and are considered ‘low lines’\n• Do not substitute feeding tubes for Umbilical Venous Catheters</tab1>"
        },
        {
            "key" : "ped_venous_lab_value",
            "title" : "Paediatric - Venous/Capillary Blood Sampling and Lab Value Interpretation",
            "type" : "medical_directive",
            "indications" : "<tab1>• To establish baseline respiratory, cardiovascular, hematological status prior to or during transport\n• To monitor changes and/or deterioration in clinical status</tab1>",
            "contraindications" : "<tab1>• Not applicable</tab1>",
            "drug_cards" : [
                {
                    "loc" : [["acp", "none"]],
                    "dose_route" : [
                        ["<b>Perform venipuncture, venous/capillary blood sampling and utilize iSTAT if available</b>"]
                    ]
                }
            ],
            "clinical" :
            "<tab1>• Management based on these results will be via patch with the Paediatric TMP\n• These tests should only be completed if absolutely essential to patient management en route and will not cause unnecessary delays in initiating transport</tab1>"
        },
        {
            "key" : "ped_arterial_lab_value",
            "title" : "Paediatric - Arterial Blood Sampling Auxiliary Medical Directive",
            "type" : "medical_directive",
            "indications" : "<tab1>• To establish baseline respiratory, cardiovascular, hematological status prior to or during transport\n• To monitor changes and/or deterioration in clinical status</tab1>",
            "contraindications" : "<tab1>• Not applicable</tab1>",
            "drug_cards" : [
                {
                    "loc" : [["pccn", "none"]],
                    "dose_route" : [
                        ["<b>Perform arterial puncture to obtain blood for diagnostic or monitoring purposes</b>"]
                    ]
                }
            ],
            "clinical" :
            "<tab1>• The need for further clinical management based on blood sample results will be discussed during patch with the Paediatric TMP\n• These tests should only be completed if absolutely essential to patient management en route and will not cause unnecessary delays in initiating transport</tab1>"
        },
        {
            "key" : "ped_invasive_monitoring",
            "title" : "Paediatric - Central Venous and Arterial Line Monitoring",
            "type" : "medical_directive",
            "indications" : "<tab1>• Established arterial and venous line</tab1>",
            "contraindications" : "<tab1>• PCP(f)s may not access, maintain or monitor a central venous access device (CVAD)</tab1>",
            "drug_cards" : [
                {
                    "loc" : [["acp", "none"]],
                    "dose_route" : [
                        ["<b>Monitor an established central venous line using the following heparin concentrations:</b>\n2 units/mL added to Normal Saline for all infants and children\n1 unit/mL added to Normal Saline for all neonates (under 28 days)"]
                    ]
                }
            ],
            "clinical" : "<tab1>• All paediatric central lines require heparinized fluids to maintain patency\n• All paediatric arterial lines require heparinized fluids to maintain patency\n• This directive does not permit access to venous devices that are located subcutaneously, such as a PortaCath or similar\n• Arterial lines are calibrated (zeroed) with any changes in level of bed &/or position of head of bed to transducer, if waveform changes and with IV tubing changes\n• Ensure all connections are tight , line is secured (i.e. arm board) and limb properly restrained as required\n• Blood backing up the transducer tubing from the patient may indicate a leak, crack or loose connections</tab1>"
        },
        {
            "key" : "ped_seizure",
            "title" : "Paediatric - Seizures",
            "type" : "medical_directive",
            "indications" : "Active seizure",
            "flowchartkeys" : [["Neonatal Seizure", "ped_seizure_0"], ["Paediatric Seizure", "ped_seizure_1"]],
            "contraindications" : "• If blood glucose < 3 mmol/L, proceed with “Hypoglycemic Emergencies”. Concurrently, medicate with a benzodiazepine (as stated below) for treatment of seizure\n• Allergy or sensitivity to the medication",
            "drug_cards" : [
                {
                    "title" : "<b>Midazolam (Versed)</b>",
                    "drugKey" : "midazolam",
                    "loc" : [["acp", "after"]],
                    "dose_route" : [["0.1 mg/kg IV/IO (MAX 4 mg)","0.2 mg/kg IM (MAX 5 mg)"]]
                },
                {
                    "title" : "<b>Midazolam (Versed)</b>",
                    "drugKey" : "midazolam",
                    "loc" : [["acp", "first"], ["pccp", "after"]],
                    "dose_route" : [["For <b>Status Epilepticus</b>"],
                    ["Midazolam bolus: 0.15 mg/kg/dose IV/IO"],
                    ["Midazolam infusion: initiate at 50 microgram/kg/hour q 5 min to a MAX of 1400 microgram/kg/hour\nBolus with 0.15 mg/kg/dose to MAX of 4 mg/dose IV/IO prior to each titration"]]
                },
                {
                    "title" : "<b>LORazepam (Ativan)</b>",
                    "drugKey" : "lorazepam",
                    "loc" : [["acp", "after"]],
                    "dose_route" : [
                        [ "< 40 kg", "0.1 mg/kg IV/IO\nTo a MAX of 4 mg\nMay repeat q 5 minutes\nTo a MAX of 8 mg"]
                    ]
                },
                {
                    "title" : "<b>Fosphenytoin</b>",
                    "drugKey" : "fosphenytoin",
                    "loc" : [["acp", "first"]],
                    "dose_route" : [
                        [ "< 40 kg", "20 mg PE*/kg IV/IM Infuse over 5 to 10 mins\nMAX dose 3 mL/site IM\nIf > 30 kg, requires multiple sites"]
                    ],
                    "notes" : "*PE (phenyTOIN equivalents)"
                },
                {
                    "title" : "<b>phenyTOIN (Dilantin)</b>",
                    "drugKey" : "phenytoin",
                    "loc" : [["acp", "first"]],
                    "dose_route" : [
                        [ "Infants (Age > 1 month) and Older Children", "20 mg mg/kg IV/IM Infuse over 20 mins\nNote: <b>USE NORMAL SALINE ONLY</b> as phenyTOIN will precipitate in dextrose solutions"]
                    ]
                },
                {
                    "title" : "<b>PHENObarbital (Phenobarbitone)</b>",
                    "drugKey" : "phenobarbital",
                    "loc" : [["ccp", "first"]],
                    "dose_route" : [
                        [ "< 40 kg", "20 mg mg/kg IV/IM over 20 minutes"]
                    ]
                }
            ],
            "clinical" :
            "• If the seizure is not terminated within five 5 minutes of administration of Midazolam, <b>AND</b> the ACP(f), CCP and the PCCP/PCCN is unable to establish contact with the TMP, a repeat dose of Midazolam (0.1 mg/kg IV) may be administered\n• Fosphenytoin is the preferred drug over phenyTOIN due to its’ enhanced safety profile, should be given in preference <u>if available</u>\n• Following benzodiazepine administration in the seizure algorithm, Fosphenytoin and/or phenyTOIN are the preferred seizure medications in Paediatrics > 1 month\n• 0.2 micron filter must be used when administering phenyTOIN\n• No micron filter is required to administer Fosphenytoin\n• Fosphenytoin/ phenyTOIN should not be used with a diagnosis of toxic ingestion or in the setting of a cardiac conduction system disturbance\n• Consider reducing the rate of phenyTOIN administration to 25 mg/min in children with cardiac conditions"
        },
        {
            "key" : "ped_traumatic_arrest",
            "title" : "Paediatric - Traumatic Cardiac Arrest",
            "type" : "medical_directive",
            "flowchartkeys" : [["Flowchart", "ped_traumatic_arrest_flowchart"]],
            "indications" : "<tab1>• Cardiac arrest due to trauma</tab1>",
            "contraindications" : "<tab1>• Vital signs present</tab1>",
            "drug_cards" : [
                {
                    "title" : "<b>0.9% Normal Saline</b>",
                    "loc" : [["acp", "after"]],
                    "dose_route" : [
                        ["20 mL/kg IV bolus\nMAX 1 L\nTarget SBP 70 + (2x age)"]
                    ]
                },
                {
                    "loc" : [["pcp", "after"]],
                    "dose_route" : [
                        ["<b>Initiate the appropriate algorithm based upon the presenting ECG rhythm</b>"]
                    ]
                }
            ],
            "clinical" : "<tab1>• PCP(f) may apply the Medical Directives for the management of cardiac arrest with semi-automated defibrillation\n• TMP patch prior to initiating transport of patient in cardiac arrest for consideration of TOR</tab1>"
        },
        {
            "key" : "ped_tbi",
            "title" : "Paediatric - Severe Traumatic Brain Injury (GCS < 8, Abnormal CT)",
            "type" : "medical_directive",
            "flowchartkeys" : [["Flowchart", "ped_tbi_flowchart"]],
            "drug_cards" : [
            {
                "loc" : [["pcp", "blank"]],
                "dose_route" : [
                    ["<b>Initiate the appropriate algorithm based upon the flowchart</b>"]
                ]
            }
            ]
        },
        {
            "key" : "ped_volume_replacement_non_hemorrhage",
            "title" : "Paediatric - Volume Replacement in Non Hemorrhagic Hypovolemic Hypotension",
            "type" : "medical_directive",
            "indications" : "<tab1>• Acute paediatric hypovolemia\n• Children exhibiting manifestations of cardiovascular compromise: delayed capillary refill time (> 3 seconds), poor peripheral pulses, pale and/or mottling, cool extremities, tachycardia\n• Hypotensive children\n• Children in cardiopulmonary arrest</tab1>",
            "contraindications" : "<tab1>• Known hypersensitivity, adverse side effects or newly presenting side effects\n• Parents refuse treatment/blood product-consult with TMP\n• Blood products when parents are known Jehovah Witness-consult with TMP</tab1>",
            "clinical" : "<tab1>• *In hypotensive DKA patients fluid boluses should be more conservative (Normal Saline 10 mL/kg IV over 1 hr)\n• Ringers Lactate should not be used in DKA patients\n• In children with known cardiovascular compromise, only give Normal Saline 5-10 mL/kg IV bolus\n• Reassess patient response to fluid bolus (i.e. Assess for decrease in heart rate, improved capillary refill time, improved pulses and urine output)\n• Severe hypovolemia from blood loss should prompt consideration for the early use of blood products. In cases requiring massive transfusion include both packed red blood cells and fresh frozen plasma</tab1>",
            "drug_cards" : [
                {
                    "loc" : [["acp", "after"]],
                    "title" : "May administer an IV crystalloid bolus of 20 mL/kg (may repeat x 1).\nThe patient must be carefully observed for any signs of fluid overload.\nAssessments re: volume status (i.e. vital signs, chest auscultation findings) should be documented frequently",
                    "dose_route" : [
                        ["<b>0.9% Normal Saline or Ringers Lactate</b>", "20 mL/kg IV/IO", "*Give rapidly for hypotension, poor perfusion - may repeat up to a MAX of 40 mL/kg IV before contact with TMP"]
                    ]
                },
                {
                    "loc" : [["acp", "first"]],
                    "title" : "Initiate or maintain the administration of blood and/or blood products as per Ornge Policy",
                    "dose_route" : [
                        ["<b>Fresh Frozen Plasma</b>", "10-20 mL/kg IV/IO", "Give over 30 min for known coagulopathy or evidence of DIC"],
                        ["<b>PRBC (O negative or cross-matched)</b>", "10-20 mL/kg IV/IO", "May repeat up to a MAX of 40 mL/kg IV/IO"]
                    ]
                }
            ]
        },
        {
            "key" : "ped_cardiovascular_support",
            "title" : "Paediatric - Cardiovascular Support",
            "type" : "medical_directive",
            "indications" : "<tab1>• Exhibiting manifestations of cardiovascular compromise, delayed capillary refill (> 3 seconds), poor peripheral pulses, mottling/pale, cool extremities</tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication</tab1>",
            "clinical" : "<tab1>• Patient must be on a cardio-respiratory monitor, with frequent blood pressure monitoring\n• Titrate infusions to keep Systolic BP > 70 + (age x 2) or Systolic BP as per Paediatric TMP order\n• Refer to Medication Information section for Medication Infusion Rate Charts</tab1>",
            "drug_cards" : [
                {
                    "loc" : [["acp", "after"]],
                    "drugKey" : "dopamine",
                    "title" : "<b>DOPamine (Intropin)</b>",
                    "dose_route" : [
                        ["< 40 kg", "5-10 microgram/kg/min IV/IO"]
                    ]
                },
                {
                    "drugKey" : "epinephrine",
                    "loc" : [["ccp", "after"]],
                    "title" : "<b>EPINEPHrine (Adrenalin)</b>",
                    "dose_route" : [
                        ["< 40 kg", "0.05-0.3 microgram/kg/min IV/IO"]
                    ]
                },
                {
                    "drugKey" : "norepinephrine",
                    "section" : "OR",
                    "loc" : [["acp", "first"]],
                    "title" : "<b>Norepinephrine (Levophed)</b>",
                    "dose_route" : [
                        ["< 40 kg", "0.05-0.3 microgram/kg/min IV/IO"]
                    ]
                }
            ]
        },
        {
            "key" : "ped_push_dose_epi",
            "title" : "Paediatric - Push Dose Epinephrine – 10 mcg/ml (1:100 000)",
            "type" : "medical_directive",
            "indications" : "<tab1>• Restoration of circulation temporarily, during paediatric PERI-ARREST and shock states presenting with severe hypotension and/or bradycardia for ages</tab1>",
            "contraindications" : "<tab1>• Patients receiving chest compressions\n• Patients in cardiac arrest</tab1>",
            "clinical" : "<tab1>• During CARDIAC ARREST <b>only</b> a dose <b>10 mcg/kg</b> of Epinephrine 1: 10 000 (100 mcg/ml) <b>Pre-loaded syringe</b> (1 mg/10 ml) should be used\n• Types of critically ill patients in whom Epinephrine 1: <b>100</b> 000 may be considered include:</tab1><tab2>\no Acute Hypotension in severe shock states\no Heart Disease (e.g. unstable coronary perfusion, cardiomyopathy, heart failure, myocarditis) Prior to intubation in patients with shock\no Patients on Epinephrine infusions >0.5 mcg/kg/min</tab2><tab1>\n• Epinephrine 1: <b>100</b> 000 allows for restoration of circulation temporarily and avoids tachycardia and vasoconstriction that can occur with CARDIAC ARREST doses (10 mcg/kg)\n• Epinephrine 1: <b>100</b> 000 may provide temporary stabilization while other therapies are added or adjusted/titrated\n• Delivered as a concentration of Epinephrine 1: <b>100</b> 000 ( 10 micrograms/ml) which is equal to a dose volume of 0.<b>1</b> ml/kg/dose</tab1>\n<title>Preparation of Epinephrine 1: 100 000</title><tab1>\n1. Using a 10 ml syringe, draw 100 microgram (i.e. 1 ml of 1: 10 000) EPINEPHrine and dilute in 9 ml of Normal Saline.</tab1>",
            "drug_cards" : [
                {
                    "loc" : [["ccp", "first"], ["pccp", "after"]],
                    "drugKey" : "epinephrine",
                    "title" : "<b>EPINEPHrine 10 mcg/ml (1: 100 000)</b>",
                    "dose_route" : [
                        ["1 mcg/kg/dose (0.1 ml/kg/dose) IV/IO\nMay repeat q 5 minutes\nTarget SBP > 70 + (2x age in years)"]
                    ]
                }
            ]
        },
        {
            "key" : "ped_sepsis",
            "title" : "Paediatric - Septic Shock",
            "type" : "medical_directive",
            "flowchartkeys" : [["Flowchart", "ped_sepsis_flowchart"]],
            "indications" : "<tab1>• Cardiovascular dysfunction (hypotension [SBP < 70 + (2x age)], prolonged capillary refill, oliguria, metabolic acidosis, elevated arterial lactate)\n• Hemodynamic abnormalities persist despite > 40 mL/kg of fluid in one hour\n• GCS < 11</tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication</tab1>",
            "clinical" : "<tab1>• Paediatrics are seldom in a pure warm shock state; Norepinephrine is <u>rarely</u> used as first line agent\n• Norepinephrine is for patients who are <b>CLEARLY</b> in warm shock state (wide pulse pressure, warm extremities, bounding pulses, brisk CRT)\n• Children are often significantly hypovolemic (from not keeping up with insensibles & 3rd spacing; especially infants who don't control their intake), therefore have a component of cold (vasoconstricted shock), myocardial dysfunction (occurs earlier in sepsis in paediatrics) and therefore an element of cardiogenic shock (cold shock)\n• Prepare 2nd line inotropes early\n<b>• Monitor peripheral infusions of Epinephrine & Norepinephrine > 0.05 mcg/kg/min closely for signs of extravasation.</b> In profound hypotension, infusions may be titrated > 0.1 mcg/kg/min, but <b>this is not optimal in peripheral IV sites and should be discussed with Paediatric TMP</b>\n• Physiologic indicators and target goals: strong distal pulses equal to central pulses, warm peripheries with CRT < 2 seconds, improved GCS (normal mental status), urine output > 1 ml/kg/hr, BP although not in itself a reliable endpoint for resuscitation, systolic BP 60 mmHg in infants , 1 month old; 70 mmHg + (2 x age in years) in children 1 month to 10 years of age; 90mm Hg in children 10 years of age or older\n• Vancomycin can be added by TMP based on severity of infection and risk factors in catchment area. Vancomycin should not be given without a patch</tab1>",
            "drug_cards" : [
                {
                    "loc" : [["acp", "none"]],
                    "title" : "<b>Isotonic Crystalloid or Colloid</b>",
                    "dose_route" : [
                        ["20 mL/kg bolus IV/IO within 20 min\n(MAX 60 mL/kg)\nTarget SBP >70 + (2 x age)"]
                    ]
                },
                {
                    "loc" : [["acp", "first"]],
                    "drugKey" : "ceftriaxone",
                    "title" : "<b>Antibiotics</b>",
                    "dose_route" : [
                        ["Ceftriaxone 100 mg/kg/dose IV/IO"]
                    ]
                },
                {
                    "section" : "<b>Fluid Refractory COLD Shock</b>",
                    "loc" : [["acp", "after"]],
                    "drugKey" : "dopamine",
                    "title" : "<b>DOPamine (Intropin)</b>",
                    "dose_route" : [
                        ["5-10 microgram/kg/min IV/IO\nTarget SBP >70 + (2 x age)"]
                    ]
                },
                {
                    "section" : "OR",
                    "loc" : [["ccp", "after"]],
                    "drugKey" : "epinephrine",
                    "title" : "<b>EPINEPHrine (Adrenalin)</b>",
                    "dose_route" : [
                        ["0.05-0.3 microgram/kg/min IV/IO\nTarget SBP >70 + (2 x age)"]
                    ]
                },
                {
                    "section" : "<b>Fluid Refractory WARM Shock</b>",
                    "loc" : [["acp", "after"]],
                    "drugKey" : "norepinephrine",
                    "title" : "<b>Norepinephrine (Levophed)</b>",
                    "dose_route" : [
                        ["0.05-0.3 microgram/kg/min IV/IO\nTitrate to effect"]
                    ]
                },
                {
                    "section" : "<b>Catecholamine Resistant Shock</b>",
                    "loc" : [["acp", "first"]],
                    "drugKey" : "hydrocortisone",
                    "title" : "<b>Hydrocortisone</b>",
                    "dose_route" : [
                        ["2 mg/kg/dose bolus IV\n(MAX 100 mg)"]
                    ],
                    "notes" : "Consider pericardial effusion, pneumothorax and increased intraabdominal pressure for persistent catecholamine resistant shock"
                }
            ]
        },
        {
            "key" : "ped_nausea",
            "title" : "Paediatric - Nausea, Vomiting and Motion Sickness",
            "type" : "medical_directive",
            "indications" : "<tab1>• The patient is <40 kg\n• The patient is suffering from nausea or vomiting\n• There is an increased risk of motion sickness in transport\n• The patient has not received <b>dimenhyDRINATE within the last 4 hours</b></tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication\n• Prolonged QT (concern in Ondansetron administration or concomitant use of other drugs that may prolong the QT interval)\n• The patient has received Ondansetron within 8 hours\n• The patient has received dimenhyDRINATE within the last 4 hours</tab1>",
            "clinical" : "<tab1>• Not applicable</tab1>",
            "drug_cards" : [
                {
                    "section" : "Consider for motion sickness",
                    "drugKey" : "dimenhydrinate",
                    "loc" : [["pcp", "after"]],
                    "title" : "<b>dimenhyDRINATE (Gravol)</b>",
                    "dose_route" : [
                        ["< 40 kg", "1 mg/kg IM/PO\nTo a MAX of 40 mg"]
                    ]
                },
                {
                    "section" : "Ondansetron is considered the first line agent for nausea and vomiting",
                    "drugKey" : "ondansetron",
                    "loc" : [["acp", "after"]],
                    "title" : "<b>Ondansetron (Zofran)</b>",
                    "dose_route" : [
                        ["< 40 kg", "0.1 mg/kg\n(MAX 4 mg)", "Oral dose > 6 months\n0.15 mg/kg/dose PO x 1 dose\n8-15 kg: 2 mg\n15-30 kg: 4 mg\n>30 kg: 8 mg"]
                    ]
                },
                {
                    "section" : "OR",
                    "drugKey" : "ondansetron",
                    "loc" : [["acp", "none"]],
                    "title" : "<b>dimenhyDRINATE (Gravol)</b>",
                    "dose_route" : [
                        ["< 40 kg", "1 mg/kg IV\n(MAX 40 mg)", "Give SLOW IV push to prevent vertigo, weakness and dizziness"]
                    ]
                }
            ]
        },
        {
            "key" : "ped_gastric_tubes",
            "title" : "Paediatric - Gastric (NG or OG) Tubes",
            "type" : "medical_directive",
            "indications" : "<tab1>• Actual or anticipated need to evacuate gastric contents in bowel obstructions\n• Intubated and ventilated patients</tab1>",
            "contraindications" : "<tab1>• Patients presenting with facial fracture or suspected basal skull fracture should not have a nasogastric tube inserted</tab1>",
            "clinical" : "<tab1>• A nasal or oral gastric tube should be placed prior to transport whenever possible with unresponsive paediatric patients</tab1>",
            "drug_cards" : [
                {
                    "loc" : [["acp", "none"]],
                    "dose_route" : [
                        ["<b>Insertion and/or Maintenance</b>\nEnsure the gastric tube is appropriately located via auscultation\nConfirm by partner prior to departure"]
                    ]
                }
            ]
        },
        {
            "key" : "ped_esophageal_probe",
            "title" : "Paediatric - Esophageal Temperature Probes",
            "type" : "medical_directive",
            "indications" : "<tab1>• Continuous monitoring of core body temperature for any intubated patient with a temperature outside normal range (36 to 37˚C)\n• Temperature monitoring during active rewarming measures\n• Continuous monitoring may be ordered by the TMP at their discretion</tab1>",
            "contraindications" : "<tab1>• Esophageal strictures\n• Esophageal varices\n• Esophageal perforation\n• Congenital anomalies such as tracheal esophageal fistula\n• Post-operative tonsillectomy and adenoidectomy patients\n• Facial trauma\n• Coagulopathies (review history with Paediatric TMP)\n• Patients receiving Anticoagulants. Anticoagulants include but are not limited to: unfractionated heparin IV bolus or infusion, Warfarin (Coumadin), Enoxaparin (Lovenox), or NOACs/DOACs</tab1>",
            "clinical" : "<tab1>• It is preferable to assess position of probe using a CXR (should not delay initiating transport)</tab1>",
            "drug_cards" : [
                {
                    "loc" : [["acp", "none"]],
                    "dose_route" : [
                        ["<b>Insert and monitor core temperature with Esophageal Temperature probe</b>"]
                    ]
                }
            ]
        },
        {
            "key" : "ped_catheter",
            "title" : "Paediatric - Urinary Catheter Insertion and Maintenance",
            "type" : "medical_directive",
            "indications" : "<tab1>• For monitoring urine output\n• For urinary tract obstruction</tab1>",
            "contraindications" : "<tab1>• Suspected pelvic fracture or urethral tear\n• Patient < 28 days or 44 weeks corrected</tab1>",
            "clinical" : "<tab1>• Urinary catheter removal can only be performed by the ACP(f), CCP and PCCP/PCCN\n• Contact the TMP if the catheter becomes obstructed during transport</tab1>",
            "drug_cards" : [
                {
                    "loc" : [["pcp", "none"]],
                    "dose_route" : [
                        ["<b>Maintenance Only</b>"]
                    ]
                },
                {
                    "loc" : [["acp", "none"]],
                    "dose_route" : [
                        ["<b>Contact the TMP if the catheter becomes obstructed during transport</b>"]
                    ]
                }
            ]
        },
        {
            "key" : "ped_fever",
            "title" : "Paediatric - Fever",
            "type" : "medical_directive",
            "indications" : "<tab1>• Temperature exceeding 38oC via the axilla route and 38.5oC via the tympanic, oral, or rectal route</tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication\n• Acetaminophen within the last 4 hours\n• Ibuprofen:</tab1><tab2>\no NSAID or Ibuprofen use within previous 6 hours\no Patient on anticoagulation therapy\no Current active bleeding\no Hx of peptic ulcer disease or GI bleed\no Pregnant\no If asthmatic, no prior use of ASA or other NSAIDs\no CVA or TBI in the previous 24 hours\no Known renal impairment\no Active vomiting\no Unable to tolerate oral medication</tab2>",
            "drug_cards" : [
                {
                    "title" : "<b>Acetaminophen (Tylenol)</b>",
                    "drugKey" : "acetaminophen",
                    "loc" : [["acp", "none"]],
                    "dose_route" : [
                        ["<center>≤ 12 years</center>"],
                        ["<center>15 mg/kg every 4 hours PO or PR\nMAX 1 gram\n(Suspension or Suppository)</center>"]
                    ]
                },
                {
                    "title" : "<b>Ibuprofen (Advil)</b>",
                    "loc" : [["acp", "none"]],
                    "dose_route" : [
                        ["<center>> 6 months and < 12 years</center>"],
                        ["<center>10 mg/kg PO\nMAX 400 mg</center>"]
                    ]
                }
            ],
            "clinical" : "<tab1>• Suppositories available in 120 mg, 325 mg and 650 mg\n• Rectal temperatures are preferred for children < 2 years of age, axillary or oral temperatures ≥ 2 years of age</tab1>"
        },
        {
            "key" : "ped_anaphylaxis",
            "title" : "Paediatric - Anaphylaxis",
            "type" : "medical_directive",
            "indications" : "<tab1>• Confirmed or suspected history of exposure to an allergen\nAND\n• Moderate to severe allergic reaction including anaphylaxis</tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication</tab1>",
            "drug_cards" : [
                {
                    "title" : "<b>EPINEPHrine (Adrenalin) (1:1000 Solution)</b>",
                    "drugKey" : "epinephrine",
                    "loc" : [["pcp", "after"]],
                    "dose_route" : [
                        ["< 40 kg", "IM EPINEPHrine dose:\n0.01 mg/kg\n(min 0.1 mg/dose to MAX 0.4 mg/dose)", "May repeat x 1 after 5 minutes <b>if symptoms persist</b>"]
                    ]
                },
                {
                    "title" : "<b>Crystalloids</b>",
                    "loc" : [["acp", "after"]],
                    "dose_route" : [
                        ["20 mL/kg IV/IO bolus if signs of hemodynamic instability\nMAX 1 Litre\nTarget SBP 70 + 2x age"]
                    ]
                },
                {
                    "title" : "<b>Salbutamol (Ventolin) Solution Via Nebulized Aerosol (2.5 mg/2.5 mL)</b>",
                    "drugKey" : "salbutamol",
                    "loc" : [["pcp", "after"]],
                    "dose_route" : [
                        ["< 10 kg", "1.25 mg* (0.5 mL)"],
                        ["10-20 kg", "2.5 mg* (1.0 mL)\nRepeat q 30 minutes - 4 hours prn"],
                        ["> 20 kg", "5 mg* (2.0 mL)\nRepeat q 30 minutes - 4 hours prn"]
                    ],
                    "notes" : "* Dilute salbutamol dose to 3 mL in normal saline; dose limit of added saline: MAX 1 mL/dose"
                },
                {
                    "title" : "<b>Salbutamol (Ventolin) via MDI</b>\n100 microgram / puff",
                    "drugKey" : "salbutamol",
                    "loc" : [["pcp", "after"]],
                    "dose_route" : [
                        ["Less than 20 kg", "4 puffs (400 microgram) q 15-20 min x 3 doses"],
                        ["Greater than 20 kg", "8 puffs (800 microgram) q 15-20 min x 3 doses"]
                    ]
                },
                {
                    "title" : "<b>diphenhyDRAMINE (Benadryl)</b>",
                    "drugKey" : "diphenhydramine",
                    "loc" : [["pcp", "after"]],
                    "dose_route" : [
                        ["< 40 kg", "1 mg/kg/dose\nTo a MAX of 40 mg/dose"]
                    ]
                },
                {
                    "section" : "<b>Refractory Shock</b>",
                    "title" : "<b>EPINEPHrine (Adrenalin)</b>",
                    "drugKey" : "epinephrine",
                    "loc" : [["ccp", "after"]],
                    "dose_route" : [
                        ["0.05-0.3 microgram/kg/min IV/IO\nTarget BP (70 + (2 x age))"]
                    ]
                }
            ],
            "clinical" : "<tab1>• Re-assess frequently during transport\n• After patch with Paediatric TMP, treatment may include administration of corticosteroids such as</tab1><tab2>\no <a href=\"drugKey=dexamethasone\">Dexamethasone</a> 0.3 mg/kg/dose IV/IM once daily (MAX 12 mg/dose), OR\no Hydrocortisone 5-10 mg/kg/dose IV q 6 hours (MAX 100 mg/dose), OR\no <a href=\"drugKey=methylprednisolone\">methylPREDNISolone</a> 1 mg/kg dose IV q 8 hours (MAX 60 mg/dose)</tab2><tab1>\n• If signs of hemodynamic instability, consider normal saline 20 mL/kg bolus IV for hypotension\n• <b>EPINEPHrine administration must not exceed one dose prior to patch.</b> Patch for further management\n• Patient may require EPINEPHrine infusion 0.1-1 microgram/kg/min in severe exacerbations</tab1>"
        },
        {
            "key" : "ped_hypoglycemia",
            "title" : "Paediatric - Hypoglycemia",
            "type" : "medical_directive",
            "indications" : "<tab1>• Blood glucose < 3 mmol/L\nAND any one of the following:</tab1><tab2>\no Altered level of consciousness (GCS <14)\nOR\no Confirmed history of diabetes mellitus\nOR\no Active seizures within the past one hour</tab2>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication</tab1>",
             "clinical" : "<tab1>• Glucagon infusions may be used for persistent hypoglycemia in neonates or children\n• Contraindications to Glucagon</tab1><tab2>\no Pheochromocytoma: tumor of the adrenal medulla or sympathetic paraganglia, characterized by hypersecretion of EPINEPHrine and Norepinephrine</tab2>",
            "drug_cards" : [
                {
                    "title" : "<b>Glucagon</b>",
                    "drugKey" : "glucagon",
                    "loc" : [["pcp", "none"]],
                    "dose_route" : [
                        ["≥ 25 kg", "0.1 mg/kg IM\nto a MAX 0.5 mg/dose", "<b>Repeat blood glucose measurement 20 minutes after the administration of Glucagon</b>\nFollow with oral carbohydrates <b>ASAP</b> if LOC permits (i.e. juice, snack)"],
                        ["> 25 kg", "1 mg/dose IM (1 mL)", "<b>Repeat blood glucose measurement 20 minutes after the administration of Glucagon</b>\nFollow with oral carbohydrates <b>ASAP</b> if LOC permits (i.e. juice, snack)"]
                    ]
                },
                {
                    "title" : "<b>10%, 25% and 50% Dextrose</b>\nTo administer D10W, mix solution according to the accompanying preparation table, and withdraw IV bolus from infusion bag\nTo administer D25W, dilute D50W 1:1 with Sterile Water\nRepeat blood glucose measurement 15 minutes after the administration of IV Dextrose\nFollow with oral carbohydrates <b>ASAP</b> if LOC permits (i.e. juice, snack)",
                    "loc" : [["acp", "after"]],
                    "dose_route" : [
                        ["< 10 kg", "0.5 gm/kg of D10W\n(5 mL/kg of D10W)"],
                        ["10 kg – 20 kg", "0.5 gm/kg of D25W\n(2 mL/kg of D25W)"],
                        ["20 kg – 39 kg", "0.5 gm/kg of D50W\n(1 mL/kg of D50W)\nTo a MAX of 25 gm (50 mL)"]
                    ]
                },
                {
                    "title" : "<b>Preparation: 10% Dextrose Solution</b>",
                    "loc" : [["nil", "nil"]],
                    "dose_route" : [
                        ["<b>IF YOU HAVE:</b>", "<b>REMOVE FROM THE BAG:</b>", "<b>ADD TO THE BAG:</b>"],
                        ["250 mL D5W", "25 mL", "25 mL of 1 prefilled syringe of D50W"]
                    ]
                },
                {
                    "title" : "<b>Glucagon Infusion</b>",
                    "drugKey" : "glucagon",
                    "loc" : [["acp", "first"]],
                    "dose_route" : [
                        ["≤ 40 kg", "1.0 mg (1 mg/mL) in 23 mL D5W or D10W and infuse at \n1 mL/hr for 24 hours (up to a MAX 2 mg in 24 mL solution over 24 hours)"]
                    ]
                }
            ]
        },
        {
            "key" : "neo_hypoglycemia",
            "title" : "Neonatal - Hypoglycemia",
            "type" : "medical_directive",
            "indications" : "<tab1>• Blood glucose < 3 mmol/L\n• Jitteriness or tremors\n• Episodes of cyanosis\n• Apneic spells\n• High pitched cry\n• Altered level of consciousness (limpless or lethargy)\n• Seizures</tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication</tab1>",
             "clinical" : "<tab1>• Risk Factors for Hypoglycemia:</tab1><tab2>\no Prematurity (< 37 wks GA), SGA, IUGR, LGA, IDM</tab2>",
            "drug_cards" : [
                {
                    "title" : "<b>10% Dextrose</b>",
                    "loc" : [["acp", "after"]],
                    "dose_route" : [
                        ["<center>Neonates\n(< 1 month)\nGlucose < 3.0 mmol/L and symptomatic</center>", "<center>0.2 gm/kg of D10W\n(2 mL/kg of D10W)</center>"],
                        ["Increase maintenance glucose concentration to D12.5W\nRepeat blood glucose 15 minutes after interventions\nIf hypoglycemia persists increase maintenance glucose concentration to D15W.\nIV D15W can only be administered in a central line (umbilical venous catheter, PICC line)"]
                    ]
                },
                {
                    "title" : "<b>Preparation: 10% Dextrose Solution</b>",
                    "loc" : [["nil", "nil"]],
                    "dose_route" : [
                        ["<b>IF YOU HAVE:</b>", "<b>REMOVE FROM THE BAG:</b>", "<b>ADD TO THE BAG:</b>"],
                        ["250 mL D5W", "25 mL", "25 mL of 1 prefilled syringe of D50W"]
                    ]
                },
                {
                    "title" : "<b>Preparation: 12.5% Dextrose Solution</b>",
                    "loc" : [["nil", "nil"]],
                    "dose_route" : [
                        ["<b>IF YOU HAVE:</b>", "<b>REMOVE FROM THE BAG:</b>", "<b>ADD TO THE BAG:</b>"],
                        ["250 mL D10W", "20 mL", "20 mL of 1 prefilled syringe of D50W"]
                    ]
                },
                {
                    "title" : "<b>Preparation: 15% Dextrose Solution</b>",
                    "loc" : [["nil", "nil"]],
                    "dose_route" : [
                        ["<b>IF YOU HAVE:</b>", "<b>REMOVE FROM THE BAG:</b>", "<b>ADD TO THE BAG:</b>"],
                        ["250 mL D10W", "25 mL", "25 mL of 1 prefilled syringe of D50W"],
                        ["<b>Syringe Preparation:</b> Add 15 mL of D50W to 35 mL of NS to create total volume of 50 mL of D15W"]
                    ]
                },
                {
                    "section" : "<b>Neonatal Glucose Infusion Rates</b>",
                    "title" : "<b>Hypoglycemia</b>",
                    "loc" : [["acp", "after"]],
                    "dose_route" : [
                        ["<b>Glucose</b>", "<b>Current Fluids</b>", "<b>Action</b>", "<b>Comment</b>"],
                        ["< 3.0 mmol/L", "D10W\n(80 mL/kg/day)", "2 mL/kg bolus of D10W increase IV fluids to D12.5W or D15W", "Reassess blood glucose\nq 15 minutes after interventions until > 3.0 mmol/L"]
                    ]
                },
                {
                    "title" : "<b>Normoglycemia</b>",
                    "loc" : [["acp", "none"]],
                    "dose_route" : [
                        ["<b>Glucose</b>", "<b>Current Fluids</b>", "<b>Action</b>", "<b>Comment</b>"],
                        ["3.0-7.0 mmol/L", "IV D10W\n(80 mL/kg/day)\nEquivalent to glucose infusion rate of 5 mg/kg/min", "Communicate blood glucose results to TMP", "Continue to monitor blood glucose as directed by TMP"],
                        ["Reassess blood glucose following changes in GIR or q 3 hrs if blood glucose remains normal"]
                    ]
                },
                {
                    "title" : "<b>Hyperglycemia</b>",
                    "loc" : [["acp", "after"]],
                    "dose_route" : [
                        ["<b>Glucose</b>", "<b>Current Fluids</b>", "<b>Action</b>", "<b>Comment</b>"],
                        ["> 7.0 mmol/L", "D10W\n(80 mL/kg/day)", "Communicate blood glucose results to TMP", "Continue to monitor blood glucose as directed by TMP"]
                    ]
                }
            ]
        },
        {
            "key" : "ped_dka",
            "title" : "Paediatric - Diabetic Ketoacidosis (DKA)",
            "type" : "medical_directive",
            "flowchartkeys" : [["DKA Algorithm page 1", "ped_dka_flowchart_1"], ["DKA Algorithm page 2", "ped_dka_flowchart_2"]],
            "indications" : "<tab1>• Hyperglycemia (blood glucose > 11 mmol/L) in a new or known diabetic\nAND\n• pH <7.30 and serum bicarbonate <15 mmol/L\nAND (if available)\n• Confirmed ketosis (positive ketones in blood or urine)</tab1>\n<title>Monitoring</title>\n<tab1>• Cardiorespiratory monitor and O2 saturation monitor\n• Monitoring of vital signs (HR, RR, BP) and neurovitals, q 10-15 minutes\n• Accurate intake and output q 1 hour\n• Bedside glucose q 1 hour</tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication</tab1>",
             "clinical" : "<tab1>• All Paediatric patients < 18 years of age should be managed using the paediatric DKA algorithm</tab1>",
            "drug_cards" : [
                {
                    "title" : "<b>0.9% Normal Saline</b>\nMAX 250 mL/hr",
                    "loc" : [["acp", "after"]],
                    "dose_route" : [
                        ["<b>3-9 kg</b>", "6 mL/kg/hr"],
                        ["<b>10-19 kg</b>", "5 mL/kg/hr"],
                        ["<b>>20 kg</b>", "4 mL/kg/hr"]
                    ],
                    "notes" : "* Add 40 mEq/L KCl to 0.9 % infusion if serum K+ < 5.5 mmol/L and patient is passing urine"
                },
                {
                    "title" : "<b>Insulin (Regular)</b>",
                    "drugKey" : "insulin",
                    "loc" : [["acp", "first"]],
                    "dose_route" : [
                        ["<b>Infusion:</b> 0.05-0.1 units/kg/hr"]
                    ]
                },
                {
                    "section" : "<b>If Neurological Deterioration</b>",
                    "title" : "<b>3% Sodium Chloride</b>",
                    "drugKey" : "3%_saline",
                    "loc" : [["acp", "first"]],
                    "dose_route" : [
                        ["<b>Bolus:</b> 3-5 mL/kg/dose over 20 min"]
                    ]
                },
                {
                    "section" : "<b>OR</b>",
                    "drugKey" : "mannitol",
                    "title" : "<b>Mannitol</b>",
                    "loc" : [["acp", "first"]],
                    "dose_route" : [
                        ["<b>Bolus:</b> 0.5-1 g/kg over 20 minutes"]
                    ]
                }
            ]
        },
        {
            "key" : "ped_opioid_od",
            "title" : "Paediatric - Suspected Opioid Overdose",
            "type" : "medical_directive",
            "indications" : "<tab1>• GCS of < 12 or altered level of consciousness\nAND\n• Respiratory rate < 10\nAND\n• Suspected acute opioid overdose</tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication\n• If Blood glucose < 3 mmol/L, proceed with “Hypoglycemic Emergencies”</tab1>",
             "clinical" : "<tab1>• Management of airway, breathing and circulation remain the first priority: adequate oxygenation and ventilation must be ensured</tab1>",
            "drug_cards" : [
                {
                    "title" : "<b>Naloxone (Narcan)</b>",
                    "drugKey" : "naloxone",
                    "loc" : [["pcp", "first"]],
                    "dose_route" : [
                        ["≤ 40 kg", "0.1 mg/kg IM every 2 minutes prn\n(up to a MAX total of 0.1 mg/kg or 2 mg)"]
                    ]
                },
                {
                    "title" : "<b>Naloxone (Narcan)</b>",
                    "drugKey" : "naloxone",
                    "loc" : [["acp", "first"]],
                    "dose_route" : [
                        ["≤ 40 kg", "0.1 mg/kg\nIV, IM, IO or ETT every 2 minutes prn\n(up to a MAX total of 0.1 mg/kg or 2 mg) (IV/IO route, followed by IM route are preferred)"]
                    ]
                }
            ]
        },
        {
            "key" : "ped_tylenol_od",
            "title" : "Paediatric - Suspected Acetaminophen Toxicity",
            "type" : "medical_directive",
            "indications" : "<tab1>• Suspected acetaminophen toxicity</tab1>",
            "contraindications" : "<tab1>• Allergy or sensitivity to the medication</tab1>",
             "clinical" : "<tab1>• Mandatory Patch required to initiate an acetylcysteine infusion\n• The ACP(f), CCP and PCCP/PCCN may maintain the administration of a MucomystTM (acetylcysteine) infusion for an acetaminophen overdose <b>in the following circumstances:</b></tab1><tab2>\no The infusion was initiated by the sending facility\no Ingested or suspected ingestion of acetaminophen dose is greater or equal to:</tab2><tab3>\n• 7.5 gm\nOR\n• 150 mg/kg</tab3><tab2>\no The rate of infusion is in accordance with the accompanying dosage table and preparation guide\no The rate of infusion cannot be altered by the Paramedic unless ordered by the Transport Medicine Physician</tab2>\n<title>Guidelines to Prepare a 3% Intravenous N-Acetylcysteine Bag</title>\nAs part of the Poison Centre’s treatment recommendations for the acetaminophen-poisoned patient, a 3 % n-acetylcysteine solution will need to be prepared. The following are instructions on how to prepare this solution in <b>D5W.</b>\nPatient is <20 kg:\n<tab1>• Remove 37.5 ml from a 250 ml bag of D5W\n• Add 37.5 ml of 20% IV N-Acetylcysteine to the remaining 212.5 ml in the D5W bag</tab1><tab2>\no 37.5 ml X 200mg/ml = 7 500 mg of N-Acetylcysteine\no 7500 mg in 250 ml yields a final solution with 30 mg/ml or 3%</tab2>\nNotes:<tab1>\n1. 20% IV N-Acetylcysteine is equivalent to 200 mg/mL\n2. The 3% solution is slightly hyperosmolar but still within the safety margin for administration via a peripheral vein\n3. It is recognized that any particular bag of IV fluid could have excessive fluid more than advertised. It is of little consequence when making this 3% solution. Assume a finished volume as advertised on the bag</tab1>\nMixing is important to ensure uniform distribution of N-Acetylcysteine in infusion solution.</tab1>",
            "drug_cards" : [
                {
                    "title" : "<b>Maintenance Infusion: 3% Mucomyst (Acetylcysteine)\nDosage Guide and Preparation for IV Administration (reference CPS)</b>",
                    "drugKey" : "acetylcysteine",
                    "loc" : [["acp", "after"]],
                    "dose_route" : [
                        ["<b>Body Weight (kg)</b>", "<b>Initial Infusion\n60 mg/kg/hr x 4 hrs</b>", "<b>Maintenance Infusion\n6 mg/kg/hr</b>", "<b>*High Risk*\nMaintenance Infusion\n12 mg/kg/hr</b>"],
                        ["", "<b>Dose\n(ml/hr)</b>", "<b>Dose\n(ml/hr)</b>", "<b>Dose\n(ml/hr)</b>"],
                        ["5", "10", "1", "2"],
                        ["7", "14", "1.4", "2.8"],
                        ["9", "18", "1.8", "3.6"],
                        ["11", "22", "2.2", "4.4"],
                        ["13", "26", "2.6", "5.2"],
                        ["15", "30", "3", "6"],
                        ["17", "34", "3.4", "6.8"],
                        ["19", "38", "3.8", "7.6"],
                        ["21", "42", "4.2", "8.4"],
                        ["23", "46", "4.6", "9.2"],
                        ["25", "50", "5", "10"],
                        ["27", "54", "5.4", "10.8"],
                        ["29", "58", "5.8", "11.6"],
                        ["31", "62", "6.2", "12.4"],
                        ["33", "66", "6.6", "13.2"],
                        ["35", "70", "7", "14"],
                        ["37", "74", "7.4", "14.8"],
                        ["39", "78", "7.8", "15.6"],
                        ["40", "80", "8", "16"]
                    ]
                }
            ]
        },
        {
            "key" : "ped_mixing_table",
            "title" : "Mandatory Paediatric Mixing and Administration Table for Continuous Infusion",
            "type" : "document",
            "content" :
            [
                [
                    ["<section><section_width=600><bg=#ffc001ff><center><b>Drug</b></center>", "<bg=#ffc001ff><center><b>Drug to Add to Diluent</b></center>", "<bg=#ffc001ff><center><b>Diluent (mL)</b></center>", "<bg=#ffc001ff><center><b>BD Library Dose Range</b></center>", "<bg=#ffc001ff><center><b>Standard Concentration</b></center>"],
                    ["<a href=\"drugKey=amiodarone\">Amiodarone</a>\n", "90 mg", "50 mL D5W", "0.01 - 1 mg/min", "1.8 mg/mL" ],
                    ["<a href=\"drugKey=dobutamine\">*DOBUTamine</a>", "50 mg", "50 mL D5W/NS", "0.01 - 30 mcg/kg/min", "1 mg/ml"],
                    ["<a href=\"drugKey=dopamine\">*DOPamine</a>", "40 mg", "50 ml", "0.01 - 30 mcg/kg/min", "800 mcg/mL"],
                    ["<a href=\"drugKey=epinephrine\">*EPINEPHrine</a>", "0.5 mg", "50 mL D5W/NS", "0.01 - 1.0 mcg/kg/min", "10 mcg/ml"],
                    ["<a href=\"drugKey=fentanyl\">FentaNYL</a>", "500 mcg", "50 mL D5W/NS", "0.01 - 4 mcg/kg/hr", "10 mcg/ml"],
                    ["<a href=\"drugKey=insulin\">Insulin</a>", "5 units", "50 mL NS", "0.01 - 0.1 units/kg/hr", "0.1 unit/mL"],
                    ["<a href=\"drugKey=ketamine\">Ketamine</a>", "50 mg", "50 mL D5W/NS", "0.01 - 4.5 mg/kg/hr", "1 mg/mL"],
                    ["<a href=\"drugKey=lidocaine\">Lidocaine</a>", "400 mg", "50 mL NS", "20 - 50 mcg/kg/min", "8 mg/mL"],
                    ["<a href=\"drugKey=midazolam\">Midazolam</a>", "50 mg", "50 mL D5W/NS", "60 - 1400 mcg/kg/hr", "1 mg/mL"],
                    ["<a href=\"drugKey=morphine\">Morphine</a>", "5 mg", "50 mL NS", "0.01 - 40 mcg/kg/hr", "100 mcg/mL"],
                    ["<a href=\"drugKey=naloxone\">Naloxone</a>", "0.4 mg", "40 mL NS", "0.25 - 2 mcg/kg/hr", "10 mcg/mL"],
                    ["<a href=\"drugKey=norepinephrine\">*Norepinephrine</a>", "0.8 mg", "50 mL D5W/NS", "0.01 - 1 mcg/kg/min", "16 mcg/mL"],
                    ["<a href=\"drugKey=propofol\">Propofol</a>", "N/A premixed", "500 mg/50 mL premixed", "0.01 - 8 mg/kg/hr", "10 mg/mL"],
                    ["<a href=\"drugKey=salbutamol\">Salbutamol</a>", "50 mg", "50 mL Undiluted", "1 - 5 mcg/kg/min", "1 mg/mL"]
                ],
                [
                    ["<b>Paediatric and neonatal medication infusions are mixed in syringes</b>"],
                    ["* If available CVL preferred"]
                ],
                [
                    ["<section><bg=#ffc001ff><center><b>IV Administration Filter Table</b></center>", ""],
                    ["<b>Medication</b>", "<b>Recommended In-Line Filter Size</b>"],
                    ["<a href=\"drugKey=phenytoin\">Phenytoin</a>", "0.22 micron" ],
                    ["<a href=\"drugKey=phenobarbital\">Phenobarbital</a>", "0.22 micron" ],
                    ["<a href=\"drugKey=amiodarone\">Amiodarone</a>", "0.22 micron" ],
                    ["<a href=\"drugKey=mannitol\">Mannitol (20%)</a>", "0.22 micron" ],
                    ["<a href=\"drugKey=fat_emulsion\">Fat Emulsion (20%)</a>", "0.22 micron" ]
                ]
            ]
        },
        {
            "key" : "neo_mixing_table",
            "title" : "Mandatory Neonatal Mixing and Administration Table for Continuous Infusion",
            "type" : "document",
            "content" :
            [
                [
                    ["<section><section_width=600><bg=#ffc001ff><center><b>Drug</b></center>", "<bg=#ffc001ff><center><b>Drug to Add to Diluent</b></center>", "<bg=#ffc001ff><center><b>Diluent (mL)</b></center>", "<bg=#ffc001ff><center><b>BD Library Dose Range</b></center>", "<bg=#ffc001ff><center><b>Standard Concentration</b></center>"],
                    ["<a href=\"drugKey=alprostadil\">Alprostadil</a>\n", "25 mcg", "25 mL NS/D5W", "0.01 - 0.1 mcg/kg/min", "1 mcg/mL" ],
                    ["<a href=\"drugKey=dobutamine\">*DOBUTamine</a>\n< 1.5 kg", "12.5 mg", "25 mL D5W", "0.01 - 20 mcg/kg/min", "0.5 mg/ml"],
                    ["<a href=\"drugKey=dobutamine\">*DOBUTamine</a>\n1.5 - < 3kg", "25 mg", "25 mL D5W", "0.01 - 20 mcg/kg/min", "1 mg/ml"],
                    ["<a href=\"drugKey=dobutamine\">*DOBUTamine</a>\n> 3 kg", "50 mg", "25 mL D5W", "0.01 - 20 mcg/kg/min", "2 mg/ml"],
                    ["<a href=\"drugKey=dopamine\">*DOPamine</a>", "20 mg", "25 ml D5W", "0.01 - 20 mcg/kg/min", "800 mcg/mL"],
                    ["<a href=\"drugKey=dopamine\">*DOPamine</a>\n1.5 - 5 kg", "40 mg", "25 ml D5W", "0.01 - 20 mcg/kg/min", "1600 mcg/mL"],
                    ["<a href=\"drugKey=epinephrine\">*EPINEPHrine</a>", "0.05 mg", "25 mL D5W", "0.01 - 1.0 mcg/kg/min", "2 mcg/ml"],
                    ["<a href=\"drugKey=fentanyl\">FentaNYL</a>", "62.5 mcg", "25 mL D5W", "0.01 - 2 mcg/kg/hr", "2.5 mcg/ml"],
                    ["<a href=\"drugKey=fentanyl\">FentaNYL</a>\n> 1.5 kg", "125 mcg", "25 mL D5W", "0.01 - 2 mcg/kg/hr", "5 mcg/ml"],
                    ["<a href=\"drugKey=midazolam\">Midazolam</a>\n< 2.5 kg", "1.25 mg", "25 mL D5W", "0.01 - 1 mcg/kg/min", "50 mcg/mL"],
                    ["<a href=\"drugKey=midazolam\">Midazolam</a>\n> 2.5 kg", "5 mg", "25 mL D5W", "0.01 - 1 mcg/kg/min", "200 mcg/mL"],
                    ["<a href=\"drugKey=morphine\">Morphine</a>\n< 5 kg", "1 mg", "25 mL D5W", "0.01 - 20 mcg/kg/hr", "40 mcg/mL"]
                ],
                [
                    ["<b>Paediatric and neonatal medication infusions are mixed in syringes</b>"]
                ],
                [
                    ["<section><bg=#ffc001ff><center><b>IV Administration Filter Table</b></center>", ""],
                    ["<b>Medication</b>", "<b>Recommended In-Line Filter Size</b>"],
                    ["<a href=\"drugKey=phenytoin\">Phenytoin</a>", "0.22 micron" ],
                    ["<a href=\"drugKey=phenobarbital\">Phenobarbital</a>", "0.22 micron" ],
                    ["<a href=\"drugKey=amiodarone\">Amiodarone</a>", "0.22 micron" ],
                    ["<a href=\"drugKey=mannitol\">Mannitol (20%)</a>", "0.22 micron" ],
                    ["<a href=\"drugKey=fat_emulsion\">Fat Emulsion (20%)</a>", "0.22 micron" ]
                ]
            ]
        },
        {
            "key" : "ped_vital_signs",
            "title" : "Guideline for Paediatric Vital Signs/Tube Sizes",
            "type" : "document",
            "content" :
            [
                [
                    ["<section><section_width=600><b>Age</b>", "<b>Wt (kg)</b>", "<b>HR</b>", "<b>BP</b>", "<b>ETT</b>", "<b>NG (FR)</b>", "<b>Foley (FR)</b>", "<b>Angio (FR)</b>"],
                    ["Birth-28 days", "3.5", "90-140", "65/40", "2.5-3.5", "8", "6", "24"],
                    ["1 month", "variable", "115-190", "80/50", "3.5", "8", "6", "24"],
                    ["3 months", "5.5", "110-180", "85/50", "3.5", "8", "8", "24"],
                    ["6 months", "7.5", "110-180", "90/55", "3.5-4.0", "10", "8", "22"],
                    ["1 year", "10", "110-160", "90/55", "4.0", "10", "8", "22"],
                    ["3 years", "15", "90-150", "92/55", "4.5", "10", "8", "22"],
                    ["5 years", "20", "80-150", "95/58", "5.0-5.5", "10", "10", "22"],
                    ["10 years", "30", "60-110", "100/62", "6.5-7.0", "10", "10", "20"],
                    ["12 years", "40", "55-110", "110/65", "7.0", "10", "10", "20"]
                ],
                [
                    ["<b>Initial endotracheal tube insertion depth ('tip to lip') for orotracheal intubation</b>"]
                ],
                [
                    ["<section><b>Gestation (weeks)</b>", "<b>Endotracheal tube insertion depth at lips (cm)</b>", "<b>Baby's Weight (grams)</b>"],
                    ["23-24", "5.5", "500-600"],
                    ["25-26", "6.0", "700-800"],
                    ["27-29", "6.5", "900-1000"],
                    ["30-32", "7.0", "1,100-1,400"],
                    ["33-34", "7.5", "1,500-1,800"],
                    ["35-37", "8.0", "1,900-2,400"],
                    ["38-40", "8.5", "2,500-3,100"],
                    ["41-43", "9.0", "3,200-4,200"]
                ],
                [
                    ["Adapted from Kempley ST, Moreira JW, Petrone FL. Endotracheal tube length for neonatal intubation. Resuscitation. 2008;77(3):369-373"]
                ],
                [
                    ["<tab1>• Mean Arterial Pressure (MAP) is variable based on patient age and cuff size, systolic blood pressure is less impacted by this, therefore thresholds for blood pressure interventions or precautions are based on systolic pressure in the < 12 years or < 40 kg paediatric population\n• Blood pressures listed in the table above are within the 50 percentile for age/weight\n• BroselowTM/paediatric tape version acceptable\n• ETT size formula: one year of age or more:</tab1><tab2>\no Uncuffed = (Age in years)/4) + 4 = tube size in mm\no Cuffed=(Age in years)/4) + 3.5 = tube size in mm\no Cuffed ETT’s can be used in any pediatric patient except newborns</tab2>"]
                ]
            ]
        },
        {
            "key" : "ped_medication_list",
            "title" : "Paediatric Medication List",
            "type" : "document",
            "content" :
            [
                [
                    ["<section><b><left><width=130>Medication</left></b>", "<b>PCP(f)</b>", "<b>ACP(f)</b>", "<width=30><b>CCP</b>", "<b>PCCP/PCCN</b>"],
                    ["3% Saline", "", "√", "√", "√"],
                    ["Acetaminophen", "√", "√", "√", "√"],
                    ["Acetylcysteine Sodium", "", "√", "√", "√"],
                    ["Acetylsalicylic Acid", "√", "√", "√", "√"],
                    ["Activated Charcoal", "", "√", "√", "√"],
                    ["Acyclovir", "", "√", "√", "√"],
                    ["Adenosine", "", "√", "√", "√"],
                    ["Amiodarone", "", "√", "√", "√"],
                    ["Ampicillin", "", "√", "√", "√"],
                    ["Atropine", "", "√", "√", "√"],
                    ["Calcium Chloride", "", "√", "√", "√"],
                    ["Calcium Gluconate", "", "√", "√", "√"],
                    ["Cefazolin", "", "√", "√", "√"],
                    ["Ceftriaxone", "", "√", "√", "√"],
                    ["Cisatracurium", "", "", "√", "√"],
                    ["Clopidogrel", "", "√", "√", ""],
                    ["D10/25/50W", "", "√", "√", "√"],
                    ["Dexamethasone", "", "√", "√", "√"],
                    ["Diazepam (IV & PR)", "", "√", "√", "√"],
                    ["Digitalis", "", "", "√", "√"],
                    ["dimenhyDRINATE (IV)", "", "√", "√", "√"],
                    ["dimenhyDRINATE (PO & IM)", "√", "√", "√", "√"],
                    ["diphenyDRAMINE", "√", "√", "√", "√"],
                    ["DOBUTamine", "", "", "√", "√"],
                    ["DOPamine", "", "√", "√", "√"],
                    ["EPINEPHrine (IM & Nebulized)", "√", "√", "√", "√"],
                    ["EPINEPHrine (IV Push ONLY for Paediatric Advanced Life Support {i.e. arrest and bradycardia with poor perfusion} and Neonatal Resuscitation)", "", "√", "√", "√"],
                    ["EPINEPHrine (IV Push in Non-Arrest)", "", "", "√", "√"],
                    ["EPINEPHrine (IV Infusion)", "", "", "√", "√"],
                    ["Ergonovine", "", "", "√", "√*"],
                    ["Esmolol HCL", "", "", "√", "√"],
                    ["Etomidate", "", "", "√", "√"],
                    ["fentaNYL", "", "√", "√", "√"],
                    ["Flumazenil", "", "√", "√", "√"],
                    ["Fomepizole", "", "√", "√", "√"],
                    ["Fosphenytoin", "", "√", "√", "√"],
                    ["Furosemide", "", "√", "√", "√"],
                    ["Gentamycin", "", "√", "√", "√"],
                    ["Glucagon (IM)", "√", "√", "√", "√"],
                    ["Glucagon (IV)", "", "√", "√", "√"],
                    ["Haloperidol", "", "√", "√", "√"],
                    ["Hemabate", "", "", "√", "√*"],
                    ["Heparin", "", "√", "√", "√"],
                    ["hydrALAZINE", "", "", "√", "√"],
                    ["Ibuprofen", "√", "√", "√", "√"],
                    ["Insulin", "", "√", "√", "√"],
                    ["Intralipid", "", "", "√", "√"],
                    ["Ipratropium Bromide", "", "√", "√", "√"],
                    ["Isoproterenol", "", "", "√", "√"],
                    ["Kayexalate", "", "√", "√", "√"],
                    ["Ketamine", "", "√", "√", "√"],
                    ["Ketorolac (IM)", "√", "√", "√", "√"],
                    ["Labetalol", "", "√", "√", "√"],
                    ["Lidocaine (IV & Topical)", "", "√", "√", "√"],
                    ["LORazepam", "", "√", "√", "√"],
                    ["Magnesium Sulphate", "", "√", "√", "√"],
                    ["Mannitol 20%", "", "√", "√", "√"],
                    ["methylPREDNISolone ACEtate", "", "√", "√", "√"],
                    ["Metronidazole", "", "√", "√", "√"],
                    ["Midazolam", "", "√", "√", "√"],
                    ["Milrinone", "", "", "√", "√"],
                    ["Morphine Sulphate", "", "√", "√", "√"],
                    ["Naloxone (IM)", "√", "√", "√", "√"],
                    ["Naloxone (IV)", "", "√", "√", "√"],
                    ["niFEDIPine", "", "√", "√", "√"],
                    ["Nitroglycerin (IV & Topical)", "", "√", "√", "√"],
                    ["Nitroglycerin (SL)", "√", "√", "√", "√"],
                    ["Norepinephrine", "", "√", "√", "√"],
                    ["Octaplex", "", "√", "√", "√"],
                    ["Octreotide", "", "√", "√", "√"],
                    ["Ondansetron", "", "√", "√", "√"],
                    ["Oxytocin", "", "√", "√", "√*"],
                    ["Pantoprazole", "", "√", "√", "√"],
                    ["PHENObarbitol", "", "", "√", "√"],
                    ["Phentolamine", "", "√", "√", "√"],
                    ["Phenylephrine", "", "", "√", "√"],
                    ["phenyTOIN", "", "√", "√", "√"],
                    ["Potassium Chloride", "", "√", "√", "√"],
                    ["Procainamide", "", "", "√", "√"],
                    ["Propofol", "", "", "√", "√"],
                    ["Prostaglandin E1", "", "", "", "√"],
                    ["Rocuronium", "", "√", "√", "√"],
                    ["Salbutamol (IV)", "", "", "√", "√"],
                    ["Salbutamol (Nebulized & MDI)", "√", "√", "√", "√"],
                    ["Sodium Bicarbonate", "", "√", "√", "√"],
                    ["Succinylcholine", "", "", "√", "√"],
                    ["Thiamine", "", "√", "√", "√"],
                    ["Ticagrelor", "", "√", "√", ""],
                    ["Tobramycin", "", "√", "√", "√"],
                    ["Tranexamic Acid (TXA)", "", "√", "√", "√"],
                    ["Vancomycin", "", "√", "√", "√"],
                    ["Vasopressin", "", "", "√", "√"],
                    ["Vecuronium", "", "√", "√", "√"],
                    ["Vitamin K", "", "√", "√", "√"]
                ],
                [
                    ["<b>PCP(f): Primary Care Flight Paramedic</b>"],
                    ["<b>ACP(f): Advanced Care Flight Paramedic</b>"],
                    ["<b>CCP: Critical Care Paramedic</b>"],
                    ["<b>PCCP/PCCN: Paediatric Critical Care Paramedic / Paediatric Critical Care Nurse</b>"]
                ],
                [
                    ["*selected CCP/PCCPs/PCCNs only"]
                ]
            ]
        },
        {
            "key" : "ped_procedure_list",
            "title" : "Paediatric Procedure List",
            "type" : "document",
            "content" :
            [
                [
                    ["<section><b>Legend: M - Monitoring, I - Initiation (includes troubleshooting), T - Troubleshooting (includes monitoring)</b>"]
                ],
                [
                    ["<section><section_width=435><b><left>Procedure</b>", "<width=45><center><b>PCP(f)</b>", "<width=45><center><b>ACP(f)</b>", "<width=45><center><b>CCP</b>", "<width=45><center><b>PCCP/PCCN</b>"],
                    ["Arterial line monitoring (transduce & blood sampling)", "", "T", "T", "T"],
                    ["Advanced Airway Management: Bougie, Direct or Video Laryngoscopy (VL)", "", "I", "I", "I"],
                    ["Bimanual uterine massage", "", "", "I", "I*"],
                    ["BiPAP/NPPV", "", "I", "I", "I"],
                    ["Blood analysis (iSTAT)", "", "I", "I", "I"],
                    ["Blood product transfusion", "", "I", "I", "I"],
                    ["Blood sampling-Peripheral venous and capillary", "", "I", "I", "I"],
                    ["Brandt maneuver", "", "", "I", "I*"],
                    ["Cardiac ECG monitoring and interpretation ‐ Lead II", "I", "I", "I", "I"],
                    ["Cardiac ECG monitoring and interpretation ‐ All leads including 12 & 15", "", "I", "I", "I"],
                    ["Chest drainage systems", "", "T", "T", "T"],
                    ["Chest x‐ray or CXR interpretation", "", "I", "I", "I"],
                    ["Doppler ultrasound assessment", "", "I", "I", "I"],
                    ["Endotracheal suctioning and maintenance", "I", "I", "I", "I"],
                    ["ETCO2 capnography (intubated & non‐intubated patients)", "", "I", "I", "I"],
                    ["External defibrillation ‐ Semi‐automatic", "I", "I", "I", "I"],
                    ["External defibrillation ‐ Manual", "", "I", "I", "I"],
                    ["Field extubation", "", "I", "I", "I"],
                    ["Foreign body removal (with McGill forceps)", "", "I", "I", "I"],
                    ["Gastric intubation", "M", "I", "I", "I"],
                    ["Intraosseous (IO) Initiation (EZ-IO & manual type)", "", "I", "I", "I"],
                    ["Intubation ‐ Nasotracheal", "", "I", "I", "I"],
                    ["Intubation ‐ Orotracheal", "", "I", "I", "I"],
                    ["Intravenous initiation (peripheral, external jugular & infant scalp vein)", "", "I", "I", "I"],
                    ["Lab value interpretation", "", "I", "I", "I"],
                    ["Manometer for positive pressure ventilation", "I", "I", "I", "I"],
                    ["Mechanical ventilation for patients weighing ≤ 5 kg", "", "", "I", "I"],
                    ["Mechanical ventilation for patients weighing > 5 kg (LTV 1200)", "", "I", "I", "I"],
                    ["Multi‐channel infusion pump/syringe", "", "I", "I", "I"],
                    ["Needle thoracostomy", "", "I", "I", "I"],
                    ["Obstetrics:\n External uterine massage\nGaskin maneuvre\nH.E.L.P.E.R. maneuvers (shoulder dystocia)\nMariceau-Smellie-Veit maneuvr\nMcRoberts maneuvre\nUmbilical cord management", "I", "I", "I", "I"],
                    ["Rapid Sequence Intubation or RSI", "", "", "I", "I"],
                    ["Reverting uterine inversion", "", "", "I", "I*"],
                    ["Supraglottic Airway (SGA)", "I", "I", "I", "I"],
                    ["Synchronized cardioversion", "", "I", "I", "I"],
                    ["Tracheostomy care:\nMaintenance & Emergency Reinsertion/Intervention", "I", "I", "I", "I"],
                    ["Transcutaneous Pacing", "", "I", "I", "I"],
                    ["Transport Isolette ‐ Care of a neonate", "", "I", "I", "I"],
                    ["Transvenous Pacing", "", "", "T", "T"],
                    ["Umbilical vein catheterization or UVC", "", "I", "I", "I"],
                    ["Urinary catheterization", "M", "I", "I", "I"],
                    ["Vascular access - Arterial stab", "", "", "", "I*"],
                    ["Vascular access - Central venous catheter (other than IO)", "", "M", "M", "M"],
                    ["Vascular access - Peripheral venous and Capillary", "", "I", "I", "I"]
                ],
                [
                    ["<b>PCP(f): Primary Care Flight Paramedic</b>"],
                    ["<b>ACP(f): Advanced Care Flight Paramedic</b>"],
                    ["<b>CCP: Critical Care Paramedic</b>"],
                    ["<b>PCCP/PCCN: Paediatric Critical Care Paramedic / Paediatric Critical Care Nurse</b>"]
                ],
                [
                    ["*selected CCP/PCCPs/PCCNs only"]
                ]
            ]
        },
        {
            "key" : "version",
            "title" : "Version",
            "type" : "document",
            "content" :
            [
                [
                    ["Ornge Medical Directives App version 1.2 build 0, last updated August 10, 2020"]
                ]
            ]
        }
    ]
}


